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ABSTRACT 
 
 
Virulence Regulation in Pseudomonas aeruginosa via the Regulators, AlgU and AlgR, 
Posttranscriptional Regulator, RsmA, & Two-component System, AlgZ/R 
 
by 
 
Sean Denver Stacey  
 
Pseudomonas aeruginosa is a Gram-negative bacillus able to colonize a wide variety of 
environments.  In the human host, P. aeruginosa can establish an acute infection or persist and 
create a chronic infection.  P. aeruginosa is able to establish a niche and persist in human hosts 
by using a wide array of virulence factors used for: movement, killing host cells, and evading 
immune cells and antibiotics.  Understanding virulence factors and their regulation has proved to 
be an important means of combating the morbidity and mortality of P. aeruginosa as well as the 
ever-increasing threat of drug resistance.  By targeting virulence factors or their regulators with 
antivirulence compounds, the bacterium is rendered defenseless and more readily cleared by the 
immune system.  In this study, we examine three different contributors to virulence factor 
regulation.  First, we examined the role of the extracellular sigma factor AlgU and its 
contribution to regulating a post-transcriptional RsmA.  AlgU is most commonly active in 
chronic infecting strains that produce copious amounts of the virulence factor, alginate.  We 
confirmed that not only was their more RsmA in this background, but that there was a previously 
unidentified promoter for rsmA regulated by AlgU.  In concert with this study, we followed up 
by studying the effects of AlgR on this unknown promoter.  AlgU and AlgR are known to work 
together, specifically on the alginate operon, and we hypothesized based off of bioinformatics 
data this was the case with RsmA.  Second, due to increased RsmA in this chronic infection 
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strain, we set out to identify potential unknown virulence targets of RsmA.  A previously 
unrevealed target, pasP, was shown to directly interact with RsmA.  Third, in an acute infection 
model strain we identified a new regulatory loop involving the two-component system AlgZ/R.  
In a pilW strain deficient in the motility virulence factor type IV pili, we showed increased levels 
of AlgZ/R compared to wildtype, PAO1.  The pilW strain produced less pyocyanin, rhamnolipid, 
and elastase and was attenuated in J774a.1 macrophages.  Overall, these studies push the 
understanding of virulence factor regulation and open the door to potential therapeutic targets in 
treating P. aeruginosa infections. 
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CHAPTER 1 
 
INTRODUCTION 
 
Pseudomonas aeruginosa 
 P. aeruginosa is most commonly known as an opportunistic pathogen.  The Gram 
negative, bacillus P. aeruginosa can also colonize any tissue in the human host (Figure 1).  In 
nature, P. aeruginosa can be found in a variety of environments from soil to water.  
Besides humans, P. aeruginosa is a known pathogen to plants, insects, and other animals.  As an 
opportunistic pathogen P. aeruginosa preys on hosts with compromised immune systems, which 
includes individuals with HIV/AIDS, on chemotherapeutic regimens,  burns on a majority of 
their body,  type II diabetes, or cystic fibrosis.   P. aeruginosa causes infections in human hosts 
with optimal immune systems too.  The bacterium is known to cause ear infections in swimmers 
as well as “hot tub rash,” which is widespread folliculitis, due to a hot tub or pool not being 
properly treated.   Pseudomonas aeruginosa has a long history as a hospital acquired infectious 
 
Figure 1.1 Gram Stain (left) and Transmission micrograph (right) of 
Pseudomonas aeruginosa 
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agent and continues today to be a leader in morbidity and mortality from nosocomial infections.  
At the end of the 19th century, Pseudomonas aeruginosa née Bacillus pyocyaneus was isolated 
from the surgical wounds of two patients at a French hospital (Villavicencio 1998).   The 
bacterium was characterized based off the blue appearance from the purulent discharge of the 
patient’s wound and the rod-like shape under microscopic observation.  In modern day hospitals 
ventilator associated pneumonia (VAP) due to P. aeruginosa has a 30% mortality rate (Gellatly 
and Hancock 2013).  P. aeruginosa is also the leading cause of morbidity and mortality in 
patients with cystic fibrosis (CF) (Salunkhe et al. 2005).  P. aeruginosa produces a resilient 
biofilm that aids in colonizing the endotracheal tube of ventilated patients or the CF lung.  This 
biofilm is also important in establishing a niche in catheter associated urinary tract infections 
(CAUTI).  As technology has advanced in treating microbial infections, so has the ability for P. 
aeruginosa to evade antibiotics and continue to infect hospital patients.   
Pseudomonas Pathogenesis 
 The versatility of P. aeruginosa to thrive in a variety of environments and infect so many 
different hosts can be found in its ability to switch between planktonic and sessile states.  As the 
bacterium scavenges for nutrients or a new niche P. aeruginosa will exhibit a number of 
structures used for locomotion, attachment, and obtaining foodstuffs (Moradali et al. 2017; 
Valentini et al. 2018).  This Pseudomonad state is also believed to represent the phenotype of 
establishing an acute infection (Figure 1.2) (Luo et al. 2015; Valentini et al. 2018).  The 
bacterium will use its flagellum and type IV pili (TFP) to adhere to a surface or host cell and 
proceed to lay down on the surface (Luo et al. 2015).  From here, the bacterium will cease to 
express the structures most recognized by the host 
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immune response and begin to reproduce and express various other weapons or virulence factors 
for uptake of nutrients (Gellatly and Hancock 2013; Valentini et al. 2018).  Over time the 
bacteria will transition from the planktonic to sessile phenotype.  The sessile state of the bacteria 
will produce compounds that will deter the inflammation response and immune cells to target P. 
aeruginosa (Gellatly and Hancock 2013; Valentini et al. 2018).  As the chronic infection 
develops, the bacteria will express even fewer recognized targets of the immune system to curb 
the inflammation response (Gellatly and Hancock 2013; Valentini et al. 2018).  In some cases, 
chronic P. aeruginosa infections have lasted for over 20 years (Gellatly and Hancock 2013). A 
number of researchers have mapped out some hierarchal pathways for both acute and chronic 
virulence factors, but there are still holes and question marks to be completed.  By understanding 
the role virulence factors help in the two phenotypic states of P. aeruginosa, better ways to 
prevent acute infections or ameliorate chronic infections can be discovered.  
Virulence Factors 
 P. aeruginosa  has one of the most well stocked caches of virulence factors of any 
bacterium.  P. aeruginosa can thrive in most environments and colonize any host tissue due to its 
wide array of weaponry.  P. aeruginosa asserts dominance over other species of bacteria by 
 
Figure 1.2. Generalization of Pseudomonas aeruginosa  attachment, initiating and 
establishing an acute infection, and development of a chronic infection. 
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injecting toxins into competitors via the type VI secretion system, sequestering iron with 
siderophores, and secreting a force field of exopolysaccharide that protects from phagocytosis 
and antibiotics (Gellatly and Hancock 2013; Park et al. 2014; Valentini et al. 2018).  P. 
aeruginosa has also developed a series of ways around antibiotics besides the exopolysaccharide 
alginate like: drug efflux pumps,  modified surface receptors and beta-lactamases (Moradali et al. 
2017).  These enhancements have been either acquiring foreign plasmid DNA or mutations that 
enhance resistance (Moradali et al. 2017).  However, understanding the role P. aeruginosa uses 
its virulence factors can lead to new ways to target and disarm this pathogen.   
Secretion Systems 
 In Gram negative organisms there is no ATP energy available inside of the periplasmic 
space, so transport of virulence factors out of the cell the bacteria will use a variety of secretion 
systems (Costa et al. 2015; Green and Mecsas 2016).  P. aeruginosa has multiple secretion 
systems, but lacks a type IV secretion system, which is commonly used by bacteria to inject 
DNA or DNA-protein complexes into host cells (Costa et al. 2015).  P. aeruginosa uses multiple 
type I, type II, and type V secretion systems to secrete proteases, adhesins, and other enzymatic 
proteins (Filloux 2011).  However, the most well studied secretion systems in P. aeruginosa are 
the type III and type VI.   
 The type III secretion system (T3SS) has been shown to have homology to the bacteria 
flagellar apparatus, but serves a completely different purpose in pathogenesis (Green and Mecsas 
2016).  Once P. aeruginosa contacts the host cell surface the T3SS is used to compromise the 
cell membrane.  The needle-like apparatus pierces the membrane and will inject a series of 
toxins, some of which are extremely lethal (Filloux 2011; Gellatly and Hancock 2013).  Multiple 
studies have shown the importance of the T3SS’s importance in virulence of P. aeruginosa and 
 20 
establishing an acute infection (Anderson et al. 2010; A.K. Jones et al. 2010; Filloux 2011; 
Schulmeyer and Yahr 2017).   
 The type VI secretion system (T6SS) is another needle-like appendage P. aeruginosa 
uses for injecting toxins.  The T6SS is homologous to the T4-bacteriophage tail spike and used in 
a similar fashion (Green and Mecsas 2016).  Uniquely, P. aeruginosa has three T6SS that have 
not been completely characterized fully, although it is believed one is for harming host cells 
(T6SS-2) while the first identified T6SS-1 is used to inject toxins into nearby bacteria (Filloux 
2011 Jul 16; Costa et al. 2015; Green and Mecsas 2016).  P. aeruginosa has one of the most 
lethal identified T6SS in Eubacteria, even dominating Vibrio cholera (Basler et al. 2013).  The 
genetic loci for the T6SS also include antitoxins so that sister cells that may be fired upon do not 
lyse from injection of toxins (Filloux 2011). The T6SS-1 is also characterized as a chronic 
virulence factor (Valentini et al. 2018). P. aeruginosa uses secretion systems like the T6SS and 
T3SS to dominate its niche amongst other microbiota, pathogens, or host cells.   
Secreted Virulence Factors 
 Besides using secretion systems, P. aeruginosa can use various membrane transporters or 
even outer membrane vesicles to release virulence factors into the extracellular milieu.  
Exopolysaccharides are used for a variety of functions to help P. aeruginosa persist in its 
environment.   P. aeruginosa secretes three types of exopolysaccharide that contribute to biofilm 
formation: alginate, pel, and psl.  Alginate is a combination of beta-D-mannuornic and alpha-L-
guluronic acids that has a overall negative charge and the consistency of mucus(Moradali et al. 
2017).  Alginate not only shields the bacteria from antibiotics, but also causes frustrated 
phagocytosis because the pseudopods of the immune cell cannot wrap around the biofilm 
protected colony of cells (Lee et al. 2011; Moradali et al. 2017).  Most commonly, P. aeruginosa 
 21 
isolates from CF sputum undergo phenotypic shifts where the strains will produce copious 
amounts of alginate. 
 While alginate production is clearly seen on a plate, P. aeruginosa PAO1 still produces 
biofilms from the exopolysaccharides pel and psl (Figure 1.3).  Pel has been 
characterized to have an overall positive charge has consists of linked N-acetylgalactosamine and 
N-acetylglucosamine (Moradali et al. 2017).  Psl contains rhamnose, glucose, and mannose with 
an overall neutral charge (Moradali et al. 2017).  Psl has also been shown to be regulated by the 
transcriptional regulator AmrZ, as well as the sigma factor RpoS and post-transcriptionally by 
RsmA (Irie et al. 2010; C.J. Jones et al. 2013).  RpoS is considered the stress response sigma 
factor (Potvin et al. 2008).  If P. aeruginosa is under attack by the innate immune response, 
biofilm production is a means of resisting the siege. 
 
Figure 1.3 Nonmucoid (PAO1) and mucoid (mucA22) strains of Pseudomonas 
aeruginosa on Pseudomonas isolation agar. 
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 While most proteases are large and require secretion systems, there are other secreted 
virulence factors besides biofilm components that are secreted by diffusion or efflux pumps.  
Pyoveridine is a compound secreted by the efflux pump PvdRT/OmpQ system (Moradali et al. 
2017).  Pyoveridine acts as an iron chelator in order for P. aeruginosa to acquire exogenous iron 
from a host (Moradali et al. 2017; Little et al. 2018).   Pyoveridine also reacts under ultraviolet 
light and can be used as a biomarker for Pseudomonas infections (Yin et al. 2014; Norbury et al. 
2016).  Hydrogen cyanide is a virulence factor produced by P. aeruginosa that is able to diffuse 
across its membrane and the membrane of host cells (Moradali et al. 2017).  Hydrogen cyanide is 
a secreted weapon that compromises cellular respiration in host cells, limiting the ability for 
immune cells to attack (Gellatly and Hancock 2013; Moradali et al. 2017). RsmA has been 
shown to post-transcriptionally regulate hydrogen cyanide production in nonmucoid/acute 
infection strains, but in mucoid/chronic infection strains (Burrowes et al. 2006; Brencic and Lory 
2009; Stacey et al. 2017).  Secreted virulence factors are important for P. aeruginosa to establish 
and persist in a host or natural environment. 
Motility Virulence  
 The most important virulence factors are those involved in motility.  P. aeruginosa has a 
single polar flagellum, type IV pili, and produces surfactants called rhamnolipids for the ability 
to move across surfaces and swim in aqueous environments (Okkotsu et al. 2013; Kazmierczak 
et al. 2015; Moradali et al. 2017).  The flagellum has been shown not only important in motility, 
but also has the ability to aid in surface attachment (Kazmierczak et al. 2015).  The 
Pseudomonas flagellum is considered an acute virulence factor because it is solely expressed 
when the bacterium is searching to establish a niche in the environment (Kazmierczak et al. 
2015; Valentini et al. 2018).  
 23 
 Touch is crucial for P. aeruginosa to take advantage of its environment and that is 
exactly what the type IV pili is used.  Type IV pili are localized like the flagellum at the poles of 
the cell (Gellatly and Hancock 2013).  The apparatus can be extended or retracted out of the cell 
and has an adhesin at the tip called PilY1 (Giltner et al. 2010; Kazmierczak et al. 2015).  The 
stalk is comprised of a major pilin unit, PilA, and several minor pilin subunits, FimUPilVWXE 
(Giltner et al. 2010).  Minor pilin mutants have been shown to have decreased virulence but the 
implications as to why have not been elucidated (Siryaporn et al. 2014; Luo et al. 2015; Marko et 
al. 2017).  It is hypothesized that the type IV pili act not only as a mechanosensory system, but 
also relay expression of the sessile-phenotype upon touching a surface (Siryaporn et al. 2014; 
Kazmierczak et al. 2015; Luo et al. 2015; Marko et al. 2017).  Marko et al. allude that there is 
influence of minor pilins on AlgZ, but to what effects have not been clarified (Marko et al. 
2017).   
Virulence Regulation 
 P. aeruginosa virulence is more complicated than just identifying virulence genes.  
Understanding the regulation of virulence factors proves to be just as important.  Virulence 
factor regulation can in some cases consist of global networks activating , repressing or co-
regulating targets.   Virulence mechanisms can consist of cascades that go from a chemical signal 
sensed from outside the bacterium to the P. aeruginosa reacting, producing, and secreting a 
toxin.  Luo et al. has shown that upon contact with a surface, the type IV pili will activate the 
diguanylate cyclase SadC to start producing cyclic di-GMP and in turn produce a biofilm (Luo et 
al. 2015).  Knowledge of virulence regulation has potential for chemotherapeutic treatments to 
exploit P. aeruginosa and turn virulence weaponry on itself.   
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Sigma Factor 
 A sigma factor is the variable portion of the RNA polymerase holoenzyme to initiate 
transcription of a gene (Potvin et al. 2008).  In P. aeruginosa there are a variety of sigma factors 
used for the expression of virulence factors, while most housekeeping genes and core metabolic 
processes are regulated by the main sigma 70, RpoD (Potvin et al. 2008).  There are specific 
sigma factors in P. aeruginosa for expressing flagella, FliA, and nitrogen metabolism, RpoN 
(Potvin et al. 2008).  Another type of alternative sigma factor is the extracytoplasmic function 
(ECF) sigma factors.  These sigma factors will respond to extracellular signals or stresses and 
lead to the expression of protective targets (Potvin et al. 2008). 
 
 The most important ECF sigma factors involved with P. aeruginosa infections in the 
cystic fibrosis lung is AlgU.  AlgU is normally sequestered by the anti-sigma factor, MucA, to 
the inner membrane (Potvin et al. 2008).  If any oxidative damage causes stress to the cell 
membranes or denatures MucA, then AlgU is released to activate its regulon.  A key component 
 
Figure 1.4 The alginate regulators, AlgU and AlgR, both converge on the algD 
promoter to activate alginate production in mucoid strains of Pseudomonas 
aeruginosa like the mucA22 strain. 
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of P. aeruginosa virulence and a chronic infection in the CF lung is the production of alginate 
(Hershberger et al. 1995; Gellatly and Hancock 2013).  Clinical isolates from CF sputum very 
often contain mutations in mucA (Potvin et al. 2008; Gellatly and Hancock 2013).  The algD 
operon is regulated by AlgU (Figure 1.4) (Hershberger et al. 1995).  AlgU has been shown to 
also regulate AmrZ, which inhibits flagellum biosynthesis and conceals the bacterium from 
immune cells (Tart et al. 2006).  Recently AlgU has been shown to regulate rsmA, in doing so, 
AlgU regulates hundreds of other targets via this post-transcriptional regulator (Stacey and 
Pritchett 2016).   
 
Post-Transcriptional Regulation 
 Bacteria use post-transcriptional regulation as a means to control translation of mRNA.  
Depending on the strain of P. aeruginosa there is up to three post-transcriptional regulators of 
secondary metabolites, RsmA/F/E (Lapouge, Sineva, et al. 2007; Schulmeyer et al. 2016).  These 
 
Figure 1.5 The post-transcriptional regulator RsmA inhibits translation 
in Pseudomonas aeruginosa by binding and blocking the ribosomal 
binding site of target messenger RNA. 
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regulators function by binding the ribosomal binding site (RBS) of the mRNA target (Figure 
1.5).  This site presents a binding motif usually consisting of AGGA on a stem-loop structure 
(Brencic and Lory 2009; Kulkarni et al. 2014).  In P. aeruginosa the action of RsmA binding the 
mRNA represses the translation of the target, which is believed to be RsmA’s sole function.  
However, the homolog of RsmA, CsrA, has been shown to interact with other proteins and 
positively influence mRNA targets(Wei et al. 2001; Mukherjee et al. 2011).  
 
 RsmA is part of a larger network of virulence regulation called the Gac/Rsm system 
(Figure 1.6).  In P. aeruginosa RsmA has two small noncoding RNA (ncRNA) antagonists, 
 
Figure 1.6  The Rsm/Gac hierarchy in Pseudomonas aeruginosa.  The two-
component system GacS/A activate the RsmA antagonists RsmY/Z.  The 
GacS/A system is inhibited by the hybrid sensor kinase, RetS.  RsmA is 
activated by two individual promoters.  In strains with mucA mutations, the 
extracytoplasmic sigma factor, AlgU, increases expression of RsmA at its distal 
promoter. 
 27 
RsmY and RsmZ (Janssen et al. 2018).  These ncRNAs are regulated by the response regulator, 
GacA, which is part of the GacS/A two-component system (TCS) (Lapouge, Schubert, et al. 
2007).  GacS responds to a still unknown signal and phosphorylates GacA that in turn activates 
expression of the ncRNAs (Lapouge, Sineva, et al. 2007).  An inhibitor of GacS 
autophosphorylation is the hybrid sensor kinase RetS.  RetS, the regulator of exopolysaccharide 
and T3SS, will heterodimerize with GacS prohibiting the phosphorylation event (Vakulskas et al. 
2015).  Contrary to RetS is the lost adherence sensor, LadS, which will assist GacS in activating 
the ncRNAs (Vakulskas et al. 2015).   
 The Gac/Rsm components are all crucial for virulence as both mutations in rsmA or gacA 
lead to attenuation(Lapouge, Schubert, et al. 2007; Gellatly and Hancock 2013; Vakulskas et al. 
2015; Valentini et al. 2018).  The Gac/Rsm system has also been shown to play an important role 
in shift from planktonic to sessile states or acute infection to chronic (Valentini et al. 2018).  
Removing any portion of the Gac arm of the network will produce an unregulated RsmA strain 
that expresses T3SS, flagellum, and type IV pili, while removing rsmA or retS will cause 
increase in biofilm and T6SS expression (Valentini et al. 2018).  As a result of either mutation 
the P. aeruginosa strain will be readily cleared by the host immune response.   
Two Component Systems 
 P. aeruginosa has over 60 two component systems in its genome (Francis et al. 2017).  A 
TCS consists of a sensor histidine kinase and a response regulator (Figure 1.7).  These 
components are highly conserved and are usually arranged in an operon together (Galperin et al. 
2016; Francis et al. 2017).  The sensor will received an extracellular signal and 
autophosphorylate itself, this phosphate will then be transferred from the histidine residue to the 
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aspartate residue of the response regulator (Podgornaia and Laub 2013).  Once phosphorylated, 
the response regulator will then activate the expression of its target genes.   
 The AlgZ/R two-component system has been shown to target multiple virulence genes in 
P. aeruginosa.  The algZ/R loci are located in an operon and shown to be regulated by the 
virulence factor regulator, Vfr (Luo et al. 2015) (Figure 1.8).  Upon phosphorylation, AlgR will 
activate expression of the minor pilin operon (Belete et al. 2008; Okkotsu et al. 2013).  However, 
conflicting studies show AlgR influencing rhamnolipid production and the Rhl quorum sensing 
system, which also controls pyocyanin and elastase (Morici et al. 2007; Okkotsu et al. 2013; 
Little et al. 2018).  AlgR when unphosphorylated can co-regulate with the ECF AlgU as seen in 
Figure 1.4 and 1.6 on the algD operon and rsmA (Salunkhe et al. 2005; Stacey et al. 2017).  Most 
 
 
Figure 1.7 A classical interpretation of a two-component system in Pseudomonas 
aeruginosa.  The sensor histidine kinase receives an external signal, which causes 
an autophosphorylation event from free ATP.  This phosphate group is then 
transferred to the sensor’s cognate response regulator at a conserved aspartate 
residue.  The activated regulator causes the expression of its regulon. 
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recently Luo et al. and Marko et al. have shown that the AlgZ/R TCS plays a larger role in P. 
aeruginosa pathogenesis.  Luo et al. demonstrated that the type IV pili regulated AlgZ/R has a 
feedback loop where by removing a minor pilin that expression of the minor pilin operon 
increased significantly (Luo et al. 2015).  Marko et al. also demonstrated via bacterial adenylate 
 
cyclase two hybrid system that AlgZ interacted with a portion of the minor pilins (Marko et al. 
2017).  The role of AlgZ/R is more complex than just regulating the minor pilin operon and may 
have greater implication in the mechanosensory network of the type IV pili.  
Antivirulence Therapeutics 
 Treating P. aeruginosa infections with conventional antibiotics has become increasingly 
difficult due to the bacterium’s ability to adapt and evolve like many other drug resistant 
 
 
 
Figure 1.8 The AlgZ/R two-component system in Pseudomonas aeruginosa.  Vfr 
regulated the algZ/R operon in P. aeruginosa.  The signal that activates the 
phosphorylation cascade of AlgZ is still unknown.  AlgZ phosphorylated AlgR at 
aspartate residue 54.  AlgR can control the expression of targets dependent and 
independent of phosphorylation. 
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bacteria.  A new means of eradicating P. aeruginosa infections is by targeting virulence factors 
with antivirulence chemotherapeutics.  Multiple researchers are investigating ways to inhibit 
aspects of P. aeruginosa’s ability to cause an infection by impairing different virulence factors.  
Novel targets include blocking adhesins from attaching to host cells, biofilm dispersal, and 
impairing the quorum sensing system, which all would lead to host clearance of P. aeruginosa 
(Fothergill et al. 2014).  Understanding virulence factor regulation is crucial for developing 
antivirulence compounds.  The regulation of the post-transcriptional regulator rsmA is 
characterized.  Upon discovery of the alginate regulators AlgU and AlgR contributing to RsmA 
levels, the RsmA regulon is characterized in a mucoid strain, mucA22.  Lastly, the role of AlgR 
on virulence in a minor pilin mutant, pilW, is characterized.  Overall, through the understanding 
of how these regulators contribute to virulence, there is potential to utilize and target these 
virulence factors as an vulnerability to help clear P. aeruginosa acute and chronic infections. 
 
Specific Aims 
Aim1: 
 
Analyze and characterize a potential second promoter upstream of the rsmA allele in 
Pseudomonas aeruginosa. 
 
Aim 2: 
 
Analyze and characterize the RsmA regulon in a mucA22 strain, since there is more RsmA made 
in a mucA22 strain of Pseudomonas aeruginosa due to the distal promoter. 
 
Aim 3: 
 
Analyze the expression and protein levels of the algZ/R operon in a pilW mutant and potential 
effects on virulence in Pseudomonas aeruginosa. 
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ABSTRACT 
 Pseudomonas aeruginosa thrives in multiple environments and is capable of causing life-
threatening infections in immunocompromised patients. RsmA is a posttranscriptional regulator 
that controls virulence factor production and biofilm formation. In this study, we investigated the 
expression and activity of rsmA and the protein that it encodes, RsmA, in P. aeruginosa mucA 
mutant strains, which are common in chronic infections. We determined that AlgU regulates a 
previously unknown rsmA promoter in P. aeruginosa. Western blot analysis confirmed that 
AlgU controls rsmA expression in both a laboratory strain and a clinical isolate. RNase 
protection assays confirmed the presence of two rsmA transcripts and suggest that RpoS and 
AlgU regulate rsmA expression. Due to the increased amounts of RsmA in mucA mutant strains, 
a translational leader fusion of the RsmA target, tssA1, was constructed and tested in mucA, 
algU, retS, gacA, and rsmA mutant backgrounds to examine posttranscriptional activity. From 
these studies, we determined that RsmA is active in mucA22 mutants, suggesting a role for 
RsmA in mucA mutant strains. Taken together, we have demonstrated that AlgU controls rsmA 
transcription and is responsible for RsmA activity in mucA mutant strains. We propose that 
RsmA is active in P. aeruginosa mucA mutant strains and that RsmA also plays a role in chronic 
infections.  
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IMPORTANCE 
 P. aeruginosa causes severe infections in immunocompromised patients. The 
posttranscriptional regulator RsmA is known to control virulence and biofilm formation. We 
identify a new rsmA promoter and determine that AlgU is important in the control of rsmA 
expression. Mutant mucA strains that are considered mucoid were used to confirm increased 
rsmA expression from the AlgU promoter. We demonstrate, for the first time, that there is RsmA 
activity in mucoid P. aeruginosa strains. Our work suggests that RsmA may play a role during 
chronic infections as well as acute infections.  
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INTRODUCTION  
 Pseudomonas aeruginosa produces a myriad of virulence factors and can cause both 
acute and chronic infections (1, 2). To survive and persist, P. aeruginosa must coordinate gene 
expression in response to changing environmental conditions. Global regulatory networks 
respond to changing environmental conditions to allow the physiological changes necessary for 
survival to be made. The P. aeruginosa genome encodes many global regulatory systems, 
including posttranscriptional regulators, such as RsmA. RsmA is important in regulating several 
virulence factors involved in acute and chronic infections (3).  
 Acute infections are characterized by motility and expression of the type III secretion 
system (4). RsmA positively regulates both motility and type III secretion system expression (4–
6). A defining characteristic of chronic infections is biofilm formation, which includes the 
production of exopolysaccharides, such as alginate, and the type VI secretion system (T6SS) (7, 
8). RsmA is a negative regulator of the exopolysaccharide gene psl and the first hemolysin-
coregulated secretion island type VI secretion system (HSI-I T6SS) (5, 8, 9). A characteristic of 
some P. aeruginosa isolates causing chronic infections, such as those found in cystic fibrosis 
patients, is alginate overproduction, which is the result of the extracytoplasmic sigma factor 
AlgU (7, 10).  
 AlgU is normally sequestered at the cytoplasmic membrane by the anti-sigma factor 
MucA (7, 10). MucA prevents AlgU from binding and activating target promoters (7, 10). Once 
liberated from MucA, AlgU activates a variety of genes, including those important for 
biosynthesizing alginate (7, 10–13). Strains overproducing alginate are termed mucoid. P. 
aeruginosa strains that initially colonize cystic fibrosis patients frequently evolve into strains that 
overproduce alginate, often because of mutations in the mucA gene (7, 10). A previous study 
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found that a mucA mutant has increased rsmA expression (14). Because mucA mutations lead to 
hyperactive AlgU (7, 10), we hypothesized that AlgU might regulate rsmA transcription.  
 RsmA is a global posttranscriptional regulator that regulates several mRNAs involved in 
virulence (5, 6). RsmA positively regulates type III secretion and type IV pilus production, both 
of which are important virulence factors for acute infections (6, 14). In the case of biofilm 
formation, RsmA inhibits exopolysaccharide production (5, 9). Therefore, RsmA is important in 
determining what virulence factors are expressed by P. aeruginosa. RsmA activity is regulated 
by two small RNAs, RsmY and RsmZ, that bind RsmA and prevent RsmA from binding target 
mRNAs (15). RsmY and RsmZ sequester RsmA, allowing the production of exopolysaccharides 
and other RsmA target mRNAs (9, 16). Increased RsmY and RsmZ levels or decreased RsmA 
activity can allow bio- film formation to occur. The expression of rsmY and rsmZ is positively 
controlled by RsmA, GacA, and LadS and negatively con- trolled by RetS (16–18). RsmA binds 
to highly conserved GGA motifs. Usually, one of the GGA motifs is found in a stem-loop 
structure formed near the ribosome-binding site (19). Multiple copies of the same GGA motif are 
also found in the inhibitory small RNAs RsmY and RsmZ (20, 21).  
 Although RsmA is important for virulence and global gene expression (5, 22, 23), little is 
known regarding the genetic controls governing rsmA expression. Currently, only a single rsmA 
promoter region, which resembles a s70 (RpoD) promoter, has been identified in P. aeruginosa 
(24–26). A recent chromatin immunoprecipitation sequencing study showed that both RpoD and 
RpoS likely control rsmA expression (27). However, another study found similar RsmA levels in 
both an rpoS mutant and the wild- type strain (9). Early studies found that optimal rsmA 
expression requires GacA and that rsmA expression increases throughout growth (28), findings 
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which support a role for RpoS in controlling rsmA expression. These seemingly contradictory 
data have not yet been clarified.  
 Given the importance of RsmA in controlling P. aeruginosa virulence and biofilm 
formation, there is a critical need to under- stand rsmA expression. In this study, we determined 
the genetic elements controlling rsmA expression. We identified a new promoter region and 
determined that AlgU and RpoS contribute to rsmA expression. Importantly, we demonstrate that 
RsmA is active in P. aeruginosa mucA mutants. This work suggests that RsmA has a role in 
regulating gene expression in mucA mutants and that AlgU is an important activator of rsmA 
expression.  
METHODS 
Strains, plasmids, and media 
 The strains used in this study are presented in Table 2.1. Escherichia coli strains were 
maintained on LB (Difco) plates or broth without or with antibiotics, as appropriate. 
Pseudomonas aeruginosa strains were grown on Pseudomonas isolation agar (PIA), LB medium, 
or Vogel-Bonner minimal medium (VBMM) supplemented with the appropriate concentrations 
of antibiotics. For E. coli, antibiotics were used at the following concentrations when 
appropriate: 10 mg/ml tetracycline, 15  mg/ml gentamicin, 100  mg/ml ampicillin, and 35  mg/ml 
kanamycin. For Pseudomonas strains, antibiotics were used at the following concentrations: 150  
mg/ml gentamicin, 50  mg/ml tetracycline, and 300  mg/ml carbenicillin. For allelic exchange, 
sucrose was supplemented at 10% in YT (1% tryptone and 0.5% yeast extract) medium.  
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Table 1. Strains and plasmids used in this study. 
Strain or Plasmid Genotype or Relevant properties Reference 
or Source 
E. coli strains   
 
NEB5α fhuA2 Δ(argF-lacZ) U169phoA, glnV44 
Φ80Δ(lacZ)M15 gyrA96 
New 
England 
Biolabs 
SM10 Thi thr leu tonA lacY supE recA::RP4-2-Tc::Mu 
KmR 
(59) 
pRK2013 Helper strain (31) 
pEX18Tc Allelic exchange vector (30) 
pEX18Gm Allelic exchange vector (30) 
∆rsmA pEX18Tc Allelic exchange for rsmA non-polar deletion This study 
∆algU pEX18Tc Allelic exchange for algU non-polar deletion (60) 
∆rpoS pEX18Tc Allelic exchange for rpoS non-polar deletion This study 
rsmAHA pEX18Gm Allelic exchange for rsmA HA allele This study 
miniCTXlacZ Transcriptional fusion vector (37) 
TF1-lacZ miniCTX Transcriptional fusion This study 
TF3-lacZ miniCTX Transcriptional fusion This study 
TF3USDM-lacZ 
miniCTX 
Site-directed mutagenesis transcriptional fusion This study 
TF2-lacZ Transcriptional fusion This study 
pTJ1 Integrating vector used for overexpression (43) 
algU pTJ1 (pAlgU) algU complementation/overexpression This study 
P. aeruginosa  
strains 
  
PAO1  Wild type (61) 
∆algU algU mutant (60) 
mucA22 mucA22 mutation (62) 
mucA22 ∆algU mucA22 strain, ∆algU This study 
2192  (45) 
383  (45) 
∆rsmA rsmA nonpolar deletion This study 
mucA22∆rsmA rsmA nonpolar deletion in mucA22 strain This study 
PAO1  
TF1-lacZ 
rsmA transcriptional fusion strain This study 
∆algU  
TF1-lacZ 
rsmA transcriptional fusion strain This study 
 
mucA22 
TF1-lacZ 
rsmA transcriptional fusion strain This study 
mucA22, ∆algU 
TF1-lacZ 
rsmA transcriptional fusion strain This study 
 
2192  rsmA transcriptional fusion strain This study 
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TF1-lacZ 
383 
TF1-lacZ 
rsmA transcriptional fusion strain This study 
383HA Nonmucoid clinical isolate with rsmAHA allele This study 
2192HA Mucoid clinical isolate with rsmAHA allele This study 
2192HAΔalgU 2192 with rsmAHA allele and algU deleted This study 
PAO1 
PE3-lacZ 
rsmA transcriptional fusion strain This study 
∆algU  
PE3-lacZ 
rsmA transcriptional fusion strain This study 
mucA22 
TF3-lacZ 
rsmA transcriptional fusion strain This study 
mucA22, ∆algU 
TF3-lacZ 
rsmA transcriptional fusion strain This study 
PAO1 
TF3USDM-lacZ 
Mutant rsmA transcriptional fusion strain This study 
∆algU 
TF3USDM-lacZ 
Mutant rsmA transcriptional fusion strain This study 
mucA22 
TF3USDM-lacZ 
Mutant rsmA transcriptional fusion strain This study 
mucA22, ∆algU 
TF3USDM-lacZ 
Mutant rsmA transcriptional fusion strain This study 
PAO1 TF2-lacZ rsmA transcriptional fusion This study 
mucA22 TF2-lacZ rsmA transcriptional fusion This study 
ΔalgU TF2-lacZ rsmA transcriptional fusion This study 
mucA22 ∆algU rsmA transcriptional fusion This study 
PAO1HA PAO1 with epitope tagged RsmA This study 
ΔalgUHA ΔalgU with epitope tagged RsmA This study 
mucA22HA mucA22 mutant with epitope tagged RsmA This study 
mucA22 ∆algUHA mucA22, ∆algU with epitope tagged RsmA This study 
PAO1HA pTJ1 PAO1 rsmAHA allele and vector pTJ1 alone This study 
PAO1HA palgU PAO1 rsmAHA allele and algU under pBAD 
promoter 
This study 
 
Strain construction 
 All PCR products were amplified from P. aeruginosa PAO1, unless otherwise noted, 
using Q5 polymerase (New England BioLabs [NEB], Ipswich, MA) and primers listed in Table 
2.2. Crossover PCR (splicing by overhang extension PCR) (29) was used to construct deletion 
mutations and to clone sequences into the suicide vector pEX18Tc or pEX18Gm (30). All cloned 
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constructs were confirmed via sequencing. P. aeruginosa strains were conjugated with E. coli as 
a donor strain and the pRK2013-containing helper strain (31). Conjugations were performed 
overnight on LB plates at 37°C, and the conjugants were plated on the appropriate selective 
medium to obtain single-crossover mutants. Merodiploids were grown without selection and then 
screened for sucrose sensitivity on YT medium–10% sucrose plates. Mutations were confirmed 
using PCR with primers containing the suffix intF and intR in Table 2.2 and sequencing of the 
resulting PCR fragment. Hemagglutinin (HA) tagging of the proteins was accomplished using 
primers containing the HA tag at the 3= end of the gene, and HA was introduced as described 
above using the suicide vector pEX18Gm.  
Table 2. Primers used in this study. 
 
 
Primer Name 
 
 
Sequence 
 
 
Use 
rsmARHindIII GCGCAAGCTTCACGCGAATATTTCAGGAC
AAC 
TF 
rsmAFHindIII GCGCAAGCTTCGGCAACATCACCACGCTG
G 
Mutant 
rsmARXbaI GCGCTCTAGAGCACGGTGATCCTGCAGAC
C 
Mutant 
rsmASOEF GCGTGAGGAGAAAGGAATGCTGCAT 
TAATTTTTATCTAATTTTCCCTTTGC 
Mutant 
rsmASOER GCAAAGGGAAAATTAGATAAAAATT 
AATGCAGCATTCCTTTCTCCTCACGC 
Mutant 
algUKOF GCGCGAGCTCGACAGCAACTCGATGTTCG
GTC 
Mutant 
algUKOR GCGCTCTAGAGTCGTACCAGGAAGCCAGC
TG 
Mutant 
algUTJ1F2 GCGCCCATGGGAATGCTAACCCAGGAACA
GGATCA 
Complementa
tion 
algU HindIIIR GCGCAAGCTTTCAGGCTTCTCGCAACAAA
GGCTGCA 
 
Complementa
tion 
algRTJ1F2 GCGCCCATGGGAATGAATGTCCTGATTGTC
GATGAC 
Overexpressio
n 
rpoS EcoRIF GCGCGAATTCGATGGCACTCAAAAAAGAA
GGGCC 
Mutant 
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rpoS HindIIIR GCGCAAGCTTTCACTGGAACAGCGCGTCA
CT 
Mutant 
rpoS intF CGTCGCTGACCGGGAGTTCG PCR check 
rpoS intR CATTTATCTACTTAGGCTCACACG PCR check 
rsmARXbaI GCGCTCTAGAGCACGGTGATCCTGCAGAC
C 
Mutant 
rsmAFHindIII GCGCAAGCTTCGGCAACATCACCACGCTG
GG 
Mutant 
rsmASDMcheckF GCCAAGGTTTCCATCGTCGG PCR check 
rsmAHAF TACCCATACGATGTTCCAGATTACGCTTA 
ATTTTTATCTAATTTTCCCTTTGC 
HA allele 
rsmAHAR TTAAGCGTAATCTGGAACATCGTATGGGT 
AATGGTTTGGCTCTTGATCTTTCTC 
HA allele 
rsmASDMAlgUF CAGAATTCTTCATTCCGGCGGGACTG SDM 
rsmASDMAlgUR CCAAACGGTCAAAAACGACAAAAG SDM 
rsmAPE1F GCGCGGTACCAAGGATCGCGCTCTTGATTT
CTGCGGATCCGCCGCCATTTCTT 
TF 
rsmAPE3F GCGCGGTACCGCTGACAGGCGAAAGGCG TF/RPA 
rsmAPE3R GCGCGGATCCTCACCCAGTATTGACCAGTC
C 
TF 
rsmAEcoRIR GCGCGAATTCACGAGTCAGAATCAGCATT
CCTTTC 
TF 
rsmAPE1 GGCGCGTTGACGCCGATGCGC Primer 
extension 
rsmAPE3 CACGCGAATATTTCAGGACAACAGTCTG 
 
Primer 
extension 
rsmAPE4 GCGCGATCCTTCACCCAGTATTGACCAGTC
C 
Primer 
extension 
gacAF GCGCGAGCTCGAGGCGACCTTGCGTCATTC Mutant 
gacAR GCGCTCTAGACGGCGATCGCCGAAACCAG Mutant 
gacASOEF-2 GCGACGAGGTGCAGCGTGATTGTGAATTC
CGCCAGCTAGATGAGCG 
Mutant 
gacASOER-2 CGCTCATCTAGCTGGCGGAATTCACAATCA
CGCTGCACCTCGTCGC 
Mutant 
gacAintF CCAGGGTGCTTGCGCTTTAC PCR check 
gacAintR CCACGTAGAGAAGCTTGGCC PCR check 
retSFSacI GCGCGAGCTCGAACGTCGCCATCGACGTG
C 
Mutant 
PA0082lacZCP GCGCAGTACTCAGCACGGTGACGATCTCC
C 
TLF 
tssA1HindIIICTXC
P 
GCGCAAGCTTAACCTTTCGAGTCATCCAAT
ATTC 
TLF 
PA0082RminiCTX GCGCGGATCCTCGAAAGGTTGGCAAAATT
CTTGT 
TXF 
tacNotIF GGCCGCTGTTGACAATTAATCATCGGCTCG TLF vector 
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Abbreviations: TF, transcriptional fusion, TLF, translational fusion, SEQ, sequencing primer; 
RPA, RNase protection assay 
 
 
Transcriptional and translational leader fusion analysis  
 Upstream DNA fragments containing promoter regions were generated by using the 
primers listed in Table 2.2 in conjunction with Q5 polymerase (NEB, Ipswich, MA). PAO1 
genomic DNA was used as the template. PCR products were cloned into pCR2.1 and then 
subcloned into miniCTXlacZ using the restriction enzymes HindIII/BamHI, HindIII/EcoRI, or 
KpnI/BamHI (New England BioLabs, Ipswich, MA). To construct rsmA transcriptional fusions, 
the primer pair rsmAHindIII/rsmAEcoRIR was used and the product was inserted into the 
SalI/EcoRI sites of miniCTXlacZ using T4 DNA ligase (NEB, Ipswich, MA). The transcriptional 
fusion PE3-lacZ was constructed using the primers rsmAPE3F and rsmAPE3R and cloning into 
the KpnI/EcoRI site of miniCTXlacZ. The transcriptional fusion TF2- lacZ was constructed 
TATAATGTGTG 
 
tacBamHIR GATCCACACATTATACGAGCCGATGATTA
ATTGTCAACAGC 
TLF vector 
   
retSRXbaI GCGCTCTAGAGCAGGTCTGGCTATGCCGG Mutant 
retSSOEF GACTTCGCCGTGGTACGGCTTTCCTGAGGG
CAGCGACGTGCT 
Mutant 
retSSOER AGCACGTCGCTGCCCTCAGGAAAGCCGTA
CCACGGCGAAGTC 
Mutant 
retSintF CAAGGTCGAGGCGACCTGGG PCR check 
retSintR GAATAACCGCGTGCGGTTATCC PCR check 
lacZScaIF GCTATGACCATGATTAGTACTGATTCACTG
GCCGTC 
TLF vector 
lacZRXhoI CCCCTCGAGCAGACATGGCCTGCCCGGTTA
TTA 
TLF vector 
lacZRforTF GATGTGCTGCAAGGCGATTAAG SEQ 
pHERDSF ATCGCAACTCTCTACTGTTTCTC SEQ 
rsmASDMAlgRF GAATTCGGCAGGAACTTTCATTCCGGC RPA 
rsmARPAR TAATACGACTCACTATAGGGAGAGATAAA
AATTAATGGTTTGGCTCTTG 
RPA 
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using primer pair rsmAPE1F/rsmAEcoRIR and cloned into miniCTXlacZ. The translational 
fusion vector CTXlacZCP was constructed by amplifying the lacZ gene using the primers listed 
in Table 2.2 in order to delete the lacZ ribosome-binding site and the translational initiation 
codon. The tssA1 leader fusion was constructed using the lacUV5 promoter in the 5= primer 
(PA0082FUV5) and primer PA0082ScaIR to amplify the tssA1 untranslated region on the basis 
of the data from the study of Brencic and Lory (5) and cloned into CTXlacZCP. The fusion 
constructs were confirmed by sequencing and conjugated into P. aeruginosa strains by 
triparental conjugation. Strains were selected for tetracycline resistance and then conjugated with 
pFLP2 to remove vector sequences (30). Strains were selected for carbenicillin resistance, grown 
overnight without selection, and plated on YT medium with 10% sucrose to select for the loss of 
pFLP2. Individual colonies were patch plated onto VBMM supplemented with 300 ︎g/ml 
carbenicillin and PIA to ensure the loss of pFLP2. To confirm the presence of the fusion 
constructs, PCR was performed using the forward primer used to construct the fusion and the 
reverse primer lacZRforTF (Table 2.2). b-Galactosidase activity was deter- mined by incubating 
cell extracts with o-nitrophenyl-b-D-galactopyranoside (4 mg/ml) as described by Miller (32). A 
strain carrying the empty vector, miniCTXlacZ, was assayed, and the value for this background 
(28 Miller units) was subtracted from all transcriptional fusions. All mucoid strains were 
confirmed to be mucoid at the end of each experiment by plating on PIA plates and making sure 
that all colonies were mucoid. Experiments were performed in triplicate at least three times.  
Site-directed mutagenesis 
 Phosphorylated primers rsmASDMAlgUF and rsmASDMAlgUR were used in an inverse 
PCR with the PE3-lacZ transcriptional fusions as the templates. The predicted AlgU-dependent 
promoter in the -35 consensus sequence was mutated from GAACTT to GAATTC. The 
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successful inverse PCR product was self-ligated, trans- formed into NEB5a cells (NEB, Ipswich, 
MA), and screened by plasmid digestion with EcoRI digestion and sequencing. The constructs 
obtained by site-directed mutagenesis were conjugated into Pseudomonas strains as described 
above.  
Western blot analysis 
 P. aeruginosa strains were grown in LB broth at 37°C for various times. The bacteria 
were collected by centrifugation, resuspended in sterile phosphate-buffered saline, and lysed by 
sonication. Total protein concentrations were quantified by the Bradford protein assay (Bio-Rad, 
Carlsbad, CA). Cell extracts (5 mg) were separated by 12% SDS-PAGE and transferred to a 
polyvinylidene difluoride membrane (Bio-Rad). The membranes were blocked and probed using 
a 1:2,500 dilution of anti-HA monoclonal antibody (Thermo Fisher, Pittsburgh, PA), followed by 
a 1:30,000 dilution of horseradish peroxidase-conjugated goat anti-rabbit immunoglobulin 
antibody (33). Arbitrary units were determined by standardizing the Western blots to the 
Coomassie- stained SDS-polyacrylamide gel of each strain using total protein analysis as 
described previously (34, 35). Detection was performed using an ECL Plus kit (Thermo Fisher, 
Pittsburgh, PA) and chemiluminescence detection (ProteinSimple, Santa Clara, CA). The blots 
and Coomassie-stained SDS-polyacrylamide gels were analyzed with ImageJ software. All 
Western blot analyses were repeated at least three times.  
Primer extension  
 Total RNA (15 mg) from P. aeruginosa was isolated using a Pure-Link RNA minikit 
(Life Technologies, Grand Island, NY). Radiolabeled primers rsmAPE1 and rsmAPE3 (Table 
2.2) were used in a reverse transcription reaction in a ThermoScript reverse transcription- 
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detected using autoradiography. Primer extension results were confirmed using two different 
primers a total of four times.  
In vitro transcription and RPA  
 The rsmA probe for the RNase protection assay (RPA) was synthesized using a PCR 
product generated with primers that incorporated a T7 promoter sequence at the 5= end and a 
MAXIscript T7 kit (Life Technologies). The reverse primer containing the T7 promoter 
sequence contained a nonhomologous sequence to discriminate between the full-length probe 
and protected fragments. The primers rsmASDMAlgRF and rsmARPAR were used to produce 
the PCR product. The probes were labeled with UTP by the use of biotin-16-UTP (Life 
Technologies) at a ratio of 4:6 and were gel purified after in vitro transcription. Twenty 
micrograms of total RNA from each P. aeruginosa strain was precipitated with 800 pg of labeled 
probe and resuspended in hybridization buffer {80% formamide, 400 mM NaCl, 40 mM PIPES 
[piperazine-N,N=-bis(2-ethanesulfonic acid); pH 6.4], 1 mM EDTA}, heated at 95°C for 5 min, 
and incubated overnight at 42°C. Negative controls consisting of the probe incubated with 10 mg 
Saccharomyces cerevisiae yeast RNA were also included. Digestion of unhybridized RNA was 
performed using RNase A at 25 mg/ml and RNase T1 at 10 U/ml. A biotinylated RNA ladder 
(Kerafast) was also used to deter- mine the size of the protected probe fragments. The products 
of the reactions were run on a 5% acrylamide– 8 M urea gel, and the gels were transferred to a 
positively charged membrane (Hybond N+; Amersham Biosciences) using a semidry blotting 
system and 0.5M Tris-borate-EDTA buffer (Hoefer, Holliston, MA). Nucleic acid was UV cross-
linked, and the probes were detected using a chemiluminescent nucleic acid detection module 
(Thermo Scientific). After washing, the blot was incubated for 5 min and developed using a 
FluoroChem M system (ProteinSimple). RNase protection assays were performed at least three 
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times.  
Overexpression/complementation studies.  
 In order to overexpress algU, the coding sequence was amplified (Table 2.2) and cloned 
into the integrating vector pTJ1 for complementation or overexpression (36). Trimethoprim-
resistant colonies were picked, cultured overnight, and diluted 1,000-fold on the following day. 
The presence of the gene of interest was confirmed using primers pTJ1R and either algUTJ1F2 
or algRTJ1F2. Cultures requiring induction used 1% arabinose and were grown for 8 h in broth 
or overnight on agar plates.  
Statistical analyses.  
 Statistical analyses were performed using Graph- Pad Prism (version 6.0) software 
(GraphPad Software, La Jolla, CA). The results of transcriptional and translational fusions and 
densitometry analysis were compared using a one-way analysis of variance (ANOVA) with 
Tukey’s posttest. ImageJ software was used for Western blot analysis.  
RESULTS 
AlgU hyperactivity significantly contributes to rsmA expression in mucA mutant strains. 
 Previous studies using an rsmA translational fusion and/or Western blot analyses found 
that RsmA levels increase throughout the growth phases (5, 21, 28), which suggests a role of the 
stationary-phase sigma factor RpoS (37). Another study using a transcriptional fusion indicated 
that a mucA strain has increased rsmA expression (14). Because the alternative sigma factor 
AlgU is available in strains lacking functional MucA, AlgU has increased activity in this 
background, and we postulated that AlgU might play a role in rsmA expression. To further 
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understand rsmA regulation at a transcriptional level, an rsmA transcriptional fusion, TF1-lacZ, 
was constructed by cloning the entire intergenic region between rsmA and lysC in the 
transcriptional fusion vector miniCTXlacZ (Fig. 2.1) (38).  
 Due to posttranscriptional rsmA autoregulation (39), it was important that only 
 
Figure 2.1 Depiction of the rsmA genomic region, the promoters controlling rsmA 
expression, and the reagents used in this study. (A) Schematic representation of the rsmA 
genomic region. The sequences below the schematic represent those of the two potential 
promoters. The bent arrows above the sequence indicate the transcriptional start sites identified 
by primer extension analysis. The primers used in the primer extension experiments are 
identified by bent arrows below the genomic schematic. The potential promoters are indicated 
by a line underneath the sequence and are in bold. Potential sigma factor consensus sequences 
are indicated below the sequence. The probe used for RNase protection assays is indicated 
below, and position numbers are relative to the rsmA translational start site. (B) The rsmA-lacZ 
transcriptional fusions constructed are indicated. Arrows indicate the primers used in the 
construction of the transcriptional fusions. The position numbers above the arrows are in 
relation to the rsmA translational start codon. The X indicates the site-directed mutagenesis of 
the putative AlgU -35 consensus sequence. 
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transcription be monitored. The miniCTXlacZ vector allows insertion of single- copy lacZ fusion 
integrants and contains an RNase III processing site to ensure that transcription is uncoupled 
from posttranscriptional effects (38, 40). In wild-type strain PAO1, the TF1-lacZ fusion had b-
galactosidase activity of 380 Miller units at 8 h (Fig. 2.2A). This result indicates that rsmA was 
expressed at low levels at this time point. The fusion was also tested at additional time points, 
including 16 h, and there was little change in TF1-lacZ activity (data not shown). In a ∆algU 
strain, the TF1-lacZ transcriptional fusion had no decrease in TF1-lacZ activity at 8 h (Fig. 
2.2A). A ∆rpoS mutant was constructed and assayed for rsmA expression. There was no 
significant decrease in b-galactosidase activity at either 8 or 16 h (Fig. 2.2A). A ∆algU ∆rpoS 
strain was constructed, and the TF1-lacZ transcriptional fusion was assayed. No change in TF1-
lacZ activity was seen in the double mutant. A ∆algR mutant had significantly increased rsmA 
expression at 8 h (Fig. 2.2A). A previous study indicated that AlgR activates rsmA expression 
(14), but the strain used, PA103, and the growth conditions differed from those used in our study. 
Our results suggest that rsmA is expressed at low levels in wild-type strain PAO1 and its mutant 
derivatives.  
 To further investigate the role of AlgU in controlling rsmA expression, the level of TF1-
lacZ fusion expression was measured in a mucA22 strain as well as the isogenic mucA22 ∆algU 
nonmucoid derivative. As shown in Fig. 2.2A, a mucA22 strain had a ~3- fold increase in rsmA 
expression compared to that in wild-type strain PAO1. In the mucA22 ∆algU strain, rsmA 
transcriptional activity was reduced to the levels in wildtype strain PAO1 (Fig. 2.2A), confirming 
that AlgU does control rsmA expression. The analysis of the TF1-lacZ transcriptional fusion 
suggests that AlgU does play a role in regulating rsmA expression, but this effect is seen only 
when mucA is mutated and not able to sequester AlgU. In addition, RpoS does not regulate rsmA 
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Figure 2.2 AlgU activates rsmA expression in mucA mutants. (A) Analysis of TF1- lacZ 
in mutant strains at 8 h of growth in LB broth. The TF1-lacZ transcriptional fusion was 
inserted into the attB site in the chromosomes of the indicated strains. Transcriptional fusion 
values are indicated as β-galactosidase activity. The values are the result of subtraction of the 
value for PAO1 containing the vector (miniCTXlacZ) alone (28 Miller units) from all test 
values. Fusion assays were all conducted at least three times. Determination of all significant 
differences from the results for the wild type was performed using a one-way analysis of 
variance and Tukey’s posttest. **, P < 0.01; ***, P < 0.001. (B) (Top) Western analysis of 
RsmA in algU mutant strains. An rsmA-HA allele was constructed and introduced into 
various strains via homologous recombination, the strains were grown for 8 h, and whole-cell 
lysates were probed with anti-HA antibody. A single band was detected in all Western blots 
using the strains containing the rsmA-HA allele. A representative Western blot is shown. 
Western blot analysis was completed at least three times. The strains assayed are listed below 
the bottom panel. PAO1 without the rsmA-HA allele was run as a negative control (data not 
shown). (Bottom) Densitometry analysis was performed for each strain. Densitometry values, 
determined using ImageJ software, were standardized by dividing the intensity of the band in 
the Western blot by the intensity of the total protein in each lane stained with Coomassie. The 
result for PAO1 was set equal to 1, and the values for the other strains were normalized using 
the value for PAO1 as a reference. A one-way ANOVA with Tukey’s posttest was used to 
determine statistical significance. ***, P < 0.0001.  
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under these conditions.  
 To determine if RsmA protein levels mirrored the findings of rsmA expression analysis, 
we constructed a hemagglutinin (HA)- tagged rsmA allele that was introduced into strains by 
allelic exchange. As shown in Fig. 2.2B, the mucA22 mutant had significantly higher RsmA 
levels than wild-type strain PAO1. Densitometry analysis indicated that there was a significant 
decrease in RsmA levels in the ∆algU mutant compared to those in wild-type strain PAO1 (Fig. 
2.2B). The mucA22 ∆algU mutant showed a drastic decrease in RsmA levels compared to those 
in the mucA22 strain (Fig. 2.2B). The results of Western blot analysis suggested that AlgU is 
required for increased rsmA expression in mucA mutant backgrounds.  
Identification of a second rsmA promoter 
 Because the sigma factor AlgU played a role in rsmA expression, the upstream region of 
rsmA was inspected for possible promoter sequences. A potential AlgU consensus sequence is 
located upstream of rsmA (Fig. 2.1A). To determine if this AlgU promoter is functional, we per- 
formed primer extension analysis. Total RNA was reverse transcribed using a radiolabeled 
primer (rsmAPE1) specific for a sequence located within the rsmA coding region, and extension 
products were detected on a denaturing polyacrylamide gel. Primer extension indicated that there 
were two transcriptional start sites (Fig. 2.3A), which suggests that rsmA has an additional 
promoter. The start site most distal to the coding region was identified as an A residue located 86 
bp upstream of the predicted rsmA translational start codon. The first and closest transcriptional 
start site was a G residue located 40 bp upstream of the rsmA coding region. Primer extension 
analysis with an additional radiolabeled primer, rsmAPE3, produced a single extension product 
and confirmed the presence of the A residue identified to be a transcriptional start site 86 bp 
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upstream of rsmA (data not shown). The second transcriptional start site was independently 
identified four times. Primer extension analysis with a third primer, rsmAPE4, whose sequence 
overlapped the most distal transcriptional start site, failed to produce an extension product, 
suggesting that rsmA has only two active promoters under the conditions tested.  
 Sequences upstream of the identified transcriptional start sites were examined for 
potential promoters (Fig. 2.1A). Three previous studies identified using transcriptome 
sequencing (25, 26) and 5’ rapid amplification of cDNA ends (24) a transcriptional start site that 
is 40 nucleotides upstream of the rsmA translational start codon. The sequence of the proximal 
promoter identified by our primer extension analysis resembled a sigma70 (RpoD) promoter 
sequence. Therefore, the proximal promoter that we identified was the same promoter previously 
identified, validating the findings of our primer extension analysis.  
 The second transcriptional start site has two possible promoter consensus regions 
upstream. A potential AlgU consensus sequence GAACTT in the -35 region (Fig. 2.1A) (11) and 
a potential RpoS -10 region are located upstream of this transcriptional start site. The potential 
RpoS consensus sequence CAATACT differs from the RpoS consensus sequence CTATACT by 
1 nucleotide (41). E. coli RpoS promoters frequently have an extended structure, denoted by a 
G/T residue directly upstream of the conserved -10 region (42). The potential RpoS promoter 
upstream of rsmA also follows this extended structure (Fig. 2.1A). The potential RpoS -10 region 
overlaps the potential AlgU -10 region (Fig. 2.1A). On the basis of the results of primer 
extension and sequence analyses, rsmA has a second promoter that is controlled by AlgU and/or 
RpoS.  
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AlgU controls the distal rsmA promoter 
 Because two rsmA transcripts were detected by primer extension (Fig. 2.3A), this led us 
to test whether rsmA has two promoters. Two transcriptional fusions were constructed using the 
data generated by primer extension analysis (Fig. 2.1) to confirm the promoter activity of these 
regions. The activity of PAO1 carrying the vector alone (28 Miller units) was subtracted from the 
values obtained. A transcriptional fusion, TF2-lacZ, was constructed by deleting the putative 
distal promoter. TF2-lacZ has the 5’ end at position -74 in relation to the rsmA translational start 
site and extends 18 nucleotides into the rsmA coding region (Fig. 2.1B). The transcriptional 
fusion TF3- lacZ was constructed using the intergenic region from lysC to the distal 
transcriptional start site at position +1 as the 3’ end of the fusion and therefore contains only the 
putative distal promoter (Fig. 2.3B). When these fusions were analyzed in wild-type strain 
PAO1, both fusions produced b-galactosidase activity (Fig. 2.3B and C), but the level of 
expression was very low. The values for both the TF2-lacZ and TF3-lacZ fusions were much 
lower than the value for TF1-lacZ, suggesting that the entire region is necessary for optimal 
rsmA expression.  
 The TF2-lacZ transcriptional fusion was constructed and tested to determine the activity 
of the proximal promoter. The TF2-lacZ fusion did not have increased reporter activity in the 
mucA22 strain (Fig. 2.4B). When algU was deleted in either background, no decrease in reporter 
activity was detected, indicating that this promoter was constitutively active at low levels in the 
strains analyzed (Fig. 2.4C).  
 To determine if AlgU affected the distal promoter that we identified, the TF3-lacZ fusion 
was analyzed in wild-type strain PAO1 and a ∆algU mutant. The activity of the TF3-lacZ fusion 
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Figure 2.3 Identification of a second rsmA promoter region controlled by AlgU. (A) 
Primer extension analysis was performed to identify the transcriptional start sites of rsmA. 
Total RNA was reverse transcribed using a radiolabeled primer, rsmAPE1 (Table 2), and run 
alongside the products of the sequencing reactions on a denaturing polyacrylamide gel. Lanes 
G, A, T, and C, the sequencing ladder generated using the same primer used in the reverse 
transcription reaction; lane 1, a control lane with total RNA without reverse transcriptase; lane 
2, reverse-transcribed PAO1 RNA. Arrows, extension products. (B) b -Galactosidase activity 
of chromosomal transcriptional fusion TF2-lacZ in the indicated strains tested in triplicate 
after incubation in LB broth for 8 h at 37°C as described in the legend to Fig. 2A. The value 
for PAO1 carrying the vector alone was subtracted from the value for each strain. (C) b -
Galactosidase activity of chromosomal transcriptional fusions of TF3-lacZ in the indicated 
strains tested in triplicate after incubation in LB broth for 8 h at 37°C. The value for PAO1 
carrying the vector alone was subtracted from the value for each strain. Transcriptional fusion 
assays were performed at least three times. All significant differences from the wild type were 
determined using a one-way analysis of variance and Tukey’s posttest. ***, P < 0.001.  
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in PAO1 was low, and no difference in activity was seen when it was tested in a ∆algU mutant at 
8 h. However, when the activity of the TF3-lacZ fusion was tested in a mucA22 strain, there was 
an ~8-fold increase (Fig. 2.3C). The activity of the TF3-lacZ transcriptional fusion in a mucA22 
∆algU strain was significantly reduced ~8- fold (Fig. 2.3C). These results show that the promoter 
contained in the TF3-lacZ fusion is AlgU dependent.  
Overexpression and complementation of algU increase rsmA expression  
 For overexpression of algU, we used an arabinose- inducible promoter to control algU 
expression (43). As shown in Fig. 2.4A, there was a statistically significant increase in TF3-lacZ 
activity when algU was induced with arabinose in strain PAO1. The results suggest a role for 
AlgU in activating rsmA expression.  
 Additionally, the ∆algU mutant containing the TF3-lacZ transcriptional fusion was 
complemented with pAlgU. When 1% arabinose was used to induce algU expression, TF3-lacZ 
activity was also increased (Fig. 2.4B). Complementation and overexpression resulted in an 
increase in TF3-lacZ activity. From these results, we conclude that AlgU is necessary for in- 
creased rsmA expression.  
 To determine if RsmA protein levels matched those of the transcriptional fusions, we 
used the PAO1 rsmA-HA strain containing epitope-tagged rsmA. When algU expression was 
induced by the addition of arabinose, there was a significant increase in RsmA levels (Fig. 2.4C). 
On the basis of this result, it was determined that algU overexpression is able to increase rsmA 
transcription.  
Site-directed mutagenesis of the putative AlgU-binding site in the distal promoter reduces rsmA 
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expression  
 Site-directed mutagenesis was performed on the TF3-lacZ transcriptional fusion to 
 
Figure 2.4 AlgU overexpression and complementation confirm the AlgU regulation of 
rsmA. (A and B) β−Galactosidase activity of the TF3-lacZ (A) and ∆algU TF3-lacZ (B) 
constructs. (A) The algU gene was cloned into the integrating vector pTJ1 and induced with 
1% arabinose. Strains were grown in LB broth for 4 h and induced with arabinose for 4 h. 
PAO1 with the vector alone (pTJ1) was used as a negative control. Data from triplicate 
experiments were averaged after subtraction of the value for PAO1 carrying the vector alone 
(28 Miller units). (B) Complementation of the ∆algU strain containing the transcriptional 
fusion TF3-lacZ was performed as described in the legend to panel A. (C) Overexpression of 
algU increased RsmA protein levels. PAO1-HA/pTJ1 was the PAO1 strain with the rsmA-HA 
allele and the vector alone. PAO1-HA/pAlgU contained the rsmA-HA allele and 
overexpressed algU when arabinose was added. ImageJ software was used for densitometry 
analysis, as described in the legend to Fig. 2B. (Top) A representative Western blot. Western 
blot analysis was performed at least three times. (Bottom) Densitometry results for the 
Western blots.  
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determine if the putative AlgU consensus sequence was required for increasing rsmA expression. 
The putative AlgU -35 sequence GAACTT was converted to GAATTC (underlined nucleotides 
indicate changes introduced) (Fig. 2.5). There was a ~3- fold decrease in the level of 
transcription in the mucA22 strain with the mutagenized AlgU promoter (Fig. 2.5). The results of 
the site-directed mutagenesis experiment demonstrate the necessity of the conserved AlgU -35 
sequence and strongly suggest that AlgU directly controls rsmA transcription by binding the 
distal rsmA promoter.  
 
AlgU regulation of rsmA is conserved 
 
Figure 2.5 The potential AlgU-binding site is required for increased rsmA expression in 
a mucA22 mutant. The TF3-lacZ transcriptional fusion was engineered with two mutations 
in the potential AlgU -35 consensus sequence (indicated by asterisks above the indicated 
nucleotides in the sequence above the graph). The transcriptional start site (the 3= end of the 
TF3-lacZ fusion) is indicated in bold. USDM indicates the fusion containing the mutation of 
the conserved AlgU -35 consensus sequence. β-Galactosidase activity was determined as 
described in Materials and Methods. Data from triplicate experiments were averaged after 
subtraction of the value for PAO1 carrying the vector (28 Miller units). A one-way ANOVA 
with Tukey’s posttest was used to determine statistical significance. ***, P < 0.0001.  
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 To determine if AlgU control over rsmA is a conserved mechanism in other P. 
aeruginosa strains, we investigated the role of AlgU in the clinical strains 2192 and 383. These 
strains were isolated from a longitudinal study (44) and have been determined to be isogenic 
(45). Strain 2192 is mucoid and has a mucA mutation (46). We took a genetic approach and 
assayed our transcriptional fusions TF1-lacZ and TF3-lacZ to determine the role of AlgU in 
activating rsmA expression in these strains (Fig. 2.6). Strain 2192 had an ~3-fold increase in the 
amounts of both the TF1-lacZ fusion and the TF3-lacZ fusion compared to those in nonmucoid 
strain 383 (Fig. 2.6A and B). These results demonstrate that the AlgU-dependent promoter 
activity is increased in strain 2192 compared to that in its nonmucoid counterpart, strain 383. A 
2192 ∆algU mutant was constructed, and assays for the expression of the TF1-lacZ and TF3-
lacZ fusions were performed to confirm a role for AlgU in other P. aeruginosa strains. As shown 
in Fig. 2.6A and B, there was a statistically significant decrease in the levels of TF1- and TF3- 
lacZ expression, supporting the role of AlgU in regulating the distal promoter. To confirm the 
transcriptional fusion results, the levels of RsmA in the clinical strains were determined using the 
rsmA-HA allele. RsmA levels were increased in strain 2192 compared to those in the nonmucoid 
383-parent strain (Fig. 2.6C), suggesting that AlgU activated rsmA expression in strain 2192. 
The 2192 ∆algU mutant had a significant decrease in the amount of RsmA compared to that in 
2192 (Fig. 2.6C). On the basis of these results, it is likely that AlgU activates rsmA expression in 
multiple strains.  
RpoS involvement in the control of rsmA 
 There are conflicting data regarding RpoS control of rsmA expression (9, 27). The 
potential RpoS-binding site upstream of rsmA implicated RpoS in the control of rsmA (Fig. 
2.1A). However, the TF1-lacZ transcriptional fusion analysis did not demonstrate a decrease in 
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rsmA 
Figure 2.6 Clinical mucA mutant strains have increased rsmA expression. (A and 
B) β-Galactosidase activities of the TF1-lacZ (A) and TF3-lacZ (B) transcriptional 
fusions. (A) The β-galactosidase activity of the TF1-lacZ transcriptional fusion was 
assayed in clinical isolates 383 and 2192 and a 2192 ∆algU strain after 8 h, as 
described in the text. Data from triplicate experiments were averaged after subtraction 
of the value for PAO1 carrying the vector alone (28 Miller units). (B) The β-
galactosidase activity of the TF3-lacZ transcriptional fusion was analyzed in strains 
383, 2192, and 2192 ∆algU at 8 h, as described in the text. Data from triplicate 
experiments were averaged after subtraction of the value for PAO1 carrying the vector 
alone (28 Miller units). A one-way ANOVA with Tukey’s posttest was used to 
determine statistical significance. ***, P < 0.0001 (C) RsmA levels are also increased 
in clinical mucA mutants. The rsmA-HA allele was exchanged for the wild-type rsmA 
allele in clinical isolates 383 and 2192. Whole-cell lysates were produced and probed 
with anti-HA antibodies. PAO1 was used as a negative control (data not shown). The 
results for PAO1-HA and mucA22-HA are shown for reference. (Top) A 
representative Western blot. (Bottom) Results of densitometry analysis of the blot 
performed using ImageJ software. Data are in arbitrary units and were produced from 
three Western blots. Densitometry analysis was performed as described in the legend 
to Fig. 2B. 
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expression in a ∆rpoS mutant. Because sigma factor competition on the distal promoter could 
have influenced our ability to detect RpoS activity on the rsmA promoter (47), we tested a 
double mutant, the ∆algU ∆rpoS mutant (Fig. 2.1A). No further decrease in TF1-lacZ activity in 
 
Figure 2.7 RpoS is not a significant regulator of rsmA expression. (A) β-Galactosidase 
activity of the TF2-lacZ transcriptional fusion in the denoted strains. Data from triplicate 
experiments were averaged after subtraction of the value for PAO1 carrying the vector 
alone (28 Miller units). (B) β-Galactosidase activity of the TF3-lacZ transcriptional fusion 
in the denoted strains. β-Galactosidase activity was determined as described in the text. 
Data from triplicate experiments were averaged after subtraction of the value for PAO1 
carrying the vector alone (28 Miller units). Significant differences from the results for the 
wild type were determined using a one-way analysis of variance and Tukey’s posttest. 
***, P < 0.001.  
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the ∆algU ∆rpoS mutant was detected. To further define the role of RpoS in controlling rsmA 
expression, we tested the TF2- and TF3-lacZ fusions for activity in either ∆rpoS strains or ∆algU 
∆rpoS strains (Fig. 2.7). Interestingly, both a ∆rpoS mutant and a ∆algU ∆rpoS mutant had 
significantly higher levels of activity when the TF2-lacZ promoter was used (Fig. 2.7A), 
suggesting that RpoS has a negative effect on transcription from the proximal rsmA promoter. 
No significant change was found when the TF3-lacZ transcriptional fusion was used in the ∆rpoS 
or ∆algU ∆rpoS mutant strains (Fig. 2.7B). From these results, the role of RpoS in regulating 
rsmA is inconclusive.  
RpoS and AlgU are necessary for rsmA expression from the distal promoter 
 RNase protection assays (RPAs) were performed using an RNA probe specific for a 
region spanning the entire rsmA coding region and 129 bp upstream of the rsmA gene (Fig. 2.1A) 
to more directly analyze rsmA transcripts and better understand the role of AlgU and RpoS in 
controlling rsmA expression. The probe also includes non-template-encoded nucleotides to 
distinguish the full-length probe from protected fragments. As shown in Fig. 2.8, the RPAs 
confirmed the findings of our primer extension and transcriptional fusion analysis by detecting 
two rsmA transcripts in wild-type strain PAO1. The expected fragments were 281 bp and 235 bp, 
on the basis of the probe used. This matched what was seen in the RPAs (Fig. 2.8). Interestingly, 
the ∆algU mutant contained the same two transcripts as wild-type strain PAO1. When the ∆rpoS 
mutant was analyzed, both transcripts were detected, with the amount of the first transcript 
resulting from the amount of the proximal promoter being increased. A ∆algU ∆rpoS strain was 
also analyzed, and the larger transcript resulting from the distal promoter completely 
disappeared, demonstrating that both AlgU and RpoS contribute to transcription from the distal 
promoter (Fig. 2.8). The mucA22 strain had both transcripts as well, with both transcripts having 
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greater intensities. The highest band in the ∆rpoS and mucA22 strains was likely undigested 
probe.  
 Three controls were included in the RPA. Two of the controls were the probe incubated 
 
Figure 2.8 RPAs confirm the presence of two rsmA transcripts. RPAs of the 
indicated strains were performed after RNA was harvested from cultures grown in LB 
broth for 8 h at 37°C. Twenty micrograms of total RNA from the indicated strains was 
hybridized with 800 pg of biotinylated probe and subjected to RNase treatment. After 
RNase inactivation, RNA was precipitated from the samples and run on a 5% denaturing 
polyacrylamide gel, transferred to a nylon membrane, UV cross-linked, and developed 
using chemiluminescent detection. The undigested probe is indicated by the large arrow 
at the top. The protected rsmA probe is indicated by the three smaller arrows. Shown is a 
result representative of results from three RNase protection assays. Ladder, molecular 
size markers.  
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with yeast RNA; one of these was treated with RNase, and the other was not. As shown in Fig. 
2.8, RNase treatment completely degraded the probe, which indicates that the probe did not bind 
nonspecifically. The intact probe can be seen at ~330 bp in the lane in Fig. 2.8 labeled “probe 
alone -RNase,” which is consistent with the additional nucleotides that are non-template 
encoded. A ∆rsmA mutant was constructed and used as an additional control. In the ∆rsmA 
mutant, there was only one discernible protected probe fragment at ~150 bp. On the basis of how 
the ∆rsmA mutant was constructed, a protected fragment of 144 bp was expected. The results 
obtained with the ∆rsmA strain support the suggestion that there are only two rsmA transcripts, at 
least under the conditions used. Altogether, the results of the RPA suggested that there are two 
rsmA transcripts and that both AlgU and RpoS are involved in controlling the distal promoter 
region, suggesting overlapping promoters.  
AlgU control of rsmA expression is responsible for RsmA activity in a P. aeruginosa mucA22 
strain 
 Because AlgU increased RsmA levels, we hypothesized that RsmA activity was also in- 
creased in a mucA22 strain. We analyzed a variety of mutant strains, including strains that should 
alter the activity of RsmA on the basis of the current RsmA paradigm (5). RetS interferes with 
GacA phosphorylation, and mutation of retS should lead to increased production of the small 
RNAs RsmY and RsmZ (18, 48). Therefore, the level of RsmA activity should be reduced. In 
contrast, mutation of gacA should lead to a reduction in the amounts of the small RNAs RsmY 
and RsmZ (49). In this case, increased RsmA activity should be observed. Mutants with 
mutations in the gacA and retS genes were constructed in both the PAO1 and mucA22 strain 
backgrounds.  
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 RsmA has previously been shown to affect the production of the exopolysaccharide genes 
pel and psl (9, 16, 50). However, no studies have investigated the involvement of RsmA in 
alginate production. We hypothesized that if RsmA inhibits biofilm formation, then RsmA would 
inhibit alginate production. Interestingly, the mucA22 ∆gacA, mucA22 ∆retS, and mucA22 
∆rsmA mutants still overproduced alginate (data not shown), and we conclude that RsmA does 
 
Figure 2.9 AlgU activation of rsmA leads to changes in tssA1 expression. (A) Schematic of 
the genomic region of the RsmA-controlled genes tssA1 and fha1. Below the genomic 
schematic is a depiction of the leader fusion that was constructed. The position numbers 
above the fusion construct indicate those of the primers used relative to the tssA1 translational 
start codon. (B) Analysis of a TssA1 leader translational fusion driven by the lacUV5 
promoter in wild-type and mutant derivative strains. All assays were repeated at least three 
times in triplicate. Data were normalized to the mean for PAO1. PAO1 activity with the 
lacUV5-tssA1-lacZ fusion was 12 Miller units. A one-way ANOVA with Tukey’s posttest 
was used to determine statistical significance. ***, P < 0.0001.  
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not affect alginate production.  
 RsmA posttranscriptional activity was tested using a tssA1 leader/translational fusion 
containing the lacUV5 promoter and the tssA1 untranslated sequence, based on the study of 
Brencic and Lory (5) (Fig. 2.9A). Due to the low level of activity of this reporter, the data are 
presented as a percentage of the wild-type activity, where the values were normalized to those 
for the PAO1 strain (12 Miller units). The mucA22 strain had fusion activity decreased ~3-fold 
compared to that of PAO1 (Fig. 2.9B). There was no difference in activity between PAO1 and a 
∆algU strain when the leader fusion was used (Fig. 2.9B). In the case of a mucA22 ∆algU strain, 
there was a 5.5-fold increase in leader fusion activity compared to that in the mucA22 strain (Fig. 
2.9B). These results suggest that RsmA is active in the mucA22 strain background and this is due 
to AlgU regulation of rsmA.  
 Further confirmation of RsmA activity in the mucA22 strain was carried out using 
mutants with mutations in gacA and retS, as described above. While the differences in activity 
were not significant by statistical analysis, there was no activity from a mucA22 ∆gacA strain, 
even after the reaction was allowed to proceed overnight. This result would be expected if RsmA 
activity were increased due to the absence of the small RNAs RsmY and RsmZ (49). As there 
was an increased amount of RsmA in the mucA22 strain due to AlgU activation of the distal 
promoter, the difference between the mucA22 strain and the mucA22 ∆gacA strain should not be 
so different if our hypothesis is correct (Fig. 2.10). The leader fusion also had increased activity 
in both the mucA22 ∆rsmA and the mucA22 ∆retS strains compared to that in the mucA22 strain 
(3-fold and 7-fold, respectively) (Fig. 2.9B).   These results also indicate the RsmA activity in 
the mucA22 strain background. The increased activity of the leader fusion indicates that the 
absence of RsmA or an abundance of RsmY and RsmZ due to the absence of RetS allows greater 
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expression from the leader fusion. Altogether, these data suggest that RsmA activity is present in 
a mucA22 strain.  
 
 
Figure 10. Model depicting the expression and activity of rsmA and the protein that it 
encodes, RsmA, in mucA mutant strains. Two transcripts of different sizes are produced. 
AlgU and RpoS control the longer transcript originating from the distal promoter. In the mucA 
strain background, AlgU increases the level of transcription from the distal promoter, but both 
transcripts are increased in amount either by transcription initiation at both promoters or by 
posttranscriptional processing of the longer message. Due to increased rsmA transcription, 
there is an increased amount of RsmA in mucA mutants. Transcriptional start sites are 
represented by bent arrows. The left and right bent arrows indicate the distal and proximal 
promoters, respectively. The +1 indicates the putative translational rsmA start site. RsmA 
levels increase, preventing translation of tssA1 and therefore production of the HSI-I T6SS. 
The dashed curved arrow on the left side indicates that AlgU either directly or indirectly leads 
to the activation of the tssA1 operon. RetS and GacA are depicted on the right to show how 
they are incorporated in the RsmA scenario. GacA, when phosphorylated by GacS, activates 
the expression of two small RNAs, RsmY and RsmZ, that bind and prevent RsmA from 
performing posttranscriptional regulation. RetS interferes with GacA phosphorylation by 
physically binding GacS and allows RsmA to regulate expression of mRNAs. The small 
RNAs RsmY and RsmZ bind and prevent RsmA activity.  
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DISCUSSION 
 RsmA is considered an important posttranscriptional regulator involved in the positive 
regulation of acute virulence factors, such as the type III secretion system and motility (5, 14). 
Little is known of the transcriptional regulation of rsmA. Initially, we undertook studies to 
determine how rsmA was regulated in P. aeruginosa. We demonstrate that AlgU activates rsmA 
expression and increases RsmA levels in a mucA22 mutant and a clinical isolate. Analysis of a 
leader fusion to assess the posttranscriptional activity of the RsmA target, tssA1 (5), led us to 
discover RsmA activity in the mucA22 strain. To our knowledge, this is the first demonstration 
of RsmA activity in a mucA mutant strain of P. aeruginosa. Our work demonstrates that 
increased rsmA expression due to AlgU activation leads to changes in the RsmA regulon. We 
hypothesize that RsmA plays an important role during P. aeruginosa chronic infection and that 
there are additional RsmA targets in mucA mutant strains.  
 One of the goals of this study was to determine how rsmA expression is regulated. 
Previous studies have raised questions about how rsmA is regulated in P. aeruginosa (9, 14, 24). 
In E. coli, five promoters control csrA (the orthologue of rsmA) expression (51). Only one rsmA 
promoter was previously identified in P. aeruginosa (24–26), and a previous study indicated that 
AlgR plays a role in regulating rsmA expression (14). Using primer extension, a new 
transcriptional start site was identified, indicating a second rsmA promoter (Fig. 2.2). Both 
transcriptional fusion analysis and RPA confirmed the presence of a second promoter (Fig. 2.3 
and 2.8). Overexpression and Western blot analyses support a role of AlgU in controlling rsmA 
expression (Fig. 2.1E and 2.4). However, when MucA is functional, such as in PAO1, it is 
difficult to detect changes in rsmA expression. This explains the low levels of activity of the 
transcriptional reporters (Fig. 2.1A and 2.2). The role of RpoS in controlling rsmA expression is 
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somewhat less clear. While we were not able to detect RpoS regulation of rsmA by 
transcriptional fusion analysis (Fig. 2.7), the results of RPA suggested that RpoS does play a role 
(Fig. 2.8). Further studies are needed to determine the significance of RpoS in controlling rsmA 
expression. A previous study identified AlgR to be a regulator of rsmA, rsmY, and rsmZ (14). It 
is possible that AlgR and AlgU work together in regulating rsmA in mucA mutant strains. It is 
clear that rsmA regulation is complex, but this work solidifies the role of AlgU as an rsmA 
activator.  
 Our finding that AlgU controls rsmA expression is bolstered by the analysis of rsmA in 
the clinical strains 2192 (mucoid) and 383 (nonmucoid) (45). These data indicate higher levels of 
RsmA in the mucA mutant strain 2192 (Fig. 2.6). The findings of our regulation studies are 
consistent with a previous observation that a mucA mutant had increased levels of rsmA 
expression (14). Thus, our work implicates RsmA to be necessary for the persistence of P. 
aeruginosa during chronic infections, because mucA mutants are found at later time points 
during infection. This is consistent with the requirement of Helicobacter pylori, which requires 
CsrA (the RsmA orthologue) for persistence in the stomach (52). Whether RsmA participates in 
regulating virulence factors in mucA mutant strains is currently not known and is an unexplored 
area.  
 After finding that AlgU, an important sigma factor in chronic infections (7), regulates 
rsmA expression, we asked if the increased RsmA levels have activity in mucA mutant strains. 
Our results support a model (Fig. 2.10) where RsmA activity in the mucA mutant background is 
due to AlgU. First, using the tssA1 leader fusion, the mucA22 strain showed decreased activity, 
indicating in- creased posttranscriptional regulation compared to that in PAO1. Second, the 
mucA22 ∆algU strain had increased leader fusion activity compared to that of the mucA22 strain, 
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which supports our conclusion that increased rsmA expression leads to increased RsmA activity. 
This result also demonstrates the importance of AlgU control of rsmA expression. Third, the 
increase in the fusion activity in the mucA22 ∆rsmA strain compared to that in the mucA22 strain 
was greater than the increase in the ∆rsmA mutant of PAO1. Further support for RsmA activity 
in mucA mutant strains comes from the increased leader fusion activity of the mucA22 ∆rsmA 
and mucA22 ∆retS strains compared to that of the mucA22 strain. An alternative explanation of 
our data is that some other form of posttranscriptional regulation occurs independently of RsmA. 
However, the gacA and retS mutants are known to regulate RsmA activity, even though rsmA is 
expressed in these strains (data not shown). We do not favor this alternative hypothesis, as 
previous studies have determined that GacA controls only rsmY and rsmZ expression (21, 49). 
Another posttranscriptional regulator, RsmF/RsmN, is also known to control tssA1 expression 
(24, 53). This could possibly have affected the fusion results found in the present study as well 
and may explain the increased expression of the tssA1 leader fusion in the mucA22 ∆retS strain. 
Regardless, the results still indicate increased posttranscriptional regulation of tssA1 in a mucA22 
strain.  
 The results of a proteomic study of the isogenic clinical strains 383 and 2192 also support 
our findings. In this study, the mucoid strain 2192 has decreased amounts of HSI-I T6SS 
components, whereas the nonmucoid strain has increased HSI-I T6SS components (54). If the 
level of RsmA was increased due to AlgU in mucoid strain 2192, as presented here (Fig. 2.6), 
then the proteomic analysis suggests that RsmA is responsible for the decreased amounts of HSI-
I T6SS components in mucoid strain 2192. We are currently examining RsmA activity in other 
clinical isolates.  
 However, a previous study did not find that RsmA posttranscriptionally regulates tssA1 in 
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a mucA mutant (14). A possible reason for the discrepancy between the findings of that study and 
those of our study is that different strains and growth conditions were used. In addition, the 
previous study found that rsmY and rsmZ expression are increased in a PA103 mucA mutant (14). 
We analyzed rsmY and rsmZ expression using transcriptional fusions and also found the same 
result (data not shown). It is not known how RsmA functions if RsmY and RsmZ levels are 
increased, and this requires further investigation. One possibility is that the promoter fusions do 
not accurately monitor the levels of the small RNAs. We are directly measuring RsmY and 
RsmZ levels in a mucA mutant strain to determine if this is the case. If RsmY and RsmZ levels 
are increased and there is still RsmA activity, then we speculate the higher-affinity target 
mRNAs present compete with RsmY and RsmZ. Alternatively, other factors that appropriately 
direct RsmA to its targets, even in the presence of RsmY and RsmZ, exist.  
 The P. aeruginosa mucA mutant strains provide a snapshot of some of the bacteria found 
in the lungs of patients with cystic fibrosis during chronic infection. The use of mucA mutant 
strains may help provide an understanding of the factors required for persistence and adaptation 
in the lung environment. For instance, the overproduction of alginate by mucA mutant strains 
provides a competitive advantage by sequestering free radicals, preventing complement attack, 
and inhibiting phagocytosis (55). Our data suggest that RsmA also plays a role in chronic 
infections, such as those that occur in the lungs of cystic fibrosis patients. The RsmA regulon 
may have additional targets in mucA mutant backgrounds that have not yet been discovered. An 
understanding of RsmA in both acute and chronic infections may provide new ways to combat P. 
aeruginosa.  
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ABSTRACT 
 Pseudomonas aeruginosa is an important pathogen of the immunocompromised, causing 
both acute and chronic infections. In cystic fibrosis (CF) patients, P. aeruginosa causes chronic 
disease. The impressive sensory network of P. aeruginosa allows the bacterium to sense and 
respond to a variety of stimuli found in di- verse environments. Transcriptional regulators, 
including alternative sigma factors and response regulators, integrate signals changing gene 
expression, allowing P. aeruginosa to cause infection. The two-component transcriptional 
regulator AlgR is important in P. aeruginosa pathogenesis in both acute and chronic infections. 
In chronic infections, AlgR and the alternative sigma factor AlgU activate the genes responsible 
for alginate production. Previous work demonstrated that AlgU controls rsmA expression. RsmA 
is a posttranscriptional regulator that is antagonized by two small RNAs, RsmY and RsmZ. In 
this work, we demonstrate that AlgR directly activates rsmA expression from the same promoter 
as AlgU. In addition, phosphorylation was not necessary for AlgR activation of rsmA using algR 
and algZ mutant strains. AlgU and AlgR appear to affect the antagonizing small RNAs rsmY and 
rsmZ indirectly. RsmA was active in a mucA22 mutant strain using leader fusions of two RsmA 
targets, tssA1 and hcnA. AlgU and AlgR were necessary for posttranscriptional regulation of 
tssA1 and hcnA. Altogether, our work demonstrates that the alginate regulators AlgU and AlgR 
are important in the control of the RsmA posttranscriptional regulatory system. These findings 
suggest that RsmA plays an unknown role in mucoid strains due to AlgU and AlgR activities.  
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IMPORTANCE 
 P. aeruginosa infections are difficult to treat and frequently cause significant mortality in 
CF patients. Understanding the mechanisms of persistence is important. Our work has 
demonstrated that the alginate regulatory system also significantly impacts the 
posttranscriptional regulator system RsmA/Y/Z. We demonstrate that AlgR directly activates 
rsmA expression, and this impacts the RsmA regulon. This leads to the possibility that the 
RsmA/Y/Z system plays a role in helping P. aeruginosa persist during chronic infection. In 
addition, this furthers our understanding of the reach of the alginate regulators AlgU and AlgR.  
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INTRODUCTION 
  The opportunistic pathogen Pseudomonas aeruginosa possesses multiple virulence 
factors for causing disease. This allows P. aeruginosa to cause both acute and chronic infections. 
Acute infecting strains are characterized by the presence of type IV pili (T4P), flagella, and a 
type III secretion system (T3SS) (1–3). In contrast, chronic infecting strains diversify (4, 5) and 
frequently do not express T3SS, T4P, or flagella (6, 7). Chronic infecting strains often form 
biofilms composed of exopolysaccharides, such as alginate, and signal a decline in lung function 
in CF patients (8–11). Alginate biosynthesis requires activation of the alternative sigma factor 
AlgU (12, 13) and the two-component transcriptional regulator AlgR (12, 14, 15).  
 Two-component signal transduction systems are important in regulating the bacterial 
response to environmental conditions. AlgR controls both acute and chronic virulence genes 
(16–18). In the case of acute infections, AlgZ phosphorylates AlgR and activates the fimU 
operon encoding minor pilins important in pilus biogenesis (19–21). The production of alginate, 
indicative of chronic infection, does not require AlgR phosphorylation (22). This fact has been 
demonstrated by deletion of the histidine sensor kinase gene algZ (23) and by the expression of 
an algR mutant allele encoding an asparagine in place of the conserved aspartate (22).  
 In chronic P. aeruginosa infections, the bacteria frequently acquire spontaneous mucA 
mutations that free the alternative sigma factor AlgU (12, 14, 24–26). AlgU and AlgR regulate 
the alginate biosynthesis genes producing mucoid colonies (12). In addition, AlgR decreases the 
expression of acute virulence factors, such as the T3SS in chronic infections when mucA 
mutations occur (7, 27). Therefore, AlgR has multiple roles depending on the type of infection 
and the phosphorylation state of AlgR: phosphorylated in acute infections activating the fimU 
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operon and unphosphorylated in chronic infections activating alginate biosynthesis.  
 Previous work implicated the AlgZ/R system in the control of rsmA expression (28), but 
a mechanism for AlgR activation of rsmA was not investigated. RsmA is considered a global 
regulator that controls the expression of many P. aeruginosa genes by binding to mRNAs (29). 
Two noncoding RNAs, RsmY and RsmZ, counteract RsmA (29, 30). In this study, we sought to 
determine how AlgR activates rsmA and further investigate the role of RsmA in P. aeruginosa 
strains containing an mucA mutation. We further examined rsmY and rsmZ expression in algR 
mutant strains.  
 We demonstrate that AlgR directly activates rsmA expression in a phosphorylation- 
independent manner and that both AlgR and AlgU are important in activating rsmA expression in 
mucoid strains. The activity of RsmA is not thought to be significant in chronic infecting strains, 
such as mucA mutants. However, we also provide evidence that RsmA is active in mucoid P. 
aeruginosa. Altogether, our work shows that the two-component regulator AlgR can affect gene 
expression through RsmA, providing another mechanism for how AlgR impacts virulence gene 
regulation. We postulate that AlgR and RsmA likely function as a rheostat, as opposed to a 
switch, and suggest that RsmA plays a role in chronic infections.  
 
MATERIALS AND METHODS 
Strains, plasmids, and media. 
 The strains used in this study are presented in Table 1. Escherichia coli strains were 
maintained on LB (Difco) plates or broth without or with antibiotics as appropriate. 
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Pseudomonas aeruginosa strains were grown on Pseudomonas isolation agar (PIA), LB, or 
Vogel-Bonner minimal medium (64) and supplemented with the appropriate concentration of 
antibiotics. For E. coli, antibiotics were used at the following concentrations when appropriate: 
10 µg/ml tetracycline, 15 µg/ml gentamicin, 100 µg/ml ampicillin, and 35 µg/ml kanamycin. For 
Pseudomonas strains, antibiotics were used at the following concentrations: 150 µg/ml 
gentamicin, 50 µg/ml tetracycline, and 300 µg/ml carbenicillin. For allelic exchange, sucrose 
was supplemented at 10% in YT (1% tryptone and 0.5% yeast extract) medium.  
Table 1. Strains and plasmids used in this study. 
Strain or plasmid  Genotype or relevant propertiesa  
 
Reference or 
source  
 
E. coli strains    
NEB5α  fhuA2 Δ(argF-lacZ)U169 phoA 
ø80Δ(lacZ)M15 gyrA96 
New England 
BioLabs  
   
pRK2013  Helper strain  67  
Plasmids    
pEX18Tc  Allelic exchange vector 66 
pEX18Gm   Allelic exchange vector 66 
pEX18Tc ΔrsmA  Allelic exchange for rsmA nonpolar 
deletion  
31 
pEX18Tc ΔalgR Allelic exchange for algR nonpolar deletion 31 
algZHSDM/pEX18Gm  Allelic exchange for making algZ mutant This study 
rsmAHA/pEX18Gm  Allelic exchange for rsmA HA allele 31 
pGEX4T-3  GST fusion vector GE Healthcare 
 82 
pGEX4T-3 algR GST fusion vector AlgR purification This study 
 miniCTXlacZ  Transcriptional fusion vector 73 
rsmATF1-lacZ Transcriptional fusion 31 
 rsmATF3-lacZ  Transcriptional fusion 31 
rsmATF2-lacZ  Transcriptional fusion 31 
rsmYTF1-lacZ  Transcriptional fusion This study  
rsmYTF2-lacZ Transcriptional fusion This study 
 rsmYTF3-lacZ  Transcriptional fusion This study 
rsmZTF1-lacZ Transcriptional fusion This study 
 rsmZTF2-lacZ  Transcriptional fusion This study 
lacUV5CTXCP  Transcriptional fusion This study 
lacUV5 tssA-lacZ Leader fusion vector This study  
 lacUV5 hcnA-lacZ  tssA1 leader fusion This study 
P. aeruginosa strains    
PAO1  Wild type 74 
ΔalgR mutant algR mutant 75 
 D54N mutant algR with asparagine instead of aspartate at 
residue 54 algR  
This study  
 D54E mutant algR with glutamate instead of aspartate at 
residue 54 
This study  
 algZ mutant  algZ mutant This study 
mucA22 mutant  mucA22 mutant 76 
mucA22 ΔalgR mutant  mucA22 ΔalgR mutant This study 
mucA22D54N mutant  mucA22 mutant strain with algR with 
asparagine instead of aspartate at residue 54 
This study 
mucA22D54E mutant mucA22 mutant strain with algR with 
glutamate instead of aspartate at residue 54 
This study 
 mucA22 algZ mutant  mucA22 mutant strain, algZ mutation This study 
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ΔrsmA mutant  rsmA nonpolar deletion 31 
mucA22 ΔrsmA mutant  rsmA nonpolar deletion in mucA22 strain  31 
ΔrsmY mutant  rsmY nonpolar deletion mutant  This study 
ΔrsmZ mutant rsmZ nonpolar deletion mutant This study 
 PAO1 rsmATF1-lacZ  rsmA transcriptional fusion strain 31 
ΔalgR TF1-lacZ mutant  rsmA transcriptional fusion strain 31 
D54N rsmATF1-lacZ mutant  rsmA transcriptional fusion strain This study 
D54E rsmATF1-lacZ mutant  rsmA transcriptional fusion strain This study 
mucA22D54N rsmATF1-lacZ rsmA transcriptional fusion strain This study 
 mutant mucA22D54E 
rsmATF1-lacZ mutant  
rsmA transcriptional fusion strain This study 
mucA22 algZ mutant  rsmA transcriptional fusion strain This study 
mucA22 TF1-lacZ mutant  rsmA transcriptional fusion strain 31 
mucA22 ΔalgR rsmATF1-lacZ 
mutant  
rsmA transcriptional fusion strain 31 
PAO1 rsmATF3-lacZ  rsmA transcriptional fusion strain 31 
 
ΔalgR rsmATF3-lacZ mutant  rsmA transcriptional fusion strain 31 
 
mucA22 TF3-lacZ mutant  rsmA transcriptional fusion strain 31 
mucA22 ΔalgR rsmATF3-lacZ 
mutant  
rsmA transcriptional fusion strain This study  
 
PAO1 rsmATF2-lacZ  rsmA transcriptional fusion strain This study  
 
ΔalgR rsmATF2-lacZ mutant  rsmA transcriptional fusion strain This study  
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mucA22 rsmATF2-lacZ mutant  rsmA transcriptional fusion strain This study  
 
mucA22 ΔalgR rsmATF2-lacZ 
mutant  
rsmA transcriptional fusion strain This study  
 
PAO1 rsmYTF1-lacZ mutant  rsmY transcriptional fusion strain This study  
 
ΔalgR rsmYTF1-lacZ mutant  rsmY transcriptional fusion strain This study  
 
algZ rsmYTF1-lacZ mutant  rsmY transcriptional fusion strain This study  
 
mucA22 rsmYTF1-lacZ mutant  rsmY transcriptional fusion strain This study  
 
mucA22 ΔalgR rsmYTF1-lacZ 
mutant  
rsmY transcriptional fusion strain This study  
 
mucA22 algZ mutant rsmY transcriptional fusion strain This study  
 
 PAO1 rsmYTF2-lacZ  rsmY transcriptional fusion strain This study  
 
ΔalgR rsmYTF2-lacZ mutant  rsmY transcriptional fusion strain This study  
 
mucA22 rsmYTF2-lacZ mutant  rsmY transcriptional fusion strain This study  
 
mucA22 ΔalgR rsmYTF2-lacZ 
mutant  
rsmY transcriptional fusion strain This study  
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PAO1 rsmYTF3-lacZ  rsmY transcriptional fusion strain This study  
 
mucA22 rsmYTF3-lacZ mutant  rsmY transcriptional fusion strain This study  
 
PAO1 rsmZTF1-lacZ  rsmZ transcriptional fusion strain This study  
 
ΔalgR rsmZTF1-lacZ mutant  rsmZ transcriptional fusion strain This study  
 
algZ rsmZTF1-lacZ mutant  rsmZ transcriptional fusion strain This study  
 
mucA22 mutant  rsmZ transcriptional fusion strain This study  
 
mucA22 ΔalgR rsmZTF1-lacZ 
mutant  
rsmZ transcriptional fusion strain This study  
 
mucA22 algZ rsmZTF1-lacZ 
mutant  
rsmZ transcriptional fusion strain This study  
 
PAO1 rsmZTF2-lacZ  rsmZ transcriptional fusion strain This study  
 
mucA22 rsmZTF2-lacZ mutant  rsmZ transcriptional fusion strain This study  
 
PAO1HA    PAO1 with epitope-tagged RsmA  31 
ΔalgRHA mutant ΔalgR mutant with epitope-tagged RsmA  This study  
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mucA22HA mutant  mucA22 mutant with epitope-tagged RsmA  
 
31 
mucA22 ΔalgRHA mutant  mucA22 ΔalgR mutant with epitope-tagged 
RsmA  
 
This study  
 
PAO1 lacUV5 hcnA-lacZ 
mutant  
PAO1 with hcnA leader fusion  
 
This study  
 
mucA22 lacUV5 hcnA-lacZ  mucA22 mutant with hcnA leader fusion  
 
This study  
 
mucA22 ΔrsmA lacUV5 hcnA-
lacZ mutant  
mucA22 ΔrsmA mutant with hcnA leader 
fusion  
 
This study  
 
mucA22 ΔalgU lacUV5 hcnA-
lacZ mutant  
mucA22 ΔalgU mutant with hcnA leader 
fusion  
 
This study  
 
mucA22 ΔalgR lacUV5 hcnA-
lacZ mutant  
mucA22 ΔalgR mutant with hcnA leader 
fusion  
 
This study  
 
PAO1 lacUV5 tssA1-lacZ  PAO1 with tssA1 leader fusion  
 
This study  
 
mucA22 lacUV5 tssA1-lacZ 
mutant  
mucA22 mutant with tssA1 leader fusion  
 
This study  
 
mucA22 ΔrsmA lacUV5 tssA1-
lacZ mutant  
mucA22 ΔrsmA mutant with tssA1 leader 
fusion  
 
This study  
 
mucA22 ΔalgU lacUV5 tssA1-
lacZ mutant  
mucA22 ΔalgU mutant with tssA1 leader 
fusion  
 
This study  
 
mucA22 ΔalgR lacUV5 hcnA-
lacZ mutant  
mucA22 ΔalgR mutant with tssA1 leader 
fusion  
 
This study  
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Mutant construction  
 All PCR products were amplified from P. aeruginosa PAO1, unless otherwise noted, 
using Q5 polymerase (New England BioLabs). Crossover PCR (SOE’ing) (65) was used to 
construct deletion mutations and to clone into the suicide vector pEX18Tc or pEX18Gm (66). 
All cloned constructs were confirmed via sequencing. P. aeruginosa strains were conjugated 
with E. coli as a donor strain and the pRK2013-containing helper strain (67). Conjugations were 
performed overnight on LB plates at 30°C, and conjugations were plated for single-crossover 
mutants on the appropriate selective media. Merodiploids were grown without selection and then 
screened for sucrose sensitivity on YT–10% sucrose plates. Mutations were confirmed using 
PCR with primers containing the suffix intF and intR shown in Table 3.2 and sequencing of the 
resulting PCR fragment. Hemagglutinin (HA) tagging of proteins was accomplished using 
primers containing the HA tag at the 3’ end of the gene and introduced as described above using 
the suicide vector pEX18Gm.  
Table 2. Primers used in this study. 
 
 
Primer Name 
 
 
Sequence 
 
 
Use 
algRTJ1F2 GCGCCCATGGGAATGAATGTCCTGATTGTCG
ATGAC 
Overexpression 
algRTJ1R GCGCAAGCTTTCAGAGCTGATGCATCAGAC
GC 
Overexpression 
algRintF GCAACTGGACTGGCAGGTGC Mutant 
algRintR CGCGACTGGTCATCGGCAG Mutant 
algRBamHIR GCGCGGATCCGTCAGAGCTGATGCATCAGA
CG 
Mutant 
   
algZHindIIIF GCGCAAGCTTCTCTCGCTGCAACAAGAAAC
GG 
 
Mutant 
algZSDMcheckF CAGCTGGGCGGAGAACTGAC Mutant 
algRD54XbaIF AACATCCGCATGCCCGGTCTAGACGGC Mutant 
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algRD54NR CAGCAGGACGATATCGGGCTTGA Mutant 
algRD54EF GTCCTTCTAGAGATCCGCATGC Mutant 
algRD54ER GATATCGGGCTTGAGGCTGTCG Mutant 
algZHSDMF GAATTCCTGTTCAACAGCCTGAACAG Mutant 
algZHSDMR CGGGCGAATCCGCGCCTGCA Mutant 
rsmARXbaI GCGCTCTAGAGCACGGTGATCCTGCAGACC Mutant 
rsmAFHindIII GCGCAAGCTTCGGCAACATCACCACGCTGG
G 
Mutant 
rsmASDMcheckF GCCAAGGTTTCCATCGTCGG PCR check 
rsmAHAF TACCCATACGATGTTCCAGATTACGCTTA 
ATTTTTATCTAATTTTCCCTTTGC 
HA allele 
rsmAHAR TTAAGCGTAATCTGGAACATCGTATGGGT 
AATGGTTTGGCTCTTGATCTTTCTC 
HA allele 
rsmASDMAlgUF CAGAATTCTTCATTCCGGCGGGACTG SDM 
rsmASDMAlgUR CCAAACGGTCAAAAACGACAAAAG SDM 
rsmYRPART72 ATGCTAATACGACTCACTATAGGGAGACTG
ACATCCGTGCTACGCCAC 
RPA 
rsmYRPAF CTTGGACGTCAGGACATTGCGCAGGAAG Northern 
rsmYT7RPAR TAATACGACTCACTATAGGGAGACAATAAA
AAACCCCGCCTTTTGGG 
Northern 
rsmZRPAT72 ATGCTAATACGACTCACTATAGGGAGAGTAT
TACCCCGCCCACTCTTCA 
RPA 
rsmZRPAF GGGCCCCACTCCTGCGTACAGGGAACAC 
 
Northern 
rsmZRPART7 TAATACGACTCACTATAGGGAGACAAAAAA
AAGGGGCGGGGTATTAC 
Northern 
rsmYTFFEcoRI GCGCGAATTCGTGTTGCCGTCGGTCCGGC TF 
rsmYTFRBamHI GCGCGGATCCTTCCTGCGCAATGTCCTGACG TF 
rsmYTFFUAS GCGCGCGGCCGCCAGCGTGTAAGCCAAGGC
TTAC 
TF/RPA 
rsmYshortEcoRIF GCGCGAATTCAAACGGCGGTGGTTTTGGCTG TF 
dnrTFRBamHI GCGCGGATCCCCATGCTGGGAAGGCTCGC TF 
rsmZKpnIF GCGCGGTACCCGTCTGGCGCAGAAGGGCG Mutant 
rsmZXbaIR GCGCTCTAGAGAGCGAAACCGCCAACATCC Mutant 
rsmZSOEF GTTTTCTGGCAGGTTGCGGGATTTGCCTGCC
GTTTTACTCGTC 
 
Mutant 
rsmZSOER GACGAGTAAAACGGCAGGCAAATCCCGCAA
CCTGCCAGAAAAC 
Mutant 
rsmZIntF GCGCGCGGCCGCACCGATCCGTGCGAGCTG Mutant 
rsmZintR CATGCAGGAATTCATCGAGCTG Mutant 
rsmYKOF CGCGGAGCTCCTGTTCACTCGAAGCACTCCA
G 
Mutant 
rsmYKOR CGCGTCTAGATTCGCCAACTCCGCTATTTCG Mutant 
rsmYSOEF GCGTAATCTTCAAACCGTCAGGATCCTGCGG Mutant 
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CCCGAGGAAAACCGCGTCG 
rsmYSOER CGACGCGGTTTTCCTCGGGCCGCAGGATCCT
GACGGTTTGAAGATTACGC 
Mutant 
rsmYintF CCTGGAGCTGGACGGGAG Mutant 
rsmYintR GGAATTCAGGAAGGTGTCCC Mutant 
tssA1annealF GATCCTTCGATGATAGGGAGATCGTCACCGT
GCTG 
Leader fusion 
tssA1annealR CAGCACGGTGACGATCTCCCTATCATCGAAG Leader fusion 
5SrRNAI TTGGACAGGATGGGGTTGGA 
 
Northern 
5SrRNA2T7 TAATACGACTCACTATAGGGA 
GACGATTGTGTGTTGTAAGG 
Northern 
   
lacZScaIF GCTATGACCATGATTAGTACTGATTCACTGG
CCGTC 
TLF vector 
lacZRXhoI CCCCTCGAGCAGACATGGCCTGCCCGGTTAT
TA 
TLF vector 
lacZRforTF GATGTGCTGCAAGGCGATTAAG SEQ 
pHERDSF ATCGCAACTCTCTACTGTTTCTC SEQ 
rsmASDMAlgRF GAATTCGGCAGGAACTTTCATTCCGGC RPA 
rsmARPAR TAATACGACTCACTATAGGGAGAGATAAAA
ATTAATGGTTTGGCTCTTG 
RPA 
rsmARSDMF CCTTTTGTCGTTTTTGAGAATTCGGCAGGAA
CTTTCATTC 
Gel Shift 
rsmARSDMR GAATGAAAGTTCCTGCCGAATTCTCAAAAAC
GACAAAAGG 
Gel Shift 
algDBS1F CGCCTCCTGGCGCTACCGTTCGTCCCTCCGA
CACCCCTGCTGCGTCGC 
 
Gel Shift 
algDBS1R GCGACGCAGCAGGGGTGTCGGAGGGACGAA
CGGTAGCGCCAGGAGGCG 
 
Gel Shift 
rsmARBS1F GCGCCTTTTGTCGTTTTTGACCGTTTGGCAG
GAACTTTCATTCCG 
Gel Shift 
rsmARBS1R CGGAATGAAAGTTCCTGCCAAACGGTCAAA
AACGACAAAAGGCGC 
 
 
Gel Shift 
rsmYRBS1F CGGCTGGGTGTTGCCGTCGGTCCGGCGAGCG
GAACTATTACAGCG 
Gel Shift 
rsmYRBS1R CGCTGTAATAGTTCCGCTCGCCGGACCGACG
GCAACACCCAGCCG 
Gel Shift 
pscFRBSF GCTGGCGGAGTGTCGCCGGGAACTGGCCAG
AGG 
Gel Shift 
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Abbreviations: TF, transcriptional fusion, TLF, translational fusion, LF, leader fusion, SEQ, 
sequencing primer; RPA, RNase protection assay 
 
algR mutant construction 
 The wild-type algR genomic region was amplified using Q5 (NEB) and primers 
algRXbaIR and algRHindIIIF and cloned into pEX18Tc. Site-directed mutagenesis was 
performed using the algRD54XbaIF/algRD54NR primers for the D54N allele or the 
algRD54EF/algRD54ER primer pair for the D54E mutation. The algZ mutant was constructed 
using the algZHSDMF/algZHSDMR primers. The primers were phosphorylated and used in site-
directed mutagenesis, in accordance with the manufacturer’s instructions, using Q5 (NEB). 
Constructs were analyzed by restriction enzyme analysis and sequencing. Mutant strains were 
constructed using homologous recombination, as described above, and were checked using PCR 
and the algRintF/algRintR primer pair and digestion with the appropriate restriction enzyme. 
pscFRBSR CCTCTGGCCAGTTCCCGGCGACACTCCGCCA
GC 
Gel Shift 
rsmYEMSAR2 GGGCGGGGTTTTGCAGACCT Gel Shift 
rsmZEMSAR2 GTATTACCCCGCCCACTCTTCA Gel Shift 
rsmAPE1F GCGCGGTACCAAGGATCGCGCTCTTGATTTC
TGCGGATCCGCCGCCATTTCTT 
Gel Shift 
rsmAPE3F GCGCGGTACCGCTGACAGGCGAAAGGCG Gel Shift 
rsmAPE3R GCGCGGATCCTCACCCAGTATTGACCAGTCC Gel Shift 
rsmAEcoRIR GCGCGAATTCACGAGTCAGAATCAGCATTCC
TTTC 
Gel shift 
rsmAR1SDMannealF CCGCGGAATTCGTCGTTTTTGACCGTTTGGC
AGGAACTTTC 
Gel Shift 
rsmAR1SDMannealR GAAAGTTCCTGCCAAACGGTCAAAAACGAC
GAATTCCGCGG 
Gel Shift 
rsmAR2SDMannealF CCGCGGAATTCGTCGTTTTTGAGAATTCGGC
AGGAACTTTC 
Gel Shift 
rsmAR2SDMannealR GAAAGTTCCTGCCGAATTCTCAAAAACGAC
GAATTCCGCGG 
Gel Shift 
rsmAGSWTannealF CCGCGCCTTTTGTCGTTTTTGACCGTTTGGCA
GGAACTTTC 
Gel Shift 
rsmAGSWTannealR GAAAGTTCCTGCCAAACGGTCAAAAACGAC
AAAAGGCGCGG 
Gel Shift 
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Additional PCR amplicons were sequenced to confirm the mutation in each strain using the same 
primers. Further confirmation of mutants was done using phenotypic assays.  
Transcriptional and translational leader fusion analysis  
 Upstream DNA fragments containing promoter regions were generated by using primers 
listed in Table 1 in conjunction with Q5 polymerase (New England BioLabs). PAO1 genomic 
DNA was used as the template. PCR products were cloned into pMiniT (NEB) and then 
subcloned into miniCTXlacZ using the restriction enzymes HindIII and BamHI, HindIII and 
EcoRI, or KpnI and BamHI (NEB). The rsmA transcriptional fusions have been previously 
described (31). To construct rsmY and rsmZ transcriptional fusions, the 
rsmYTFFEcoRI/rsmYTFR and rsmZTFF/rsmZTFR primer pairs, respectively, were used. PCR 
products were purified, cut with restriction enzymes, and inserted into the EcoRI and BamHI 
sites of miniCTXlacZ using T4 DNA ligase (NEB). The leader fusion vector was constructed by 
annealing the lacUV5NotI/lacUV5BamHI primer pair together and cloning into the NotI/BamHI 
site of CTXCP (31). Translational/leader fusions were constructed using the tssA1annealF/R and 
hcnAannealF/R primer pairs (Table 1) and were cloned into the ScaI/BamHI site of the leader 
fusion vector. Fusion constructs were confirmed by sequencing and conjugated into P. 
aeruginosa strains by triparental conjugation. Strains were selected for tetracycline resistance 
and then conjugated with pFLP2 to remove vector sequences (66). Strains were selected for 
carbenicillin resistance, grown overnight without selection, and plated on YT medium with 10% 
sucrose to select for the loss of pFLP2. Individual colonies were patch-plated onto VBMM 
CB300 and PIA to ensure the loss of pFLP2. To confirm the presence of the fusion constructs, 
PCR was performed using the forward primer used to construct the fusion and the reverse primer 
lacZRforTF (Table 1). b -Galactosidase activity was determined by incubating cell extracts with 
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o-nitrophenyl- b -D-galactopyranoside (ONPG) (4 mg/ml), as described by Miller (68). A strain 
carrying the empty vector miniCTXlacZ was also conjugated into PAO1 and assayed, and this 
background (28 Miller units) was subtracted from all transcriptional fusions. The 
translational/leader fusion backbone CTXCPlacUV5 had no background activity. All mucoid 
strains were confirmed mucoid at the end of each experiment by plating on PIA plates to ensure 
all colonies were mucoid. Three biological replicates were reproduced for all assays.  
AlgR purification  
 The algR gene was PCR amplified using Q5 (NEB) and PAO1 chromosomal DNA using 
oligonucleotides algRSal1F and algRNot1R (Table 1). A 754-bp SalI/NotI fragment was cloned 
into pGEX-4T-3 (Novagen) to be expressed as a glutathione S-transferase–AlgR (GST-AlgR) 
fusion protein. The resulting plasmid (pGEX-4TAlgR) was transformed into E. coli BL21(DE3) 
(NEB) cells and incubated overnight. The colonies from this transformation were collected, 
inoculated into LB supplemented with 100 µg/ml ampicillin, and grown to an optical density at 
600 nm (OD600) of 0.6; 0.2 mM isopropyl-b-D- galactopyranoside (IPTG) was added to induce 
AlgR expression for 4 h at 15°C. The cells were collected by centrifugation (6,740 x g, 15 min), 
washed once in 20 ml of phosphate-buffered saline (PBS), and resuspended in 1 ml of PBS 
containing protease inhibitors (Thermo Fisher). AlgR was purified from this supernatant using 
the GST spin purification kit (Thermo Fisher). After binding of the fusion protein and washing 
the column, AlgR was cleaved away from GST with 10 U of thrombin/column overnight at 
22°C. Purified protein was dialyzed using a Slide-A-Lyzer (Thermo Fisher) and storage buffer 
(20% glycerol, 20 mM Tris [pH 7.5], 5 mM MgCl2, and 1 mM dithiothreitol [DTT]) overnight at 
22°C. The identity of the purified protein was determined by mass spectrometry. The purity of 
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AlgR was visually determined in a Coomassie-stained 7.5% electrophoresis gel (SDS-PAGE).  
EMSAs 
 Purified AlgR was used in electrophoretic mobility shift assays (EMSAs) using either 
PCR amplicons or annealed primers using the LightShift kit, in accordance with the 
manufacturer’s instructions (Thermo Fisher Scientific). For rsmA, the rsmAPE3F/rsmAPE3R, 
rsmAPE1F/rsmAEcoRIR, or rsmAPE3F/ rsmAEcoRIR primer pair was used to produce PCR 
amplicons using Taq polymerase (NEB). Amplicons were gel extracted and biotinylated using 
the 3’ biotinylation kit (Thermo Fisher Scientific). Annealed primers were heated to 95°C for 5 
min and cooled to room temperature. The annealed primers were biotinylated and incubated with 
purified AlgR. Purified AlgR was incubated at increasing concentrations to determine the 
suitable concentrations to be used. The nonspecific competitor poly(dI-dC) at 25 ng/µl was used 
for all gel shift reactions. DNA and protein were electrophoresed through 5% or 10% native 
polyacrylamide gels, transferred to a nylon membrane using a semidry apparatus (Hoefer), UV 
cross- linked, developed using the chemiluminescence detection kit (Thermo Fisher Scientific), 
and visualized using a charge-coupled-device (CCD) camera (ProteinSimple). The gel shift 
assays were repeated at least two times.  
Western blot analysis 
 P. aeruginosa strains were grown in LB at 37°C for 8 h. The bacteria were collected by 
centrifugation, resuspended in sterile PBS, and lysed by sonication using a Branson sonifier. 
Total protein concentrations were determined by the Bradford protein assay (Bio-Rad, Carlsbad, 
CA). Cell extracts (5 to 10 µg) were separated by 15% SDS-PAGE gels and transferred to a 
polyvinylidene difluoride membrane (Bio-Rad). The membranes were blocked and probed using 
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a 1:2,500 dilution of anti-HA monoclonal antibody in blocking buffer (Thermo Fisher, 
Pittsburgh, PA), followed by a 1:30,000 dilution of horseradish peroxidase-conjugated goat anti-
rabbit antibody (69). Densitometry of Coomassie-stained SDS-PAGE gels was used to 
standardize the Western blots using total protein analysis, as described previously (70, 71). 
Detection was performed using the ECL Plus kit (Thermo Fisher) and chemiluminescence 
detection (ProteinSimple, Santa Clara, CA). The blots and Coomassie-stained SDS-PAGE were 
analyzed using ImageJ analysis. All Western blotting was repeated at least four times.  
Primer extension 
  Total RNA (15 µg) from P. aeruginosa was isolated using the PureLink RNA minikit 
(Life Technologies, Grand Island, NY). Radiolabeled primers rsmYPE1 and rsmZPE1 (see Table 
1) were used in a reverse transcription reaction using ThermoScript (Life Technologies). A 
temperature of 42°C was used for the extension. The same primer used for primer extension was 
also used in a sequencing reaction with the rsmY or rsmZ upstream sequence in pGEM-T 
(Promega, Madison, WI) using the Sequenase 7-deaza-deoxy-GTP (7-deaza-dGTP) kit 
(Affymetrix, Cleveland, OH). Both primer extensions and sequencing reactions were run on a 
6% acrylamide-8 M urea gel. The gel was dried and extension products detected using 
autoradiography.  
In vitro transcription and RPA 
 The rsmA, rsmY, and rsmZ probes for RNase protection assay (RPA) were synthesized 
using a PCR product generated with primers that incorporated a T7 promoter sequence at the 5= 
end and using the MAXIscript T7 kit (Life Technologies) (Table 1). The reverse primer 
containing the T7 promoter sequence contained a nonhomologous sequence to discriminate 
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between the full- length probe and protected fragments. The primers rsmASDMAlgRF and 
rsmARPAR were used to produce the PCR product for rsmA. The rsmYRPAT&R/rsmYRPAF 
primer pair for rsmY or rsmZRPAT7RPAF/ rsmZRPAF primer pair for rsmZ was used to 
produce probes for the appropriate target. Probes were labeled by biotin-11-UTP (Life 
Technologies) at a ratio of 4:6 with UTP and were gel purified after in vitro transcription. Five 
micrograms of total RNA from each P. aeruginosa strain was precipitated with 800 pg of labeled 
probe and resuspended in hybridization buffer [80% formamide, 400 mM NaCl, 40 mM 
piperazine-N,N=-bis(2-ethanesulfonic acid) (PIPES) (pH 6.4), 1 mM EDTA], heated 95°C for 5 
min, and incubated overnight at 42°C. Negative controls using the probe incubated with 10 µg of 
yeast RNA were also included. Digestion of unhybridized RNA was performed using RNase A 
at 25 mg/ml and RNase T1 at 10 U/ml. A biotinylated RNA ladder (Kerafast) was also used to 
determine the size of protected probe fragments. The reactions were run on a 5% acrylamide-8 M 
urea gel for rsmA and a 10% acrylamide-8 M urea gel for rsmY and rsmZ. RNA was transferred 
to a positively charged membrane (Hybond N+; Amersham Biosciences) using a semidry 
blotting system and 0.5X Tris-borate-EDTA (TBE; Hoefer, Holliston, MA). Nucleic acid was 
UV cross-linked and probes detected using the chemiluminescent nucleic acid detection module 
(Thermo Scientific). After washing, the blot was incubated for 5 min and developed using a 
FluorChem M (ProteinSimple). RNase protection assays were performed at least three times.  
Northern blot analysis 
 Total RNA was extracted from strains using the PureLink RNA minikit (Thermo Fisher). 
RNA was quantitated using a NanoDrop (Thermo Fisher). Two to 5 µg of total RNA was 
electrophoresed through a 10% acrylamide-8 M urea gel using formaldehyde-loading buffer. 
After electrophoresis, RNA was transferred using a semidry blotter (Hoefer, Holliston, MA) at 
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300 mAmp for 45 min and the membranes cross-linked using UV light (Bio-Rad). Probes 
produced by in vitro transcription were biotin labeled and hybridized to the membrane using 
ULTRAhyb buffer (Thermo Fisher) at 65°C overnight. The primers used to make probes for 
rsmY and rsmZ are listed in Table 2. For rsmY, the rsmYRPAF/rsmYT7RPAR primer pair was 
used. For rsmZ, the rsmZRPAF/rsmZRPART7 primer pair was used. Membranes were washed 
with two 5-min low-stringency washes at room temperature and 2 high-stringency washes for 15 
min at 65°C. Blots were developed using the chemiluminescence detection kit (Thermo Fisher), 
in accordance with the manufacturer’s instructions. For normalization, 5S RNA probes (Table 2) 
made by in vitro transcription were used using primers 5SrRNAI and 5SrRNA2T7. Northern 
blotting was repeated more than three times.  
Statistical analyses 
 Statistical analyses were performed using Graph- Pad Prism (version 6.0) software 
(GraphPad Software, La Jolla, CA). The results of transcriptional and translational fusions and 
densitometry analysis were compared using a one-way analysis of variance (ANOVA) with 
Tukey’s posttest. ImageJ software was used for Western blot analysis.  
RESULTS 
mucA mutant strains require AlgR for increased rsmA expression 
 Previous studies suggested that AlgU and AlgR control rsmA expression (28, 31). 
However, whether both AlgZ and AlgR were involved in the control of rsmA expression was not 
tested. We constructed and assayed an rsmA transcriptional fusion (Fig. 3.1A) that contains both 
rsmA promoters (rsmATF1-lacZ). The rsmATF1-lacZ fusion was analyzed in the wild-type 
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strain P. aeruginosa PAO1, ΔalgR and algZ mutants, and in the corresponding mucA22 mutants. 
The algZ mutant has a mutation in the conserved histidine residue, which prevents AlgZ-
 Figure 3.1 AlgR, but not AlgZ, is necessary for increased rsmA expression in mucoid 
strains. (A) Schematic of rsmA genomic region. The sequence below the genomic schematic 
indicates the AlgU-dependent promoter region. Underlined sequences are potential AlgR-
binding sites. The bent arrow and bold nucleotide indicate the transcriptional start sites. The 
rsmA transcriptional fusion rsmATF1-lacZ used in this study is listed below. Arrows indicate 
the primers used and the numbers indicate the primer locations relative to the translational 
start site. (B) The transcriptional fusion rsmATF1-lacZ (Fig. 1A) was assayed in the indicated 
strains after growth for 8 h in LB broth. Significant differences from the wild type were 
determined using a one-way analysis of variance and Tukey’s posttest. Asterisks indicate P 
values of 0.01 (*) and <0.0001 (***). (C) Western blot analysis of the indicated strains 
containing an HA-tagged rsmA allele. PAO1 without the rsmAHA allele was run as a negative 
control. Densitometry analysis was performed using a duplicate gel and staining for total 
protein using Coomassie blue, and all strains were normalized to PAO1 containing the 
rsmAHA allele. Western blotting was performed four times, and densitometry analysis is 
indicated below the Western blot. A representative Western blot is shown above the 
densitometry. A one-way ANOVA with Tukey’s posttest was used to determine statistical 
significance. **, P <0.001; ***, P < 0.0001.  
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mediated phosphorylation of AlgR (19, 32) but does not disrupt the internal algR promoter (33). 
As shown in Fig. 1B, there was a slight increase in rsmATF1-lacZ activity in a ΔalgR mutant. 
When the rsmATF1-lacZ fusion was assayed in an algZ mutant strain, there was also a slight 
increase in reporter activity (Fig. 3.1B). The modest increase in reporter activity suggests that 
AlgZ and AlgR have a minor role in rsmA regulation in strain PAO1.  
 As previous studies also indicated a role for AlgU in regulating rsmA expression, the 
rsmATF1-lacZ transcriptional fusion was assayed in a mucA22 strain, where AlgU is most 
active. Reporter activity was increased ~3-fold in a mucA22 strain, as previously described (31) 
(Fig. 3.1B). However, in the mucA22 ΔalgR double mutant, there was a drastic decrease (~3-
fold) in rsmATF1-lacZ activity (Fig. 3.1B). The mucA22 algZ mutant strain had rsmATF1-lacZ 
activity almost identical to that of the mucA22 mutant strain (Fig. 3.1B). These data implicate 
AlgR but not AlgZ in rsmA regulation in a mucA22 mutant strain and suggest that AlgR 
phosphorylation is not necessary for rsmA activation.  
 To confirm that AlgR affected rsmA expression, an epitope-tagged rsmA allele was 
introduced  into the wild-type strain (PAO1), mucA22 mutant, and respective algR mutant strains 
and analyzed by Western blot analysis. As shown in Fig. 3.1C, a slight decrease in RsmA levels 
in the ΔalgR mutant strain was detected compared to the wild-type strain PAO1. As reported 
previously (31), a mucA22 mutant strain had drastically increased RsmA levels (Fig. 3.1C). The 
mucA22 ΔalgR mutant strain had significantly decreased RsmA compared with the mucA22 
mutant strain (Fig. 3.1C). The Western blot analysis confirmed the transcriptional fusion analysis 
and supported a significant role for AlgR activating rsmA in the mucoid mucA22 mutant strain 
but not in the nonmucoid strain PAO1.  
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AlgR phosphorylation is not required for activation of rsmA expression  
 To further investigate the role of AlgR phosphorylation in the regulation of rsmA, algR 
site-directed mutants were constructed that mimic either the unphosphorylated (D54N) or 
phosphorylated form of AlgR (D54E). The algRD54N and algRD54E mutant alleles were also 
constructed in the mucA22 mutant background to confirm a phosphorylation- independent mode 
of AlgR activation of rsmA. Both the mucA22 algRD54N and the mucA22 algRD54E mutant 
strains were mucoid (data not shown), supporting the notion that phosphorylation is not 
necessary for alginate production and that the mutant AlgR proteins produced in these strains 
were still functional. The mucA22D54N mutant had increased rsmA reporter activity compared 
to a mucA22 mutant strain (Fig. 3.2). The mucA22 algRD54E strain had decreased rsmATF1-
 
Figure 3.2 AlgR phosphorylation is not required for rsmA activation. Mutants containing 
either a mutated aspartate to asparagine (D54N) or aspartate to glutamate (D54E) were 
constructed in both the wild-type background PAO1 and the mucA22 mutant background. The 
rsmA transcriptional fusion rsmATF1-lacZ was introduced into the strains indicated, resulting 
in single-copy chromosomal transcriptional fusions. The indicated strains were grown for 8 h 
in LB broth and assayed for b-galactosidase activity. Values indicate the actual b -
galactosidase activity minus the vector control (~28 Miller units). Differences from the wild-
type strain PAO1 or mucA22 mutant were determined using a one-way analysis of variance 
and Tukey’s posttest. Triple asterisks indicate P values of <0.0001.  
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lacZ activity compared to the mucA22 mutant (Fig. 3.2). Because the mucA22 algRD54N and the 
mucA22 algZ mutant strains had elevated and similar levels, respectively, of rsmATF1-lacZ 
activity (Fig. 3.2 and 3.1B, respectively) compared to the mucA22 mutant strain, this suggests 
that phosphorylation of AlgR is not required for rsmA activation. 
AlgR regulates the distal rsmA promoter  
 Previous work determined that rsmA has two promoters (31). An RNase protection assay 
was performed using a probe spanning the upstream region of rsmA (Fig. 3.3A) to determine 
which rsmA message AlgR affected. As we previously reported (31), two rsmA messages were 
seen in both the wild-type strain PAO1 and the mucA22 mutant strain, with the longer transcript 
increased in the mucA22 mutant strain (Fig. 3.3B). There was little difference in the rsmA 
transcripts between PAO1 and the ΔalgR mutant (Fig. 3.3B). In contrast, there was a substantial 
decrease in the longer rsmA transcript in the mucA22 ΔalgR mutant strain compared to the 
mucA22 parent strain (Fig. 3.3B). The specificity of the rsmA probe was confirmed using the 
probe incubated with yeast tRNA (-RNase) and using a ΔrsmA mutant (Fig. 3.3B). These results 
suggest that AlgR is most important for rsmA control in the mucA22 background and that AlgR 
controls the distal rsmA promoter that is also under control by AlgU.  
 To confirm that AlgR regulates the distal rsmA promoter, transcriptional fusions 
containing individual rsmA promoters were used (Fig. 3.3A; see also Fig. 3.S1A in the 
supplemental material). The transcriptional fusion rsmATF2-lacZ contains only the proximal 
rsmA promoter (Fig. 3.S1A). The transcriptional fusion rsmATF3-lacZ (Fig. 3.3A) contains only 
the distal promoter that has been shown to be controlled by AlgU (31). The deletion of algR had 
no effect in the rsmATF2-lacZ transcriptional fusion in the wild-type or a mucA22 background 
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Figure 3.3 AlgR controls the distal AlgU- 
dependent rsmA promoter. (A) Schematic of the  
RNase protection assay probe used. Numbers indicate  
distances from the rsmA translational start site. The 
transcriptional fusion rsmATF3-lacZ is indicated at 
the bottom. Arrows indicate the primers used and  
their location in reference to the rsmA translational 
start site. (B) A representative RNase protection  
assay performed on the indicated strains after 8 h  
of growth in LB broth. Total RNA was isolated  
from each strain and hybridized to 800 pg of  
biotinylated rsmA probe. After treatment with  
RNase A/RNase T1, protected probe fragments  
were detected after electrophoresis through a  
denaturing polyacrylamide gel and transfer to a  
nylon membrane. Protected probe fragments are  
indicated by solid arrows. The broken arrow  
indicates a full-length probe. Biotinylated molecular 
size markers are indicated to the left. RNase  
protection assays were performed three times.  
(C) The rsmA transcriptional fusion rsmATF3-lacZ 
 was introduced into the indicated strains to  
generate strains containing single-copy  
chromosomal fusions. The strains were grown for  
8 h in LB broth and assayed for b -galactosidase  
activity minus the vector control. Differences  
from the wild-type strain PAO1 or mucA22 mutant 
were determined using a one-way analysis of  
variance and Tukey’s posttest. Triple asterisks  
indicate P values of <0.0001. Fusion analysis  
was performed in triplicate three times.  
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 (Fig. 3.S1B). The transcriptional fusion rsmATF3-lacZ had increased reporter activity in a 
mucA22 mutant strain compared to that in PAO1 (Fig. 3.3C). Compared to PAO1, no change in 
rsmTF3-lacZ activity was seen in a ΔalgR mutant strain (Fig. 3.3C). However, algR deletion in a 
mucA22 mutant strain (mucA22 ΔalgR) resulted in a significant decrease in rsmATF3-lacZ 
activity (Fig. 3.3C), supporting the RNase protection assay. Taking these results together, we 
conclude that AlgR activates the distal rsmA promoter, and this further suggests that AlgU and 
AlgR both are required to activate rsmA transcription from the distal promoter.  
AlgR directly binds the distal rsmA promoter  
 We hypothesized that AlgR directly activated the distal rsmA promoter. In support of this 
idea, two potential AlgR-binding sites are located upstream of rsmA. One of the potential AlgR-
binding sites is 2 nucleotides away from the AlgU -35 consensus promoter (Fig. 3.4A). Purified 
AlgR was tested in gel shift studies with biotinylated rsmA promoter fragments (Fig. 3.4A). A 
biotinylated pscF gene, a component of the T3SS (34, 35), was used as a negative control and 
did not shift when incubated with purified AlgR (Fig. 3.4B to D). A PCR fragment representing 
the entire rsmA upstream region containing both promoters was dramatically shifted using 
purified AlgR (Fig. 3.4B), suggesting that AlgR directly binds to at least one of the AlgR-
binding sites upstream of rsmA. To further define the region upstream of rsmA that was bound by 
AlgR, PCR amplicons that corresponded to the transcriptional fusion constructs containing 
individual rsmA promoters (Fig. 3.4A) were biotinylated and tested via gel shift analysis. A 
biotinylated probe containing the proximal promoter (TF2) and upstream sequence to the more 
distal transcriptional start site did not shift when incubated with purified AlgR (Fig. 3.4B). This 
result suggested that AlgR does not bind the proximal rsmA promoter. As shown in Fig. 3.4B, 
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Figure 3.4 AlgR directly binds the AlgU-dependent rsmA promoter and requires both 
AlgR-binding sites. Purified AlgR was incubated with either biotinylated PCR products or 
annealed primers. (A). Schematic of the rsmA genomic region. Below are fragments or 
annealed primers and the approximate location upstream of rsmA. Promoters are indicated 
above as bent arrows and are denoted by PAlgU or PRpoD. The arrowheads indicate the 
approximate location of the putative AlgR-binding sites. (B) Analysis of biotinylated PCR 
fragments in gel shift studies. The PCR fragment TF1 represents the entire rsmA upstream 
region (see panel A). Fragments TF2 and TF3 correspond to the separated rsmA promoters 
(see Fig. 1). TF2 corresponds to the proximal rsmA promoter, and TF3 corresponds to the 
distal AlgU-dependent promoter. A minus sign indicates probe alone. A plus sign indicates 
AlgR concentration of 2.5 µM. pscF was used as a negative control. Shaded arrowheads 
indicate shifted fragments. White arrowheads indicate unbound probe. (C) Titration and 
competition assay using purified AlgR and the TF3 fragment corresponding to the distal rsmA 
promoter. The pscF fragment was used as a negative control. TF3 was incubated with 
different concentrations of AlgR (indicated by the graded triangle; 0.05, 0.25, 1.25, and 2.5 
µM). TF3 was also used in a competition assay using unlabeled TF3 as a competitive 
inhibitor. Ratios below indicate the ratio of labeled to unlabeled probe. Shaded arrowheads 
indicate shifted fragments. White arrowheads indicate unbound probe. A minus sign indicates 
probe alone. (D) Two AlgR-binding sites are upstream of the distal rsmA promoter. Annealed 
primers containing either wild-type or two different mutated AlgR-binding sites were tested in 
gel shift experiments. The pscF fragment was used as a negative control. The rsmA lanes 
indicate the probe using annealed primers with both AlgR-binding sites intact. M1 indicates 
the same as rsmA, except that the furthest upstream AlgR-binding site was mutated. M2 
indicates the same as rsmA, except that the further downstream AlgR-binding site is mutated. 
Shaded arrowheads indicate shifted fragments. White arrowheads indicate unbound probe. 
Minus signs indicate probe alone. Plus signs indicate an AlgR concentration of 2.5 µM. 
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AlgR bound the distal promoter sequence fragment, TF3, containing the AlgU-dependent 
promoter and potential AlgR-binding sites. The TF3 fragment containing the AlgU promoter was 
tested in a competition assay using increasing concentrations of AlgR and unlabeled probe. A 1:1 
ratio of labeled to unlabeled probe was capable of decreasing the shift of the TF3 probe (Fig. 
3.4C). Competition with the unlabeled specific probe in a 1:5 or 1:10 ratio was able to compete 
for AlgR binding, as indicated by severe reduction of the probe shift (Fig. 3.4C). These data 
suggest that AlgR specifically binds the AlgU- dependent promoter region and strongly suggests 
that AlgR binds at least one of the AlgR consensus sequences located in this promoter region.  
 AlgR has previously been shown to bind an 11-bp consensus sequence, with nucleotides 
2 to 10 being the most conserved (36). To determine if one, or both, of the putative AlgR-binding 
sites were required for AlgR binding, we used annealed primers upstream of the distal promoter 
in gel shift analyses. Approximately 30-bp primers were annealed and biotinylated that contained 
the predicted AlgR-binding sites. AlgR was able to shift the annealed biotinylated primers 
containing the two predicted AlgR-binding sites (Fig. 3.4D). The first putative AlgR-binding 
site, CCTTTTGTC, was mutated, and this mutation resulted in a loss of AlgR binding (Fig. 
3.4D), suggesting that the first AlgR-binding site is required for AlgR binding to the rsmA 
promoter. The second putative AlgR-binding site, CCGTTTGGC, is located 7 bp downstream 
and directly adjacent to the AlgU -35 consensus sequence. When the second AlgR-binding site 
was mutated, AlgR was no longer able to bind to the annealed primers (Fig. 3.4D). These data 
suggest that AlgR binds both of the consensus sequences in order to activate rsmA expression.  
AlgR regulates rsmY expression indirectly  
 A previous study indicated that rsmY and rsmZ expression was also increased in a mucA 
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mutant background and required AlgR (28). The transcriptional start site of rsmY was determined 
in Pseudomonas fluorescens using 5’ rapid amplification of cDNA ends (RACE), and this 
information was used to deduce the transcriptional start site in P. aeruginosa (30, 37). To 
confirm the P. aeruginosa rsmY transcriptional start site, we performed primer extension. As 
indicated in Fig. 3.5A, a single extension product was obtained after reverse transcription of total 
RNA that confirmed the rsmY transcriptional start site assigned using P. fluorescens.  
 A transcriptional fusion, rsmYTF1-lacZ (Fig. 3.5B), was constructed and assayed in algR 
and algZ mutants in both the PAO1 (wild-type) and the mucA22 background. When a ΔalgR or 
algZ mutant was tested for rsmY reporter activity, there was no decrease compared to PAO1 
(Fig. 3.5C). There was a ~3-fold increase in rsmYTF1-lacZ activity in a mucA22 mutant strain 
Figure 3.5 AlgR indirectly increases rsmY expression in a mucA22 mutant strain. (A) 
Primer extension analysis performed on total RNA from strain PAO1. GATC indicates the 
sequencing ladder. -C is a control without reverse transcriptase. PAO1 is reverse-transcribed 
PAO1 mRNA. Below is the sequence of the rsmY promoter region. The asterisk denotes the 
transcriptional start site identified. (B) Schematic of the rsmY genomic region. The UAS is 
indicated between the numbers from the transcriptional start site. The bent arrows above 
indicate the primers used for the transcriptional fusions, and the numbers correspond to the 
distance from the transcriptional start site. P and the bent arrow indicate the start site of 
transcription. The arrowheads represent potential AlgR-binding sites. The bent arrow below 
indicates the primer used in the primer extension experiment. Indicated below is the probe 
generated by in vitro transcription for Northern analysis. Transcriptional fusions are indicated 
below. Numbers above the arrows indicate the distance from the transcriptional start site. (C) 
Transcriptional fusion rsmYTF1-lacZ was introduced into the indicated strains in single copy, 
grown for 8 h in LB broth, and assayed for b -galactosidase activity. Significant differences 
from the wild type were determined using a one-way analysis of variance and Tukey’s 
posttest. Asterisks indicate P values of 0.001 (**) and <0.0001 (***). (D) Northern blot 
analysis of RsmY in the indicated strains after growth for 8 h in LB broth. The ΔrsmY mutant 
was used as a control. The top half is a membrane probed with the RsmY probe, and the 
bottom portion is a second independent blot of the loading control probed with a 5S rRNA 
probe. Northern blotting was performed at least three times. (E) Transcriptional fusion 
rsmYTF2-lacZ was introduced into the indicated strains in single copy, grown for 8 h in LB 
broth, and assayed for b -galactosidase activity. Significant differences from the wild type 
were determined using a one-way analysis of variance and Tukey’s posttest. Triple asterisks 
indicate P values of <0.0001. All transcriptional fusion analyses were performed at least three 
times.  
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compared to PAO1 (Fig. 3.5C). When tested in a mucA22 ΔalgR mutant strain, the increased 
activity in the mucA22 mutant strain was reduced to PAO1 levels (Fig. 3.5C). In the case of the 
mucA22 algZ mutant strain, there was a slight but statistically significant decrease in rsmYTF1-
lacZ activity (Fig. 3.5C). Overall, the fusion results suggest that AlgR affects rsmY expression, 
but only in the mucA22 background.  
 To confirm that the rsmY levels decreased, Northern blotting was performed on the same 
strains. Two bands hybridized to the rsmY probe, as has been seen previously (Fig. 3.5D) (30, 
38). Little difference was seen between a ΔalgR mutant strain and the wild-type PAO1 (data not 
shown). However, an increase in both hybridizing RNAs was seen in a mucA22 mutant strain 
(Fig. 3.5D). The mucA22 ΔalgR and mucA22 algZ mutant strains had decreased hybridizing 
fragments (Fig. 3.5D). The loading control used (5S rRNA) was consistently uneven upon 
repeated attempts, but the Northern blotting does confirm the transcriptional fusion analysis. A 
second probe using proC was also used and gave similar results. A ΔrsmY strain had no 
hybridizing RNA, confirming the specificity of the rsmY probe. Overall, these results support 
AlgR control of rsmY expression in the mucA22 strain.  
 Both rsmY and rsmZ contain upstream activating sequences (UAS) that GacA con- trols 
(39). A potential AlgR-binding site is located 23 nucleotides upstream of the UAS for rsmY. An 
additional AlgR-binding site is present further upstream on the opposite strand (Fig. 3.5B). Two 
additional transcriptional fusions, rsmYTF2-lacZ and rsmYTF3-lacZ (Fig. 3.5B and 3.S2A), 
were constructed to determine the sequences required for AlgR control. The rsmYTF2-lacZ 
transcriptional fusion deletes the AlgR-binding sites but retains the UAS sequence (Fig. 3.5B). 
When assayed in the algR mutant strains in both PAO1 and mucA22 backgrounds, a difference 
was only seen in the mucA22 background (Fig. 3.5E). This result suggests that the potential 
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AlgR-binding sites are not necessary for increased rsmY reporter activity.  
 An additional rsmY reporter, rsmYTF3-lacZ, was constructed that does not contain the 
UAS sequence. This fusion had very low activity in both PAO1 and mucA22 (Fig. 3.S2B). This 
result suggests that the UAS is required for increased rsmY reporter activity in a mucA22 mutant 
strain as well as PAO1. Overall, the data suggest that AlgR and AlgU indirectly affect rsmY 
expression.  
AlgR regulates rsmZ expression indirectly  
 The regulation of rsmZ is more complex than rsmY and includes regulators other than 
GacA (38, 40, 41). Primer extension analysis confirmed the location of the transcriptional start 
site in P. aeruginosa that was predicted from P. fluorescens (Fig. 3.6A) (42, 43). A 
transcriptional fusion, rsmZTF1-lacZ, was assayed in the algZ and algR mutants (Fig. 3.6B). 
There was no difference in the rsmZ reporter in the ΔalgR or algZ mutant compared to PAO1 
(Fig. 3.6C). There was a 5-fold increase in rsmZTF1-lacZ activity in the mucA22 mutant strain 
compared to PAO1 (Fig. 3.6C). In a mucA22 ΔalgR mutant strain, there was a significant 
decrease in rsmZTF1-lacZ activity. In a mucA22 algZ mutant strain, there was a significant but 
slight decrease in rsmZTF1-lacZ activity compared to the mucA22 mutant (Fig. 3.6C). In all, 
these results suggest that AlgR plays a major role and AlgZ plays only a minor role, if any, in 
terms of rsmZ expression in the mucA mutant background.  
 To confirm the transcriptional fusion results, we again wanted to monitor the actual RNA 
levels. Using Northern blot analysis, a trend was seen similar to that in the transcriptional 
fusions. As shown in Fig. 3.6D, there were two bands detected, with the larger fragment being 
the most intense. Previous studies utilizing Northern blotting suggested that the smaller 
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Figure 3.6 AlgR increases rsmZ expression in a mucA22 mutant strain indirectly. (A) 
Primer extension analysis using total RNA isolated from PAO1. GATC indicates the 
sequencing ladder. -C is a control without reverse transcriptase. PAO1 is reverse-transcribed 
PAO1 mRNA. Below is the sequence of the rsmZ promoter region. The asterisk denotes the 
transcriptional start site identified. (B) Schematic of the rsmZ genomic region. The bent arrow 
on top indicates the primer used for transcriptional fusion construction. The bent arrow 
indicated by a “P” indicates the transcriptional start site. The bent arrow below indicates the 
primer used in primer extension. (C) Transcriptional fusion ZTF1-lacZ was introduced into 
the indicated strains in single copy, grown for 8 h in LB broth, and assayed for b -
galactosidase activity. Significant differences from the wild type were determined using a 
one-way analysis of variance and Tukey’s posttest. Asterisks indicate P values of 0.001 (**) 
and <0.0001 (***). Transcriptional fusion analysis was performed in triplicate three times. 
(D) Northern analysis of the indicated strains grown for 8 h in LB broth and total RNA probed 
with and rsmZ probe. A ΔrsmZ mutant strain was used to denote the specificity of the probe. 
A separate blot of the same strains was probed using a 5S rRNA probe (shown below). 
Northern blotting was performed three times.  
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hybridizing fragment represents the small RNA lacking the stem-loop found at the 3’ end of the 
small RNA (30). Therefore, the smaller hybridizing bands may represent the small RNAs lacking 
a transcriptional terminator. A ΔrsmZ mutant was used as a negative control. The mucA22 
mutant strain had increased RsmZ compared to PAO1 (Fig. 3.6D). The mucA22 ΔalgR mutant 
strain had the most drastic decrease in RsmZ levels, and there was a slight decrease in RsmZ 
levels in the mucA22 algZ mutant (Fig. 3.6D). Altogether, these results suggest that AlgR plays a 
role in increasing the RsmZ small RNA in the mucA22 background.  
 We hypothesized that like rsmY expression, AlgR indirectly affects rsmZ expression. An 
additional transcriptional fusion, rsmZTF2-lacZ (Fig. 3.S3A), was constructed and assayed in the 
wild-type strain PAO1 and a mucA22 mutant strain, which lacks the UAS sequence. Both strains 
had drastically decreased reporter activity (Fig. 3.S3B). Interest- ingly, the mucA22 mutant strain 
had significantly decreased activity compared to PAO1 (Fig. 3.S3B). Further support for an 
indirect mechanism of AlgR activation was obtained using gel shift analysis of a PCR amplicon 
of the rsmZ upstream region (Fig. 3.S3A). Purified AlgR was not able to shift the rsmZ upstream 
region tested (Fig. 3.S3C), suggesting AlgR does not directly activate rsmZ expression. These 
results suggest that the UAS is required for increased rsmZ expression, and we conclude that 
AlgR affects rsmZ expression indirectly.  
AlgR is necessary for RsmA activity in a mucA mutant background  
 To ascertain whether AlgR control of rsmA was significant in a biological context, the 
direct RsmA targets hcnA and tssA1 were used to assess RsmA activity (29). A new integrating 
vector was constructed that contains the lacUV5 promoter and lacks a ribosome-binding site or a 
start codon for lacZ. When tested in the wild-type strain PAO1, there was no activity of the 
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vector alone.  
 The hcnA gene encodes part of the hydrogen cyanide synthase enzyme that is implicated 
in virulence (44, 45). RsmA was shown to previously negatively affect a leader fusion using the 
tac promoter and the ribosome-binding site region of hcnA (45). An hcnA leader fusion was 
constructed by annealing 33 nucleotides, including one of the predicted RsmA-binding sites, the 
ribosome-binding site, and the translational start codon of hcnA. As shown in Fig. 3.7A, the 
lacUV5 hcnA-lacZ fusion had activity in strain PAO1. When assayed in a mucA22 mutant strain, 
there was an ~2.5-fold decrease in reporter expression (Fig. 3.7A), consistent with increased 
RsmA levels in the mucA22 mutant strain. If rsmA expression requires AlgR and AlgU, mutating 
algR and algU should result in increased fusion activity in the mucA22 background due to 
decreased rsmA expression. Both the mucA22 ΔalgR and the mucA22 ΔalgU mutant strains had 
at least a 3-fold increase in reporter expression compared to the mucA22 strain (Fig. 3.7A). The 
mucA22 ΔrsmA mutant strain was assayed and had a 3.6-fold increase in reporter activity 
compared to the mucA22 mutant (Fig. 3.7A). Overall, these results are consistent with the 
conclusion that RsmA is active in the mucA22 strain and that AlgU and AlgR are important for 
the decreased posttranscriptional regulation of hcnA.  
 Another RsmA target, tssA1, was also analyzed. The tssA1 gene encodes a portion of the 
T6SS and is directly regulated by RsmA (29, 46). Previous studies have used a lacUV5 tssA1 
construct containing 227 bp of tssA1 upstream sequence that had extremely low activity (28, 29, 
31). However, this fusion was found to contain additional transcriptional controls that resulted in 
low activity (data not shown). To more carefully assess RsmA activity using tssA1, we 
constructed a new leader fusion by annealing 31 nucleotides, including the predicted RsmA-
binding site, the ribosome-binding site, and the translational start codon of tssA1. The lacUV5 
 112 
 
Figure 3.7 RsmA is active in a mucA22 mutant strain. (A) Leader/translational fusion 
lacUV5 hcnA-lacZ (above graph) was introduced into the indicated strains in single copy, 
grown for 8 h in LB broth, and assayed for b -galactosidase activity. Significant differences 
from the wild type were determined using a one-way analysis of variance and Tukey’s 
posttest. Triple asterisks indicate P values of <0.0001. (B) Leader/ translational fusion 
lacUV5 tssA1-lacZ (above graph) was introduced into the indicated strains in single copy, 
grown for 8 h in LB broth, and assayed for b -galactosidase activity. Significant differences 
from the wild type were determined using a one-way analysis of variance and Tukey’s 
posttest. Triple asterisks indicate P values of <0.0001. All leader/translational fusions were 
assayed in triplicate three times.  
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tssA1-lacZ fusion had approximately 200 times the activity as the previously constructed lacUV5 
tssA1-lacZ fusion containing 227 bp of upstream sequence in the wild-type strain PAO1 (Fig. 
3.S4). There was no activity when this fusion was assayed in a mucA22 mutant strain (Fig. 3.7B 
and 3.S4). The lacUV5 tssA1-lacZ fusion confirmed our previous result (31), demonstrating 
increased activity in the mucA22 ΔalgU mutant strain, validating the use of this construct. When 
a mucA22 ΔalgR mutant was tested, the fusion was also increased from the mucA22 mutant 
strain to levels similar to those of the mucA22 ΔalgU mutant strain (Fig. 3.7B). A mucA22 
ΔrsmA mutant strain also had statistically significant activity compared to that of the mucA22 
mutant (Fig. 3.7B). These results demonstrate that AlgR and AlgU are necessary for 
posttranscriptional regulation of tssA1. From these data, we conclude that AlgU and AlgR are 
both required for increased rsmA expression in the mucA mutant background and that this leads 
to posttranscriptional regulation on two known RsmA targets, most likely through RsmA.  
 
DISCUSSION 
 AlgR is an important two-component regulator having roles in both acute and chronic 
infections. In the case of acute infections, AlgR activates the fimU operon, enabling the 
production of T4P (19, 21, 47). In chronic infections, AlgR, AlgU, and other transcriptional 
regulators activate the production of alginate (22, 48–50). These and other virulence factors in P. 
aeruginosa are often considered mutually exclusive, de- pending on whether there is an acute or 
chronic infection (51–53). This work demonstrates that another effect of a mucA mutation is that 
AlgR activity is directed at increasing the posttranscriptional regulator RsmA. AlgR activation of 
rsmA may help explain how AlgR participates in the mutually exclusive production of some 
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virulence factors depending on acute or chronic infection.  
The initial description of AlgR as a regulator of rsmA (28) did not evaluate the contribution of 
AlgR phosphorylation by AlgZ or a mechanism for AlgR activation of rsmA. Because AlgR is 
part of a two-component system that is important for both acute and chronic infections (19, 32), 
it was necessary to address the mechanism for AlgR activation of rsmA in order to create a 
framework to understand how AlgR regulation of rsmA might impact virulence gene expression. 
AlgR binds a consensus sequence CCGTTCGTC (21, 48, 49), and phosphorylation is thought to 
enable AlgR to bind potential binding sites that deviate from this consensus, such as the sites 
found in the fimU promoter (32, 47). However, the rsmA promoter deviates from the AlgR-
binding consensus, and AlgR phosphorylation was not required for rsmA expression. This argues 
against phosphorylation as the sole mechanism for AlgR binding less well-conserved consensus 
sequences. The studies using the mucA22 mutant strain, the algZ mutant, and the D54N mutant 
are consistent with the conclusion that AlgR phosphorylation is not required for rsmA activation. 
As AlgR phosphorylation is not required for alginate expression (22), our results are consistent 
with the conclusion that AlgR activates rsmA expression in mucoid strains.  
 The mechanism for AlgR activation of rsmA is by directly binding upstream of the AlgU-
dependent promoter, further supporting our model (Fig. 8). Gel shift studies determined that two 
AlgR-binding sites are required for in vitro binding. The location of the AlgR-binding sites, the 
in vitro gel shift analysis, transcriptional fusions, and RNase protection assay all support AlgR 
binding the distal promoter region of rsmA and are in accord with the activation of the AlgU-
dependent promoter.  
Our data suggest that AlgR plays a more important role in regulating rsmA expression in mucA 
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mutant strains, such as those found in CF patients. If AlgU and AlgR activate rsmA expression, 
as predicted by our model (Fig. 8), this would explain why AlgR did not appear to play a 
significant role in regulating rsmA in the wild-type PAO1 strain (Fig. 1B and C, 2, and 3). From 
this work, we conclude that AlgR and AlgU play a greater role in rsmA activation in mucA 
mutant strains. However, it is possible that in vivo conditions differ and that nonmucoid wild-
type strains also have increased regulation of rsmA under other conditions.  
 The mucA mutation leads to AlgU and AlgR activation of rsmA, suggesting that RsmA 
may regulate specific targets in mucA mutant strains. RsmA is a posttranscriptional regulator that 
binds mRNAs, in many cases, at or near the ribosome-binding site of targets (54). It is likely that 
 
 
 
Figure 3.8 Model for AlgR activation of rsmA and RsmA activity in mucoid strains. In 
chronic infections, mucA mutants arise, leading to increased AlgU activity. In the case of 
rsmA, AlgR and AlgU activate the distal rsmA promoter. The dark-shaded triangles indicate 
the AlgR-binding sites located upstream of rsmA. The light-shaded triangle indicates the 
AlgU-dependent promoter. The model predicts that increased expression of rsmA leads to 
increased RsmA activity, as indicated by the negative regulation of the RsmA targets, hcnA 
and tssA1.  
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RsmA has unknown targets in a mucA mutant background due to transcriptional differences 
between nonmucoid and mucoid strains (55–59). Therefore, RsmA will bind only to targets that 
are present at a given time, supporting RsmA working as a rheostat. An alternative explanation is 
that our conditions of growth in the laboratory environment do not represent the conditions in the 
CF lung. While this is quite obvious, it is known that the mutation in mucA leads to alginate 
production in vivo (11, 60, 61). In addition, nonmucoid P. aeruginosa also has active AlgU and 
AlgR during infection because of alginate secretion by nonmucoid P. aeruginosa from CF 
patients (62, 63). Therefore, it is highly probable that AlgU and AlgR activity in vivo would 
increase RsmA levels during infection. What role RsmA plays due to AlgU and AlgR regulation 
in vivo is not known.  
 The significance of AlgU and AlgR control of rsmA is demonstrated by the analyses of 
RsmA targets. The posttranscriptional activity of the RsmA targets, tssA1 and hcnA, was greater 
in the mucA22 background than in the wild-type PAO1 strain (Fig. 7). We also observed a lack 
of posttranscriptional activity on RsmA targets when algU or algR was inactivated in a mucA22 
mutant strain (Fig. 7), due to the decreased expression of rsmA. Therefore, we conclude that 
RsmA is active in an mucA22 mutant strain and that RsmA activity requires AlgU and AlgR to 
increase rsmA gene expression in this back- ground. The correlation between increased AlgR 
activity and increased RsmA activity in mucA mutants also supports these systems acting as a 
rheostat to fine-tune gene expression, as opposed to an on/off switch. When AlgU and AlgR 
increase RsmA levels, the indirect effects of these two regulators may be due to RsmA. Further 
work is necessary to pursue this exciting discovery that could help explain the exclusive 
expression of particular virulence genes in a given background.  
 The role of AlgU and AlgR on the RsmA-antagonizing small RNAs rsmY and rsmZ is 
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likely indirect. While our Northern blot data were not strong, they did support our transcriptional 
fusion analysis. Our transcriptional fusions mirrored what was seen in a previous study (28), 
supporting the idea of AlgR indirectly controlling rsmY and rsmZ expression. We hypothesize 
that AlgU and AlgR activities may coincide with factors that lead to increased GacA 
phosphorylation, resulting in the increased expression of rsmY and rsmZ. Further work is 
necessary to establish the mechanism for increased expression of the small RNAs in a mucA 
background.  
 Another question raised by our study is how RsmA remains active when the antagonizing 
small RNAs are increased. One possibility is that RsmA preferentially binds its targets in the 
mucA mutant strains better than the antagonizing small RNAs. This might also result from other 
regulators, either protein or other small RNAs that are currently unknown and affect the ability 
of RsmA to interact with the antagonizing small RNAs RsmY and RsmZ.  
 Altogether, our work demonstrates that AlgR is required for increased rsmA expression in 
mucA mutant strains. Phosphorylation of AlgR was not required for rsmA activation. The 
increased RsmA levels in a mucA22 mutant strain result in increased RsmA activity, even though 
the antagonizing small RNAs are also increased. What roles RsmA plays and how RsmA 
functions in chronic infecting strains are not known. To better understand the role of RsmA, we 
are currently investigating new possible RsmA targets in AlgU-active strains. A further 
understanding of the RsmA regulon in mucA mutants may provide additional insight into how P. 
aeruginosa becomes such a successful CF pathogen and has implications for the important role 
of RsmA in all types of P. aeruginosa infections.  
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SUPPLEMENTAL FIGURES 
 
 
 
 
 
Figure 3. S1 algR deletion has no effect on the proximal rsmA promoter. (A) Schematic 
of the rsmA genomic region and the transcriptional fusion rsmATF2- lacZ. Numbers 
indicate distance from the rsmA translational start site. The translational start site is 
indicated by a +1. The AlgU and RpoD promoters are indicated by bent arrows. The 
transcriptional fusion rsmATF2-lacZ is indicated directly below and the arrows indicate the 
primers and the numbers their location relative to the rsmA translational start site. (B) The 
rsmA transcriptional fusion rsmATF2-lacZ was introduced into the indicated strains to 
generate strains containing single-copy, chromosomal fusions. The strains were grown for 8 
hours in LB broth and assayed for β-galactosidase activity minus the vector control. 
Differences from the wild-type strain PAO1, mucA22, or ∆algR mutants, were determined 
using a one-way analysis of variance and a Tukey’s post-test. Transcriptional fusions were 
assayed in triplicate three times.  
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Figure 3. S2. The GacA binding site is necessary for increased rsmY expression. (A) 
Schematic of the rsmY genomic region and the transcriptional fusion rsmYTF3-lacZ. 
Numbers indicate distance from the rsmY transcriptional start site. The transcriptional start 
site is indicated by a bent arrow and +1. The UAS controlled by GacA is indicated with the 
distances from the transcriptional start site indicated below. The transcriptional fusion 
rsmYTF3-lacZ is indicated directly below and the arrows indicate the primers and the 
numbers their location relative to the rsmY transcriptional start site. (B) Transcriptional 
fusion rsmYTF3-lacZ was introduced into the indicated strains in single-copy, grown for 8 
hours in LB broth and assayed for β-galactosidase activity. Significant differences from the 
wild type were performed using a one-way analysis of variance and a Tukey’s post-test. 
Transcriptional fusions were assayed in triplicate three times.  
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Figure 3. S3. AlgR does not directly affect rsmZ expression. (A) Schematic of the rsmZ 
genomic region and the transcriptional fusion rsmZTF2-lacZ and the PCR product used for 
gel shift analysis. Numbers indicate distance from the rsmZ transcriptional start site. The 
transcriptional start site is indicated by a bent arrow and +1. The UAS controlled by GacA 
is indicated with the distances from the transcriptional start indicated below. The 
transcriptional fusion rsmZTF2-lacZ is indicated directly below and the arrows indicate the 
primers and the numbers their location relative to the rsmZ transcriptional start site. (B) 
Analysis of rsmZTF2-lacZ in PAO1 and a mucA22 strain. The indicated strains were grown 
for 8 hours and assayed for β-galactosidase activity. Assays were repeated three times. 
Significant differences from the wild type were performed using a one-way analysis of 
variance and a Tukey’s post-test. Asterisks indicate P values of 0.001 (**) to < 0.0001 
(***). (C) Gel shift analysis of the rsmZ upstream region with purified AlgR. Open 
arrowheads indicate probes alone. Blackened arrowheads indicate shifted probe. pscF is a 
negative control. algD is a positive control. ZF1 is the rsmZ upstream region. The – symbol 
means a probe with no added AlgR. The + symbol indicates 2.5µM of AlgR added with the 
probe.  
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Figure 3. S4. Comparison of tssA1 leader/translational fusions. The previously used 
leader/translational fusion was based on a 5’ RACE study by Brencic and Lory (1) and 
includes 227bp of upstream sequence of tssA1 that was previously used to investigate 
posttranscriptional regulation of tssA1 (1-3). On the left is the original lacUV5tssA1-lacZ 
fusion assayed in PAO1 and mucA22 at 8 hours. On the right is the new lacUV5tssA1-lacZ 
leader/translational fusion using annealed primers of 31bp cloned into the same vector and 
assayed at 8 hours in the indicated strains. Assays were repeated three times. Significant 
differences from the wild type were performed using a one-way analysis of variance and a 
Tukey’s post-test. Asterisks indicate P values of 0.001 (**) to < 0.0001 (***).  
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ABSTRACT 
 Pseudomonas aeruginosa is an opportunistic pathogen able to colonize any host tissue. 
When Cystic fibrosis (CF) patients are infected with P. aeruginosa, the bacteria can develop a 
niche in the CF lung and establish a chronic infection.  A majority of CF chronic infection 
isolates contain a mutation in mucA that encodes an anti-σ factor that sequesters the σ factor 
AlgU.  AlgU regulates the chronic virulence factor alginate.  Strains that overproduce alginate 
are termed mucoid.  We have shown that AlgU also regulates the gene for the posttranscriptional 
regulator rsmA.   Based on our previous data demonstrating that the alginate regulators AlgU and 
AlgR activate rsmA expression, we hypothesize rsmA has increased expression due to AlgU and 
AlgR in mucoid strains of P. aeruginosa and this in turn affects the RsmA regulon.  First, we 
wanted to characterize observed phenotypic variations in the mucA22 ∆rsmA strain and study 
any effects on virulence.  Due to increased RsmA levels in mucoid strains and blatant variation 
in phenotypes between mucA22 and mucA22 rsmA, we expected to identify novel RsmA targets 
in the mucoid background.  Therefore the mucA22 and mucA22∆rsmA proteomes were analyzed 
using 2D-gel electrophoresis and isobaric tagging by relative and absolute quantification 
(iTRAQ).  The mucA22∆rsmA strain showed increases in previously unidentified targets: 
PA3866, AlgP, PasP, AhpC, and OprF.   We constructed a pasP leader fusion with a 
constitutively active lacUV5 promoter and compared PAO1, mucA22, and the mucA22 ∆rsmA 
mutant strains to confirm the iTRAQ data.  Next, we demonstrated a direct interaction of RsmA 
with pasP. These data show that rsmA has increased expression in mucA mutant strains and 
identified new RsmA targets. We also showed a significant increase in rsmA expression in 
several mucoid clinical isolates compared to nonmucoid strains.  Overall, RsmA regulation is 
important not only in nonmucoid strains like PAO1, but also mucoid strains of P. aeruginosa. 
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INTRODUCTION  
 Pseudomonas aeruginosa is a Gram-negative bacillus capable of growing in a wide 
variety of environments.  While P. aeruginosa is capable of causing an infection in any human 
host, the bacterium is more widely known as an opportunistic pathogen, causing afflictions in 
individuals with a compromised immune system (1) (2).  P. aeruginosa is a major contributor to 
morbidity and mortality in individuals with major burns, type II diabetes, HIV/AIDS, and cystic 
fibrosis(CF) (3-6).  In the case with CF, P. aeruginosa establishes a niche in the lung that can 
develop into a chronic infection (7).  P. aeruginosa chronic infection isolates often present a 
variant phenotype from acute infection isolates and express less inflammatory virulence factors, 
like flagella, allowing them to persist in the CF lung (8).   
 P. aeruginosa in the CF lung is targeted by neutrophils releasing reactive oxygen and 
nitrogen species (7).  This attack causes osmotic stress on the bacteria and affects the integrity of 
membrane bound proteins.  The anti-sigma factor, MucA, is an inner membrane bound protein 
that sequesters the extracytoplasmic sigma factor, AlgU (9).  The release of AlgU allows for a 
phenotypic shift where P. aeruginosa begins to produce copious amounts of the 
exopolysaccharide alginate.  P. aeruginosa strains that overproduce alginate are termed mucoid.  
This thick protective biofilm allows for P. aeruginosa to evade phagocytosis, secreted reactive 
species, and antibiotics (7, 9, 10).  The AlgU regulon has been shown to contribute to the 
expression of virulence factors like proteases lasB and the metalloproteinase aprA (11).  Our 
previous work has also shown AlgU contributes to posttranscriptional regulation of virulence 
factors by regulating the expression of rsmA (12).   
 RsmA regulates hundreds of targets by binding the ribosomal binding site of a messenger 
RNA (mRNA) and inhibiting translation (13).  RsmA is antagonized by two small noncoding 
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RNA called RsmY and RsmZ (14).  RsmA is also parth of the Gac/Rsm hierarchal system.  The 
two component system GacA/S activate rsmY/Z expression (15).  GacS, the sensor, can also 
dimerize with another sensor, RetS, which will inhibit the phosphorylation of GacA and 
therefore not make the RsmA antagonists (15-17).  The RsmA homolog, CsrA, has been more 
characterized and shown to not only inhibit translation, but also positively influence the 
translation of some targets (18).  CsrA has also been shown to form protein-protein interactions 
(19, 20).  In P. aeruginosa RsmA has been shown to inhibit the production of virulence factors 
like the Type VI secretion system and hydrogen cyanide synthase while positively influencing 
other virulence factors like type IV pili (13).   Originally, the function of RsmA was to regulate 
as a switch from acute to chronic infection virulence factors (21).  Most studies of RsmA targets 
via microarray were investigated in acute/nonmucoid strains of P. aeruginosa like PAO1 or 
PAK.   
 However, our work investigating AlgU controlling rsmA expression showed that more 
RsmA was present in a chronic/mucoid strain where AlgU is not sequestered by MucA (12).  Not 
only was there more RsmA present in the mucA22 strain, but we also showed this abundance in 
RsmA was inhibiting the translation of the type six secretion component, tssA1, and hydrogen 
cyanide synthase, hcnA (12).   Due to bacteria tightly controlling the regulation of their various 
products, these data suggested an importance to the abundance of RsmA in mucoid chronic 
infection strains.  We also hypothesized from these results that there might be more RsmA 
targets or different targets in mucoid strains. 
 In this study, we continue our understanding of RsmA in a mucoid chronic infection 
model strain.  We characterize a mucoid ∆rsmA strain in terms of virulence factor production and 
also the effects on virulence of this mutation.  Since RsmA is known to regulate hundreds of 
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targets post-transcriptionally and previous works examined the transcriptome of P. aeruginosa, 
we decided to compare the proteome of the mucoid mucA22 strain and its rsmA mutant.  We 
hypothesized proteomic analysis would produce a better representation of RsmA targets in the 
mucoid background.  Lastly, we demonstrated a direct interaction with RsmA and a previously 
unknown target, pasP, a small protease.  Overall, this work furthers the understanding of the 
RsmA regulon in mucoid strains of P. aeruginosa. 
 
METHODS 
Strains, plasmids, and media 
 The strains used in this study are presented in Table 4.1. Escherichia coli strains were 
maintained on LB (Difco) plates or broth without or with antibiotics, as appropriate. 
Pseudomonas aeruginosa strains were grown on Pseudomonas isolation agar (PIA), LB medium, 
or Vogel-Bonner minimal medium (VBMM) supplemented with the appropriate concentrations 
of antibiotics. For E. coli, antibiotics were used at the following concentrations when 
appropriate: 10 µg/ml tetracycline, 15 µg/ml gentamicin, 100  µg/ml ampicillin, and 35  µg/ml 
kanamycin. For Pseudomonas strains, antibiotics were used at the following concentrations: 150  
µg/ml gentamicin, 50  µg/ml tetracycline, and 300  µg/ml carbenicillin. For allelic exchange, 
sucrose was supplemented at 10% in YT (1% tryptone and 0.5% yeast extract) medium.  
TABLE 4.1 
Strain or Plasmid Genotype or Relevant properties Reference 
or Source 
E. coli strains   
 
NEB5α fhuA2 Δ(argF-lacZ) U169phoA, glnV44 New 
England 
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Φ80Δ(lacZ)M15 gyrA96 Biolabs 
pRK2013 Helper strain 21d 
rsmAHA pEX18Gm Allelic exchange for rsmA HA allele 12 
TF3-lacZ miniCTX Transcriptional fusion 12 
hcp1-lacZ Transcriptional fusion This study 
lacUV5-pasp-lacZ Leader fusion This study 
P. aeruginosa  
strains 
  
PAO1  Wild type 50 
mucA22 mucA22 mutation 51 
FRD1 Mucoid clinical isolate 52 
PAO568 Mucoid clinical isolate 53 
8830 Mucoid clinical isolate 54 
383 Nonmucoid clinical isolate 55 
2192 Mucoid clinical isolate 55 
∆lasR ∆rhlR Attenuated control strain 56 
mucA22 ∆retS Mucoid retS mutant 12 
∆rsmA rsmA nonpolar deletion 12 
mucA22∆rsmA rsmA nonpolar deletion in mucA22 strain 12 
PAO1 
TF3-lacZ 
rsmA transcriptional fusion strain 12 
mucA22 
TF3-lacZ 
rsmA transcriptional fusion strain 12 
2192 TF3-lacZ rsmA transcriptional fusion strain 12 
383 TF3-lacZ rsmA transcriptional fusion strain 12 
FRD1 TF3-lacZ rsmA transcriptional fusion strain This Study 
PAO568 TF3-lacZ rsmA transcriptional fusion strain This Study 
8830 TF3-lacZ rsmA transcriptional fusion strain This Study 
PAO1 hcp1-lacZ hcp1 transcriptional fusion strain This Study 
mucA22 hcp1-lacZ hcp1 transcriptional fusion strain This Study 
mucA22∆rsmA  
hcp1-lacZ 
hcp1 transcriptional fusion strain This Study 
PAO1 
lacUV5-pasp-lacZ 
PAO1 with pasP leader fusion This Study 
 
mucA22 
lacUV5-pasp-lacZ 
mucA22 with pasP leader fusion This Study 
mucA22∆rsmA 
lacUV5-pasp-lacZ 
mucA22∆rsmA with pasP leader fusion This Study 
PAO1HA PAO1 with epitope tagged RsmA This study 
mucA22HA mucA22 mutant with epitope tagged RsmA This study 
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Strain construction 
 All PCR products were amplified with DNA from P. aeruginosa PAO1, unless otherwise 
noted, using Q5 polymerase (New England BioLabs [NEB], Ipswich, MA) and primers listed in 
Table 4.2. Crossover PCR (splicing by overlapping extension PCR) (21b) was used to construct 
deletion mutations and to clone sequences into the suicide vector pEX18Tc or pEX18Gm (21c). 
All cloned constructs were confirmed via sequencing. P. aeruginosa strains were conjugated 
with E. coli as a donor strain and the pRK2013-containing helper strain (21d). Conjugations were 
performed overnight on LB plates at 37°C, and the conjugants were plated on the appropriate 
selective medium to obtain single-crossover mutants. Merodiploids were grown without 
selection and then screened for sucrose sensitivity on YT medium–10% sucrose plates. 
Mutations were confirmed using PCR with primers containing the suffix intF and intR in Table 
4.2 and sequencing of the resulting PCR fragment. Hemagglutinin (HA) tagging of the proteins 
was accomplished using primers containing the HA tag at the 3’ end of the gene, and HA was 
introduced as described above using the suicide vector pEX18Gm.  
TABLE 4.2 
Primer Sequence Use 
Hcp1-lacZF GCGCGGATCCACACCGACTTCGCCGCCTTC Transcriptional 
fusion 
Hcp1-lacZR GCGCAAGCTTCTTTCCTCCCGTGTGGCTC Transcriptional 
fusion 
lacUV5pasP
F 
GATCCGGACGTTAAGGAGAATGTCCAT Leader fusion 
lacUV5pasp
R 
AATTCATGGACATTCTCCTTAACGTCC Leader fusion 
Paspt7emsa
F 
TGTAATACGACTCACTATAGGGACGTTAAGGAGAAT
GTCCAT 
EMSA 
Paspt7emsa
R 
ATGGACATTCTCCTTAACGTCCCTATAGTGAGTCGT
ATTACA 
EMSA 
rsmyemsaF TGTAATACGACTCACTATAGGGGTCAGGACATTGCG
CAGGAAG 
EMSA 
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rsmyemsaR AAAACCCCGCCTTTTGGGCGG  EMSA 
 
Phenotypic Assays 
 Various virulence products were assayed in the P. aeruginosa strains in this study.  All 
strains were grown in LB broth at 37ºC for 16 hours.  Biofilm production was assayed by using 
Congo Red plates and a 96-well plate biofilm quantification (22, 23).  Strains were spotted onto 
agar plates in 10 µl drops and incubated at 37ºC overnight.  For quantification, strains were 
resuspended in M63 media per O’Toole and quantified using a spectrophotometer.  Skim milk 
agar (Difco) was used to observe any differences of casein digestion (24).  Strains were spotted 
onto the agar in 10 µl drops and incubated overnight at 37ºC.  Pyocyanin was assayed by 
centrifuging the culture and collecting the supernatant.  Then 2 mL of chloroform was used to 
extract any pyocyanin produced in the culture by vortexing vigorously and allowing to set for 10 
minutes.  The chloroform layer was removed and 1 mL of 0.1 N HCl was added and vigorously 
vortexed and allowed to set for 10 minutes.  0.1 N HCl was used to blank the spectrophotometer 
at OD562nm.  Values were normalized to PAO1.   
C. elegans Assay 
 Caenorhabditis elegans  was maintained on NGM agar plates with OP50 E. coli (25).  
Once plates were fully saturated with C. elegans eggs, eggs were harvested and worms were 
synced via bleaching (26).  The following day worms were put on NGM media with OP50 and 
allowed to grow to L1 stage.  P. aeruginosa strains were incubated at 37ºC on fast killing media 
on 20 cm plates(27).  C. elegans were harvested and cleaned of E. coli  and 30-50 worms were 
plated on P. aeruginosa strains (27).  C. elegans viability was recorded every 12 hours for 2.5 
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days.  Experiments were performed in triplicate two times. 
Macrophage Survival Assays 
 P. aeruginosa strains were incubated with ATCC J774a.1 macrophages to assess 
macrophage survivability.  Macrophages were grown in Corning cellgro DMEM with L-
Glutamine, 4.5g/L Glucose, and 10% fetal bovine serum and 100 I.U./ml penicillin 100 µg/mL 
streptomycin.  Cells were maintained in a 37ºC incubator with 5% CO2 and humidity.  Cells were 
counted and plated in 12-well plates at 1x10^6 cells per well in media without pen/strep.  
Overnight LB cultures of P. aeruginosa strains were diluted to 1% and allowed to grow for 2 
hours at 37ºC at 250 rpm.  Cultures were then centrifuged and washed with 1X PBS.  Strains 
were then aliquot to an OD600nm of 0.1 and incubated with macrophages up to 6 hours.   The 
inoculum of bacteria was also measured in CFU/mL.  Macrophages were collected at 2, 4, and 6 
hour time points and 1 mL of culture was mixed with 100 µL of 0.4% trypan blue to measure 
viability.  Experiments were performed three times in triplicate (n=9). 
Western blot analysis 
 P. aeruginosa strains were grown in LB broth at 37°C for various times. The bacteria 
were collected by centrifugation, resuspended in sterile phosphate-buffered saline, and lysed by 
sonication. Total protein concentrations were quantified by the Bradford protein assay (Bio-Rad, 
Carlsbad, CA). Cell extracts (5 µg) were separated by 12% SDS-PAGE and transferred to a 
polyvinylidene difluoride membrane (Bio-Rad). The membranes were blocked and probed using 
a 1:20,000 dilution of anti-HA monoclonal antibody (Thermo Fisher, Pittsburgh, PA), followed 
by a 1:20,000 dilution of horseradish peroxidase-conjugated goat anti-mouse immunoglobulin 
antibody or a 1:20,000 dilution of anti-Hcp1 polyclonal antibody followed by a 1:20,000 dilution 
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of horseradish peroxidase-conjugated goat anti-rabbit immunoglobulin antibody (27b). The 
membrane was stripped per Abcam mild stripping protocol and then probed with RpoA primary 
antibody (1:20,00 dilution) followed by 1:20,000 dilution of horseradish peroxidase-conjugated 
goat anti-mouse immunoglobulin antibody.  Detection was performed using an ECL Plus kit 
(Thermo Fisher, Pittsburgh, PA) and chemiluminescence detection (ProteinSimple, Santa Clara, 
CA).  All Western blot analyses were repeated at least three times.  
Two dimensional gel electrophoresis 
 Strains were started as overnight cultures and the following day diluted to a fresh LB 
broth at 1% and grown for 8 hours at 37ºC at 250 rpm.  The bacteria were collected by 
centrifugation, resuspended in sterile phosphate-buffered saline, and lysed by sonication with 10 
µL of lysozyme 20 mg/ml added.  Samples were centrifuged for 10 minutes at 10,000 x g.  
Samples were quantified using a BCA assay.  Four hundred micrograms of each sample was then 
acetone precipitated with ice-cold acetone and left at -20ºC overnight.  Samples were then 
centrifuged at 14K x g for 15 minutes at 4ºC, then washed with 80% cold acetone and 
centrifuged at 14K x g for 15 minutes at 4ºC twice.  Pellet was dried in a speed vac centrifuge 
after aspirating off 80% acetone.  Using the Invitrogen ZOOM 2D kit, 1X IEF rehydration buffer 
was mixed per 400 µg (309 µl ZOOM 2D Protein Solubilizer 1.1, Ampholytes 6.4 µl, 7 µl 0.1% 
bromophenol blue, 31.6 µl deionized water, 6 µl 1M DTT).  1X IEF rehydration buffer was 
added to each pellet.  Samples were incubated on over end rotator for 1 hr at room temp.  
Centrifuged samples at 12K x g for 10 minutes at 4ºC. Each Novex ZOOM strip was rehydrated 
with 155 µl of rehydration buffer and incubate cassette for at least 2 hours on rocker at room 
temp.  Strips were then run following the IPG Runner program protocol B (200 V for 20 min, 
450 V for 15 min, 750 V for 15 min, 2000 V for 65 min).  ZOOM trays were then reduced and 
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alkylated before running second dimension.  Strips were added to a Novex 4-20% Tris-glycine 
ZOOM gel and run for 165 minutes at 125V.  Gels were fixed and Coomassie Blue stained and 
then analyzed with Dymension Software.  Significant spots were in-gel trypsin digested and 
cleaned up to run through a Thermofisher LTQ XL mass spectrometer for protein identification.  
Experiments were performed in duplicate twice. 
In-gel trypsin digestion 
 Gel pieces were added to a microcentrifuge tube.  To shrink the pieces, 50 µl of 
acetonitrile was added and incubated for 15 minutes at RT.  Gel pieces were then dried using a 
speed vac centrifuge.  To digest, 75 µl of a 10 ng/µl stock of trypsin was added to cover the gel 
pieces and incubated at 37ºC overnight.  The solution was removed and added to a new 
microcentrifuge tube.  Elution buffer (0.1% formic acid, 50% acetonitrile, 49.9% water) was then 
added to cover the gel piece and incubated for 15 minutes then added to the new microcentrifuge 
tube.  Using Zip Tips (µ-C18) purification to prepare the sample for mass spectrometry, samples 
were run through the tip column and then eluted off with elution buffer.  The sample was 
pelleted and dried using speed vac centrifugation.  Samples were resuspended in 8 µl of mass 
spec buffer (0.1% formic acid in 100 µl of acetonitrile and 400 µl HPLC water).   Samples were 
then sent through the LTQ XL mass spectrometer and analyzed using Proteome Discover 3.1 
software to determine protein identified in sample and identifying only high confidence peptides. 
iTRAQ 
 Strains were started as overnight cultures and the following day diluted to a fresh LB 
broth at 1% and grown for 8 hours at 37ºC at 250 rpm.  The bacteria were collected by 
centrifugation, resuspended in sterile phosphate-buffered saline, and lysed by sonication with 10 
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µL of lysozyme 20 mg/ml added.  Samples were centrifuged for 10 minutes at 10,000 x g.  
Samples were quantified using a BCA assay.  One hundred and ten micrograms of each sample 
was then acetone precipitated with ice-cold acetone and left at -20ºC overnight.  Samples were 
then centrifuged at 14K x g for 15 minutes at 4ºC, then washed with 80% cold acetone and 
centrifuged at 14K x g for 15 minutes at 4ºC twice.  The Sciex iTRAQ labeling protocol was 
followed for labeling peptides.  After labeling trypsin digested peptides, SCX spin tips were used 
to create a gradient to identify lower frequency peptides in the labeled samples.  Samples were 
fractionated over 20 concentrations of increasing ammonium formate (15 to 500 mM) and 
decreasing amount of 10% acetonitrile (985 µl to 500 µl).  Fractions were then speed vac 
centrifuged and resuspended in 8 µl of mass spec buffer.  iTRAQ Samples were analyzed using 
Bioworks 3.3 software with peptide confidence threshold set to 10-3 for only high confidence 
peptides that also had iTRAQ label quantification.  The p-value of comparison between labels 
was performed using Student’s t-test.  Experiments were performed in duplicate twice. 
Transcriptional and translational leader fusion analysis  
 Upstream DNA fragments containing promoter regions were generated by using the 
primers listed in Table 4.2 in conjunction with Q5 polymerase (NEB, Ipswich, MA). PAO1 
genomic DNA was used as the template. PCR products were cloned into pCR2.1 and then 
subcloned into miniCTXlacZ using the restriction enzymes HindIII/BamHI, HindIII/EcoRI, or 
KpnI/BamHI (New England BioLabs, Ipswich, MA). The translational fusion vector 
CTXlacZCP was constructed by amplifying the lacZ gene using the primers listed in Table 4.2 in 
order to delete the lacZ ribosome-binding site and the translational initiation codon. The fusion 
constructs were confirmed by sequencing and conjugated into P. aeruginosa strains by 
triparental conjugation. Strains were selected for tetracycline resistance and then conjugated with 
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pFLP2 to remove vector sequences (21c). Strains were selected for carbenicillin resistance, 
grown overnight without selection, and plated on YT medium with 10% sucrose to select for the 
loss of pFLP2. Individual colonies were patch plated onto VBMM supplemented with 300 µg/ml 
carbenicillin and PIA to ensure the loss of pFLP2. To confirm the presence of the fusion 
constructs, PCR was performed using the forward primer used to construct the fusion and the 
reverse primer lacZRforTF (Table 4.2). β-Galactosidase activity was deter- mined by incubating 
cell extracts with o-nitrophenyl-β-D-galactopyranoside (4 mg/ml) as described by Miller (27c).  
All mucoid strains were confirmed to be mucoid at the end of each experiment by plating on PIA 
plates and making sure that all colonies were mucoid. Experiments were performed in triplicate 
at least three times.  
RsmA purification 
 The rsmA gene was PCR amplified using Q5 (NEB) and PAO1 chromosomal DNA using 
oligonucleotides rsmASal1F and rsmANot1R (Table 4.2). A 186-bp SalI/NotI fragment was 
cloned into pGEX-4T-3 (Novagen) to be expressed as a glutathione S-transferase–RsmA (GST-
RsmA) fusion protein. The resulting plasmid (pGEX-4T-RsmA) was transformed into E. coli 
BL21(DE3) (NEB) cells and spread on LB Amp100 agar. The colonies from this transformation 
were PCR confirmed and struck for isolation.  The confirmed isolate was inoculated into LB 
Amp100 at 37ºC at 250 rpm overnight. A 1% dilution was added to 250 mL of LB Amp100 and 
grown to an OD600nm of 0.6 at 37ºC at 250 rpm; 0.2 mM isopropyl-β-D- galactopyranoside 
(IPTG) was added to induce RsmA expression for 6 h at the same conditions. The cells were 
collected by centrifugation (7,000 g, 10 min) and frozen overnight.  Pellets were thawed and 
lysed using BPER with 4 µl of lysozyme 20 mg/mL and 2 µL of DNase I per mL of BPER along 
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with a 1X concentration of protease inhibitors. RsmA was purified from this supernatant using 
the GST spin purification kit (Thermo Fisher). After binding of the fusion protein and washing 
the column, RsmA was cleaved away from GST with 10 U of thrombin/column overnight at 
22°C on an end over rocker. Purified protein was dialyzed using a Slide-A-Lyzer (Thermo 
Fisher) and storage buffer (20% glycerol, 20 mM Tris [pH 7.5], 5 mM MgCl2, and 1 mM 
dithiothreitol [DTT]) for 2 hours at room temperature twice and overnight at 4°C. The identity of 
the purified protein was determined by mass spectrometry. The purity of RsmA was visually 
determined in a Coomassie-stained 15% electrophoresis gel (SDS-PAGE).  
RNA EMSA 
 Annealed oligomers or PCR amplicons with T7 promoters on the forward primer were 
used to construct RNA probes for electromobility shift assays with RsmA (Table 4.2).  
Oligomers were either annealed or amplified using Taq polymerase from NEB and gel purified 
using an NEB Monarch gel extraction kit.  In vitro transcription was performed using the NEB 
HiScribe T7 High Yield RNA synthesis kit.  Upon completion, the Pierce RNA 3’ End 
Biotinylation kit was used to generate probes.  The kit control was also biotinylated as a control 
for this step and the EMSA as it has an RsmA binding motif (AGGA).  Purified RsmA was used 
in this study.  The Pierce RNA EMSA kit was used for the detection of protein-RNA 
interactions.  Reactions were run on a 15% native PAGE and transferred to a nylon membrane at 
35 mA for 35 minutes.  The membrane was then UV cross linked for 60 seconds.  The membrane 
was then treated using the Thermofisher LightShift Chemiluminescent detection kit.  Membranes 
were developed using chemiluminescence detection on a ProteinSimple developer.   
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Statistical analyses.  
 Statistical analyses were performed using Microsoft Excel software (Microsoft, 
Redmond, WA).  
 
RESULTS 
mucA22 ∆rsmA has variant phenotypes 
 In P. aeruginosa RsmA has been shown to regulate hundreds of targets through 
posttranscriptional regulation (13, 28).  Our lab has previously shown that in a mucA22 strain, 
AlgU and AlgR increase the expression of rsmA (12, 29).  The rsmA mutation did not affect the 
ability for alginate to be produced and both rsmA and mucA22 rsmA both appeared bluish on PIA 
 
(Figure 4.1a).  To investigate other simple phenotypic assays, the rsmA mutants were also 
Figure 4.1 Appearance of rsmA mutants appear similar on PIA and skim milk agar.   
 
P. aeruginosa strains on PIA (A) or skim milk agar (B).  PIA is standard growth 
media for Pseudomonas strains and blue pigmentation is typical of rsmA mutants.  
Skim milk plates are used to observe the ability of a strain to digest casein protein.   
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screened on skim milk agar (Figure 4.1b) and analyzed for biofilm production (Figure 4.2).  
Skim milk agar looks specifically at the ability of the bacteria to digest the milk protein, casein 
(24).  The parent strains were able to generate clear zones of digested casein much more readily 
than either rsmA mutant.   
  Biofilm production was quantified using a 96-well plate and visualized using 
crystal violet and Congo Red agar (22, 30).  rsmA mutants produce more of the secondary 
Figure 4.2 mucA22 rsmA produces more biofilm.   
 
A) A 96-well microtiter plate biofilm assay was performed to quantify amounts of biofilm 
between P. aeruginosa strains.  All strains were normalized to PAO1 or percent of wildtype.  
***represents a p < 0.01. B) Photos of below and the side of wells with P. aeruginosa strains 
stained with crystal violet.  C) Colonies of P. aeruginosa strains grown on LB supplemented 
with Congo Red and Bromophenol Blue.  Experiments were performed in triplicate (n=9). 
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messenger cyclic di-GMP (31).  This compound indirectly contributes to biofilm formation.  The 
transcriptional regulator, AmrZ, also contributes to biofilm formation and is regulated by AlgU 
(32, 33).   In the mucA22 rsmA strain both AlgU is active and RsmA does not repress cyclic di-
GMP production.   The rsmA strain showed a slight decreased in the biofilm assay, but appeared 
slightly darker than PAO1 on the Congo Red plate.  This result has been previously reported 
where rsmA has impaired binding on a plate (28).  mucA22 showed an even more significant 
decrease in biofilm production.  P. aeruginosa produces three known exopolysaccharides: 
alginate, pel, and psl (32, 34, 35).  The mucA22 strain has an abundance of alginate and RsmA, 
which can repress the ability for biofilm formation (36).  The mucA22 rsmA strain showed the 
most increase in biofilm production in the microtiter plate assay and was also starkly different on 
the Congo Red plate.  Congo Red is bound by the biofilm compounds of P. aeruginosa and 
causes the visual difference (22).  The difference between rsmA mutants suggests RsmA has 
potential for regulation of other targets in the mucA22 background compared to the nonmucoid 
PAO1 strain. 
C. elegans more susceptible to mucA22 ∆rsmA pyocyanin levels 
 RsmA has been shown to regulate pyocyanin production through anthranilate levels 
increasing in an rsmA mutant (28).  Pyocyanin is a blue pigment produced by P. aeruginosa that 
blocks the effects of reactive oxygen species from host immune cells and creates an observable 
blue appearance during skin infections (2, 37).  Pseudomonas on PIA media will appear bluer if 
there is increased pyocyanin production.  Both rsmA mutants appeared blue on PIA, but 
pyocyanin can be quantified as well (Figure 4.3a).  The parent strains, PAO1 and mucA22, 
produced no difference in pyocyanin levels.  The nonmucoid rsmA mutant showed the expected 
increase has reported previously (28).  Similarly to the biofilm assay, the mucA22 rsmA strain 
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produced a four-fold increase in pyocyanin compared to mucA22.  This significant increase 
showed further importance of studying the effects of RsmA in the mucoid background.   
 To analyze the effects of increased pyocyanin on virulence, a fast killing assay with C. 
elegans can be used to screen for viability(27).  In Figure 4.3b the rsmA were more lethal to the 
C. elegans due to increased pyocyanin production.  A lasR rhlR mutant was included due to this 
strain being attenuated and also deficient in pyocyanin production (38).  There was no difference 
between the lethality of PAO1 with rsmA, however the four-fold increase in pyocyanin 
production was significant after two days between mucA22 and mucA22 rsmA.  The fast killing 
assay with C. elegans showed increased lethality in the mucA22 rsmA strain.  Pyocyanin is an 
important factor in this assay and the mucA22 rsmA strain produces four times as much 
compared to the attenuated mucA22 strain. 
Figure 4.3 mucA22 rsmA mutant produces more pyocyanin and is more lethal in a fast-
killing assay than mucA22. 
 
A) Pyocyanin assay was used to quantify production of pyocyanin by P. aeruginosa strains. 
Experiments were performed in triplicate (n=9).  B) Fast-killing assays were used to confirm 
production of pyocyanin.  C. elegans is more susceptible to pyocyanin with this media.  P. 
aeruginosa strains were incubated with C. elegans for 2.5 days.  A lasR rhlR strain produces little 
if no pyocyanin and was used as a control. Experiments were performed in triplicate (n=6). *** 
represents a p < 0.01. 
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Macrophages have increased survivability with mucA22 ∆rsmA 
 To investigate the effects of mucA22 rsmA virulence further on a level more relevant to 
higher organisms, P. aeruginosa strains were assayed with J774a.1 macrophages (Figure 4.4).  A 
lasR rhlR strain was used as a negative control since this strain is attenuated for multiple 
virulence factors(39).  mucA22, rsmA, mucA22 rsmA were all attenuated compared to PAO1.  
Even more interesting was the significant increase in macrophage viability in the mucA22 rsmA 
compared to mucA22.  Since RsmA regulates multiple virulence factors and indirectly promotes 
Figure 4.4 mucA22 ∆rsmA kills fewer J774a.1 macrophages than PAO1 and mucA22 after 6 hour 
incubation. 
  
J774a.1 macrophages were incubated with PBS or P. aeruginosa strains for up to 6 hours in 12-well 
plates.  Macrophages were scraped and strained for viability with 0.4% Trypan blue strain.  Experiments 
were performed in triplicate (n=9).  a represents p < 0.01 compared to PAO1.  b represents p < 0.01 
compared to mucA22.   
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acute virulence factors an rsmA mutant has been shown to be attenuated with epithelial cell 
infection, which explains the increase in survivability with macrophages(15).  Pyocyanin 
production has also been demonstrated to affect macrophage phagocytosis but due to incubation 
time and the cell culture media used, pyocyanin production does not seem to effect this assay 
(37).  Overall, the role of RsmA in the mucoid background effects virulence factor regulation 
and pathogenesis, as we show herein that the mucA22 ∆rsmA is less lethal to J774a.1 
macrophages.  
Proteomics approach reveals new targets of RsmA 
 RsmA targets had been studied in the nonmucoid background previously using PAO1 and 
PAK via a transcriptomics approach (13, 28).  RsmA is expressed throughout  
the P. aeruginosa growth phases and most expression of RsmA in nonmucoid strains occurs  
around 9 hours (13, 40).  A time course western blot was performed to identify the optimally  
expressed hour for investigating RsmA in the mucoid strain, mucA22 (Figure 4.5).  While RsmA  
is present even at 24 hours in mucA22, P. aeruginosa cultures were collected at 8 hours to be 
consistent with nonmucoid studies.   
 Since RsmA regulates targets by inhibiting translation of mRNA, a better representation 
of RsmA targets would be through a proteomics approach versus transcriptomics (15).  In Figure 
4.6a and b 2-dimensional gels were initially used to investigate the proteomes between mucA22 
Figure 4.5 RsmA levels are increased in mucA22 across all time points compared to 
PAO1. 
  
Western blot analysis of PAO1 and mucA22 strains at 4, 6, 8, 10, 12, and 24 hours.  Blots 
were probed for RsmA-HA with anti-HA monoclonal antibodies.  A PAO1 strain lacking an 
HA-epitope was used as a negative control.  Experiments were performed twice. 
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and mucA22 rsmA.  In this proteomic approach, a known target of RsmA, Hcp1, was shown to be 
increased in the mucA22 rsmA background(13).  In order to streamline the proteomic approach, 
the P. aeruginosa strains were analyzed though iTRAQ  
(isobaric tagging relative and absolute quantification).  mucA22 rsmA was compared to mucA22 
and an abbreviated list of proteins can be observed in Table 4.3.  In the iTRAQ screen the 
mucA22 rsmA strain showed increases in known RsmA targets, hcp1 and  phnA (28, 41).  The 
small protease PasP was increased in not only the 2D gel but also 2-fold in the iTRAQ.  PasP had 
not shown up in any of the transcriptome studies of RsmA, and it has been implemented in 
Figure 4.6 2D-gel analysis reveals new RsmA targets. 
 
A) and B) 2D gels of mucA22 (green) and mucA22 rsmA (pink) overlaid using Dymension 
software.   Molecular weight markers are designated on the left side of the gels.  Isoelectric 
points are designated on the bottom of the gels. Increases in the mucA22 background (M) or 
in the mucA22 ∆rsmA background (MR) were picked and in-gel trypsin digested.  C) Table 
identifying the proteins via mass spectrometry analysis present in the selected spots. 
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affecting P. aeruginosa virulence (42, 43). Interestingly, these proteomic experiments are more 
Table 4.3. iTRAQ analysis between mucA22 and mucA22 rsmA 
 
Abbreviated data of iTRAQ results.  Green shows a > 1.5 increased protein abundance in 
mucA22 rsmA compared to mucA22.  Red shows a ≤ 0.76 decreased protein abundance in 
mucA22 rsmA compared to mucA22.  Bold lines outline previously identified targets, or 
targets identified in 2D-gel analysis.  Experiments were performed in biological duplicate 
for each iTRAQ label.  Thermofisher Bioworks software was used for determining peptide 
confidence and iTRAQ label amounts.  No proteins under a 10-3 peptide confidence were 
included meaning peptides had 99.95% confidence of correct identification. 
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insight into RsmA’s regulon in the mucoid background. 
RsmA targets hcp1 and pasP in mucA22 
 iTRAQ, just like an RNA-seq or microarray, has to be confirmed because effects can be 
indirect results of a mutation.  In the case of RsmA, this is especially necessary since it regulates 
hundreds of targets.  Since RsmA had been known to target hcp1 already, there was no need to 
prove a direct interaction (41).  The effects of hcp1 in the mucoid background had not been 
investigated so transcription and western blot analysis was employed to confirm the 2D gel and 
iTRAQ results.  In Figure 4.7a hcp1 expression was no different between PAO1 and mucA22, 
however expression was decreased in mucA22 rsmA.  The decreased expression levels of hcp1 in 
an ∆rsmA mutant was not expected as nonmucoid ∆rsmA mutant is known to have increased 
levels of Hcp1.  Western blot analysis was employed to look at whether RsmA was in fact 
having a role in Hcp1 translation in the mucoid strain.  A mucA22 retS strain was included as a 
control since RetS has been shown to negatively affect the levels of type VI secretion system 
(T6SS) protein (44).  The mucA22 retS strain showed more Hcp1 compared to mucA22 as 
expected.  Both rsmA mutants showed increased Hcp1 levels compared to the parent strains.  The 
T6SS is used to fend off other foreign bacteria, but not thought to be expressed in mucoid strains.   
A previous proteomic comparison between co-cultured nonmucoid and mucoid strains, 383 and 
2192, showed 2192 had less Hcp1 (45).  Because RsmA is in higher abundance in mucA22, 
RsmA inhibits the translation of the T6SS in the mucoid background. 
 Since pasP has never been shown to be a target of RsmA, confirmation of the 2D gel and 
iTRAQ had to also include a direct interaction.  The posttranscriptional effect on pasP was first 
investigated using a lacUV5 leader fusion for its intergenic region (Figure 4.8a).  The fusion was  
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very active in PAO1, but in mucA22 where there is an abundance of RsmA, the fusion decreased 
100-fold.  When the rsmA allele was removed in mucA22, reporter activity went up 50- fold.  
RsmA is known to target an AGGA motif that is usually presented in the loop of a stem-loop 
structure (13).  Using m-fold predictive software, Figure 4.8b shows the intergenic region of 
Figure 4.7. RsmA represses T6SS component Hcp1 in mucA22. 
 
A) Strains were assayed for hcp1 expression using a transcriptional fusion with lacZ reporter.  
P. aeruginosa strains were grown in LB broth overnight and then a 1% inoculum was grown 
for 8 hours. β-galactosidase assay was performed to measure expression using a LacZ reporter 
per Miller. Experiments were performed in three technical triplicates with three biological 
replicates (n=9).  Student’s t-test showed no significant difference between PAO1 and 
mucA22, however statistical analysis showed a decrease with p <0.001 in mucA22 rsmA 
compared to mucA22 represented by ‡.  B) Western blot analysis with antibodies to Hcp1 in 
P. aeruginosa strains.  P. aeruginosa strains were grown in LB broth overnight and then a 1% 
inoculum was grown for 8 hours.  Nonmucoid and mucoid rsmA mutants had increased Hcp1 
levels compared to their respective parent strains.  A retS mutation, known to suppress T6SS 
production, is similar to a rsmA mutation and was used as a control in this analysis.  ImageJ 
software was used to analyze densitometry. 
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Figure 4.8. RsmA interacts directly with pasP in mucA22. 
 
A) Constitutively active fusion with lacZ reporter constructed with lacUV5 promoter and 
intergenic upstream region of pasP to quantify posttranscriptional activity of RsmA.  .  P. 
aeruginosa strains were grown in LB broth overnight and then a 1% inoculum was grown 
for 8 hours. β-galactosidase assay was performed to measure expression using a LacZ reporter 
per Miller. Experiments were performed in three technical triplicates with three biological 
replicates (n=9).  Student’s t-test was performed to compare PAO1 and mucA22 as well as 
mucA22 and mucA22 rsmA.  Both showed statistical significance with p < 0.001 demonstrated by 
‡.  B) Predicted secondary RNA structure of the pasP upstream intergenic region between PA0422 
and pasP.  The RsmA binding motif “AGGA” is highlighted at the top of the stem loop structure. 
C) and D) RNA electrophoretic mobility shift assay (EMSA) with purified RsmA to illustrate 
direct interaction between RNA of rsmY (C) or pasP (D) and RsmA.  Twice as much 
unbiotinylated (cold) rsmY RNA was used to demonstrate specificity and outcompete the 
biotinylated probe.  IRE (iron responsive element) RNA provided in the Pierce 3’ OH RNA 
biotinylation kit has no RsmA binding motif and was used as a negative control. 
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PA0422 and pasP, which contains the AGGA motif in a stem-loop.  To confirm a direct 
interaction with pasP, RsmA was purified and first tested with its ncRNA antagonist RsmY 
(Figure 4.8c).  RsmA was then incubated with a biotinylated pasP probe to prove if pasP was a 
previously unknown target of RsmA (Figure 4.8D).  RsmA could also be competed away with 
unlabeled RsmY transcript in both experiments confirming specificity of RsmA for the probe, 
RsmY or PasP (Figure 4.8c and d).  
Mucoid clinical isolates have increased rsmA expression 
 P. aeruginosa commonly undergoes phenotypic variation when exposed to the hostile 
response of a host’s immune system (46).  Isolates from cystic fibrosis patients commonly 
Figure 4.9. Mucoid strains of P. aeruginosa express more rsmA through rsmA’s distal 
promoter.  
 
Strains of P. aeruginosa were assayed for rsmA expression using a transcriptional fusion 
(TF3-lacZ) that is regulated by AlgU and AlgR.  P. aeruginosa strains were grown in LB 
broth overnight and then a 1% inoculum was grown for 8 hours. β-galactosidase assay was 
performed to measure expression using a LacZ reporter per Miller. Experiments were performed in 
three technical triplicates with three biological replicates (n=9).  Student’s t-test was performed 
between PAO1 and 383, which showed no significant difference.  Student’s t-test was performed 
between nonmucoid PAO1 and mucoid strains where  ‡ represents p < 0.001. 
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convert to the mucoid phenotype.  In our previous work, we investigated rsmA expression in a 
nonmucoid isolate 383 and a mucoid isolate 2192 that were co-cultured from the same cystic 
fibrosis patient (12, 55).  The mucoid 2192 strain had increased RsmA levels via western blot 
analysis (12).  Because our iTRAQ results showed new potential targets, more mucoid clinical 
isolates were investigated for rsmA expression using the TF3-lacZ fusion which relies on the 
AlgU promoter (12) (Figure 4.9).  mucA22 has the most increased rsmA expression all of the 
mucoid clinical isolates have at least 3-fold increased expression compared to the nonmucoid 
strains, PAO1 and 383.  The increase of rsmA levels in mucoid strains lends credence to the 
importance of understanding the RsmA regulon in the mucoid background. 
 
DISCUSSION 
  P. aeruginosa  can cause many life threatening infections from acute to chronic.  In the 
case of cystic fibrosis, P. aeruginosa will establish an infection in the lung where it can evade 
the host response and antimicrobials to persist and develop into a chronic infection (47, 48).  
Some clinical isolates from cystic fibrosis patients produce the phenotype termed mucoid, which 
is commonly indicative of a chronic infecting strain.  The mucoid phenotype is produced by the 
extracytoplasmic sigma factor AlgU which regulates the alginate operon along with other 
transcription factors like AlgR(9, 49).  Our previous work showed that AlgU and AlgR also 
contribute to rsmA expression and that there is increased RsmA levels in mucoid strains (12, 29).  
Most of the work on the RsmA regulon has been done in nonmucoid strains investigating the 
transcriptome (13, 28).  However when compared to the nonmucoid rsmA mutant, the mucoid 
mucA22 rsmA varies phenotypically.  The mucA22 rsmA strain produced more casein digestion, 
more biofilm, and more pyocyanin than the rsmA strain.  We hypothesized that these results 
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would lead to increased virulence of the mucA22 rsmA strain.  However, the mucA22 rsmA strain 
was attenuated compared to mucA22 and rsmA with J774a.1 macrophages due to an unknown 
mechanism.   
 These stark differences between rsmA mutants in virulence factor production and 
attenuation with macrophages led us to hypothesize that the RsmA regulon in mucoid strains 
would be different that previously reported targets from transcriptome analysis.  Our proteomic 
approach demonstrated a better representation of posttranscriptional regulation by RsmA in 
comparison to past transcriptomics analyses.  If RsmA was not present to inhibit the translation 
of its targets, the proteins would appear in abundance.  We initiated this screen with 2D-gel 
electrophoresis and identified previously unknown targets as well as known targets.  In order to 
screen the potential hundreds of targets of RsmA, we streamlined this approach with iTRAQ.  
Using iTRAQ we confirmed already known targets of RsmA like Hcp1 and PhnA but also 
previously unknown targets (Figure 4.10).  Unfortunately with all global experiments, results can 
be indirect.  Direct interactions of RsmA and iTRAQ targets must be confirmed.  However, the 
virulence factors that are repressed in the mucA22 rsmA have potential to be positively regulated 
RsmA targets just like CsrA is known to do with flagellum synthesis proteins in E. coli (18).   
 One new target we were able to confirm a direct interaction with RsmA is the P. 
aeruginosa small protease, PasP.  PasP has been shown to aid in P. aeruginosa virulence in a 
rabbit corneal infection model (42, 43).  Purified PasP was shown to also digest type I and IV 
collagens in these studies (42, 43).  PasP has also been shown to be important in the infection 
process of a cystic fibrosis patient (48).  We were able to show a direct interaction between 
biotinylated in vitro transcribed probes for RsmY and PasP with purified RsmA.  By competing 
the RsmA away with cold in vitro transcribed RsmY, RsmA was shown to have specificity for 
 157 
the pasP message.  Further work on the role PasP plays on the infection of P. aeruginosa is 
important to elucidate the purpose of RsmA in regulating this target so heavily in mucoid strains.  
Overall, studying the RsmA regulon in mucoid strains can help explain the role RsmA plays in 
the infection process especially with cystic fibrosis.  Also, by knowing what targets will and will 
not be expressed direct antivirulence compounds in concert with antimicrobials can lower the 
morbidity and mortality in cystic fibrosis patients with P. aeruginosa infections.   
 
Figure 4.10. Model of RsmA in mucoid strains. 
 
In mucoid strains of P. aeruginosa AlgR and AlgU co-regulated the distal promoter of 
rsmA.  This activity leads to increased expression of rsmA in the mucoid background.  The 
mucoid P. aeruginosa RsmA regulon is similar and different to the targets of RsmA in 
nonmucoid P. aeruginosa strains, PAO1 and PAK.  RsmA targets T6SS components by 
blocking the ribosomal binding site and inhibiting translation, but also represses previously 
unknown targets like pasP.  RsmA affects pyocyanin in both nonmucoid and mucoid 
backgrounds, however a complicated pathway produces pyocyanin and direct targets have 
yet to be elucidated. 
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ABSTRACT 
 Pseudomonas aeruginosa is an opportunistic pathogen and causes the most complications 
in hosts with compromised immune systems like diabetes, HIV/AIDS, and cystic fibrosis.  P. 
aeruginosa wreaks havoc with an armamentarium of virulence factors able to evade immune 
defenses and thrive in these hosts.  P. aeruginosa regulates multiple virulence factors via two 
component systems (TCS).  TCS are composed of a sensor histidine kinase that receives an 
external signal, autophosphorylates, and then phosphorylates its response regulator, which 
activates or represses target genes.  One TCS, AlgZ/R, activates the expression of the minor pilin 
operon (fimUpilVWXY1Y2E) important in type IV pili (TFP).  Previous work has shown that 
some minor pilins can cause increased expression of the minor pilin operon via a feedback loop, 
but the mechanism is unclear.  algZ and algR transcriptional fusions were analyzed in a pilW 
mutant strain of PAO1 to see if activity was affected due to the increase of minor pilin 
expression.  A 10-fold increase in algZ expression was seen in the pilW mutant.  A previous 
work performed a transposon mutagenesis screen to identify the regulator of this increase in algZ 
expression.  In this study, we show that the increase in minor pilin expression in a pilW mutant is 
due to increased algZR expression and that phosphorylated AlgR is required for this increase. 
These results were confirmed with qPCR and western blot analysis. These effects were also 
examined in a pilW, phospho-deficient algR mutant (pilW algRD54A) that restored algZR 
expression to wildtype levels.  The biological effects of increased phosphorylated AlgR levels 
were assayed with phenotypic assays for pyocyanin, elastin, and rhamnolipids, all showing 
significant decreases in a pilW strain, but restoring levels to wildtype in pilW algRD54A.  Lastly, 
due to decreases in these virulence factors in pilW,  the survivability of J774a.1 and RAW264.7 
macrophages were assayed in the presence of the pilW and pilW algRD54A strains.  Overall the 
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overexpression of algZR in a pilW mutant leads to decreased virulence and demonstrates an 
Achilles’ heel for P. aeruginosa. 
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INTRODUCTION  
 Pseudomonas aeruginosa is an opportunistic pathogen capable of infecting any host 
tissue.  P. aeruginosa mostly causes acute infections in individuals with HIV/AIDS, with burns 
over a majority of their body, and with ventilator assisted respiration (1, 2).  These acute 
infections can lead to septicemia and eventually death (3, 4).  P. aeruginosa compromises its 
host and evades the host immune system with the help of an armamentarium of virulence factors 
(1, 5).  The bacterium contains a diverse network of sensors and regulators controlling the 
expression of virulence factors as to efficiently establish a niche and fully reap the host’s 
nutrients.   
 One simple mechanism that P. aeruginosa uses to sense environmental signals is a two-
component system (TCS) (6).  TCSs are composed of a membrane bound sensor histidine kinase 
that autophosphorylates upon binding its signal and then transfers this phosphate to a specific 
response regulator.  While many pathogens use TCSs, there are more identified TCSs in P. 
aeruginosa than any other studied pathogen (7).  These TCSs contribute to P. aeruginosa 
pathogenesis in multiple ways including: biofilm development, attachment, antibiotic resistance, 
suppressing posttranscriptional regulation, cyclic di-GMP production, and motility (5).   
 While some TCSs can have specific control over a single virulence mechanism, there are 
TCSs that contribute to regulation of multiple virulence factors.  The TCS AlgZ/R has been 
shown to regulate rhamnolipids, pyocyanin, small noncoding RNAs, and type IV pili (TFP) (8, 
9).  This system consists of the histidine kinase, AlgZ, and the response regulator, AlgR.  AlgZ 
and AlgR are located in an operon together, like most TCSs (6).  AlgZ is bound to the inner 
membrane and the environmental signal it receives has still not been elucidated.  The histidine 
residue at 175 transfers the phosphate to AlgR’s aspartate at residue 54.  AlgR contains the same 
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motifs of most response regulators including the helix-turn-helix DNA binding domain (10).  
Interestingly, AlgR can activate its targets in the phosphorylated form, like the TFP, or in a 
phosphorylation independent manner, like rsmA (8, 11).   
 AlgR contributes to the production of TFP by regulating the expression of the minor pilin 
operon (fimUpilVWXY1Y2E).  These minor pilins are incorporated into the TFP stalk along with 
the major pilin, PilA, and allow for P. aeruginosa to attach to surfaces and also perform motility 
in the form of twitching (12).  The TFP structure has two ATPase motors at its base for extension 
and retraction of the stalk, allowing the bacterium to move across a surface (13, 14).  Previous 
work has shed light on the fact that the TFP not only contribute to adhesion and motility, but that 
the tip of the TFP stalk, PilY1, contributes to expression of other virulence factors by acting as a 
mechano-sensory apparatus, proving to be important in initiating an infection (14).  Luo et al. 
also showed that by removing the minor pilin operon, it caused a significant increase in minor 
pilin expression (14).  However, the actual mechanism by which the TFP works on regulating 
other virulence factors has not been elucidated. 
 In this study, we expand upon the master’s thesis of Danielle A. Williams where she 
performed a transposon mutagenesis with a pilW mutant containing an algZ-lacZ transcriptional 
fusion (30).  Her master’s work identified that in this background algZ expression was elevated, 
but was significantly decreased when algR was interrupted by the transposon (30).  We 
hypothesized due to AlgR regulating minor pilin in a phosphorylation dependent manner and by 
removing a minor pilin allele like pilW caused a significant increase in minor pilin expression 
that not only was this due to increased levels of phosphorylated AlgR, but also these levels of 
AlgR were causing a significant increase in algZ expression.  In order to confirm this hypothesis 
a pilW phospho-deficient strain, pilW algRD54A, was used.  We assessed the pilW strain for 
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AlgZ and AlgR levels, production of virulence factors regulated by AlgR, and whether or not the 
increase in algZ/R expression had an effect on virulence.  Overall, our work shows that targeting 
the TFP can lead to manipulating the AlgZ/R TCS to make P. aeruginosa less virulent and in 
combination with antibiotics, more readily cleared by the immune system. 
 
METHODS 
Strains, plasmids, and media 
 The strains used in this study are presented in Table 5.1. Escherichia coli strains were 
maintained on LB (Difco) plates or broth without or with antibiotics, as appropriate. 
Pseudomonas aeruginosa strains were grown on Pseudomonas isolation agar (PIA), LB medium, 
or Vogel-Bonner minimal medium (VBMM) supplemented with the appropriate concentrations 
of antibiotics. For E. coli, antibiotics were used at the following concentrations when 
appropriate: 10 µg/ml tetracycline, 15 µg/ml gentamicin, 100 µg/ml ampicillin, and 35  µg/ml 
kanamycin. For Pseudomonas strains, antibiotics were used at the following concentrations: 150  
µg/ml gentamicin, 50  µg/ml tetracycline, and 300  µg/ml carbenicillin. For allelic exchange, 
sucrose was supplemented at 10% in YT (1% tryptone and 0.5% yeast extract) medium.  
Table 5.1 
Strain or Plasmid Genotype or Relevant properties Reference or 
Source 
E. coli strains   
 
NEB5α fhuA2 Δ(argF-lacZ) U169phoA, glnV44 
Φ80Δ(lacZ)M15 gyrA96 
New England 
Biolabs 
pRK2013 Helper strain 16 
BTH101 
F
-
, cya-99, araD139, galE15, galK16, rpsL1 (Str r), Euromedex 
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hsdR2, mcrA1, mcrB1 
algZHA 
pEX18Gm 
Allelic exchange for algZ HA allele 30 
algZ-lacZ 
miniCTX 
Transcriptional fusion 30 
pAlgRD54E Overexpression of AlgRD54E This study 
P. aeruginosa  
strains 
  
PAO1  Wild type 32 
algR algR mutant 33 
algZ algZ mutant 30 
algZHSDM algZ mutant with histidine 175 replaced with glutamate 11 
pilA pilA mutant 30 
lasR rhlR Quorum sensing deficient strain 29 
pilW pilW mutant 31 
pilY1 pilY1 mutant 30 
vfr pilW Double mutant 30 
pilW algR Double mutant 30 
pilW algRD54A Double mutant 30 
pilW algZHSDM Double mutant 30 
PAO1HA PAO1 with epitope tagged AlgZ This study 
pilWHA mucA22 mutant with epitope tagged AlgZ This study 
 
Strain construction 
 All PCR products were amplified from P. aeruginosa PAO1, unless otherwise noted, 
using Q5 polymerase (New England BioLabs [NEB], Ipswich, MA) and primers listed in Table 
5.2. Crossover PCR (splicing by overhang extension PCR) (14b) was used to construct deletion 
mutations and to clone sequences into the suicide vector pEX18Tc or pEX18Gm (15). All cloned 
constructs were confirmed via sequencing. P. aeruginosa strains were conjugated with E. coli as 
a donor strain and the pRK2013-containing helper strain (16). Conjugations were performed 
overnight on LB plates at 37°C, and the conjugants were plated on the appropriate selective 
medium to obtain single-crossover mutants. Merodiploids were grown without selection and then 
screened for sucrose sensitivity on YT medium–10% sucrose plates. Mutations were confirmed  
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Table 5.2 
Primer Sequence Use 
algZqPCRF GACCTGTCCGACCTGTTCCGG qPCR 
algZqpcrR CCAGCAGCGGCTGCAAGGTC qPCR 
algRqPCRF GCGGCAGCGGTCCGCGAG qPCR 
algRqpCRR CTTGTGGTCGGCAATGAAG qPCR 
uvrDqpcrR GGCGTCCCTGGTTGTT housekeeper 
uvrDqpcrF GCAGTTCAGCGACGAC housekeeper 
mreBqpcrR CGCCGCAACTACGGCAG housekeeper 
mreBqpcrF GGTTGCGGCCGCGGA housekeeper 
algZTSFF GCGCGGATCCGTTCATGTGCACGTCTTCCAGG Transcriptional 
fusion 
algZTSFR GCGCAAGCTTCGACAGAGTTTCCGCAAGG Transcriptional 
fusion 
AlgRR GCGCGGTACCCAGAGCTGATGCATCAGACGC BACTH 
AlgRF GCGCGGATCCGAATGTCCTGATTGTCGATGACG  BACTH 
AlgZF GCGCGGATCCGCCTATCCGATTCAAGCCCGG BACTH 
AlgZR GCGCGGTACCCAGGCTTCCTGCATGAGTCGC BACTH 
AlgZTruncR GCGCGGTACCGCGCGTGCCGCAGATACAG BACTH 
using PCR with primers containing the suffix intF and intR in Table 5.2 and sequencing of the 
resulting PCR fragment. Hemagglutinin (HA) tagging of the proteins was accomplished using 
primers containing the HA tag at the 3’ end of the gene, and HA was introduced as described 
above using the suicide vector pEX18Gm.  
Site-directed mutagenesis 
 Phosphorylated primers algRD54AF/algRD54EF and algRD54AR/algRD54ER were 
used in an inverse PCR with the algR allele in pEX18Gm as the templates. The aspartate at 
residue 54 of the algR allele was mutated into either an alanine with an NheI restriction site or a 
glutamate with an XbaI site. The successful inverse PCR product was self-ligated, transformed 
into NEB5α cells (NEB, Ipswich, MA), and screened by plasmid digestion with respective 
restriction enzyme digestion and sequencing. The constructs obtained by site-directed 
mutagenesis were conjugated into Pseudomonas strains as described above.  
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BACTH 
 Bacterial adenylate cyclase two-hybrid system from Euromedex was used to test for 
protein-protein interactions (17).  The algR, algZ, and a truncated form of algZ were amplified 
from PAO1 with primers listed in Table 5.2.  These genes were cloned into the BACTH vectors.  
For algR and the truncated C-terminus algZ either N-terminus or C-terminus fusions were used.  
For the full-length algZ allele, only the C-terminus fusion was used.  These vectors were 
transformed into NEB5α cells and selected for on their respective antibiotic LB media, Amp100 
or Kan50.  After colony PCR confirmation, the strain was struck for isolation, frozen down and 
set up for a plasmid precipitation using NEB Monarch plasmid prep kits.  These plasmids were 
than digested with the respective restriction enzymes and confirmed on a 1% agarose gel.  
BTH101 cells were then transformed with the appropriate control vectors: empty Kan and Amp 
vectors for negative control, leucine zipper positive controls, and the alleles to be investigated.  
Cells were spread on MacConkey agar (Difco) with 1% Maltose, Amp100, and Kan50 or 
LB/IPTG/XGal, Amp100, and Kan50 per Euromedex protocol.  Colonies were PCR confirmed 
for inserts before assaying.  Assaying consisted of measuring β-galactosidase activity per Miller. 
qPCR 
 P. aeruginosa strains were grown in LB broth at 37ºC overnight and then a 1% dilution 
of the overnight culture was grown for 6 hours.  The bacteria were collect by centrifugation 
following the ZymoResearch Direct-zol RNA kit protocol.  Upon elution from the column, RNA 
was treated with DNase-I from NEB for 30 minutes at 37ºC.  RNA was then precipitated with 
200 proof EtOH and frozen overnight.  The following day, the samples were centrifuged at 15k x 
g for 10 minutes at 4ºC.  The EtOH was aspirated off, 1 mL of 70% EtOH was added , and 
 173 
centrifugation repeated.  EtOH was again aspirated off and samples were left to air dry.  Pellets 
were resuspended in 40 µl of Nuclease free water and quantified using a Thermofisher 
NanoDrop.  To generate cDNA, 5 ng of RNA was used with 2.5 ng random hexamers/µL (New 
England Biolabs, Ipswitch, MA), 0.5 mM dNTPS, and followed Invitrogen superscript IV 
reverse transcriptase protocol.  A no RT control was generated.  For qPCR NEB Luna was used 
with a BioRad CFX96 Real-Time PCR detection system to quantify amplicons.   Primers listed 
in Table 5.2 were designed for inside the coding region of the target.  Two house-keeping genes, 
UvrD and RpoS, were used as controls along with no RT wells and wells for dilution of a PCR 
amplicon of the gene of interest.  Data analysis was performed using the CFX Manager software.  
Experiments were repeated four times (n=12). 
Western blot analysis 
 P. aeruginosa strains were grown in LB broth at 37°C overnight and then a 1% dilution 
of the overnight culture was grown for 6 hours. The bacteria were collected by centrifugation, 
resuspended in sterile phosphate-buffered saline, and lysed by sonication. Total protein 
concentrations were quantified by the Bradford protein assay (Bio-Rad, Carlsbad, CA). Cell 
extracts (5 µg) were separated by 12% SDS-PAGE and transferred to a polyvinylidene difluoride 
membrane (Bio-Rad). The membranes were blocked and probed using a 1:20,000 dilution of 
anti-HA monoclonal antibody (Thermo Fisher, Pittsburgh, PA), followed by a 1:20,000 dilution 
of horseradish peroxidase-conjugated goat anti-mouse immunoglobulin antibody (18)or 1:20,000 
dilution of AlgR antibody followed by 1:20,000 dilution of horseradish peroxidase-conjugated 
goat anti-rabbit immunoglobulin antibody. The membrane was stripped per Abcam mild 
stripping protocol and then probed with RpoA primary antibody (1:20,00 dilution) followed by 
1:20,000 dilution of horseradish peroxidase-conjugated goat anti-mouse immunoglobulin 
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antibody.  Detection was performed using an ECL Plus kit (Thermo Fisher, Pittsburgh, PA) and 
chemiluminescence detection (ProteinSimple, Santa Clara, CA). All Western blot analyses were 
repeated at least twice.  
Phenotypic Assays 
 Various virulence products were assayed in the P. aeruginosa strains in this study.  All 
strains were grown in LB broth at 37ºC for 16 hours.  Pyocyanin was assayed by centrifuging the 
culture and collecting the supernatant.  Then 2 mL of chloroform was used to extract any 
pyocyanin produced in the culture by vortexing vigorously and allowing to set for 10 minutes.  
The chloroform layer was removed and 1 mL of 0.1 N HCl was added and vigorously vortexed 
and allowed to set for 10 minutes.  0.1 N HCl was used to blank the spectrophotometer at 
OD562nm.  Values were normalized to PAO1.  Elastase was assayed using Elastin-Congo Red 
(ECR) from Sigma Aldrich.  Strains were centrifuged and 100 µL taken from the supernatant.  
This was mixed with 900 µL of ECR solution ( 100 mM Tris, 1 mM CaCl2, pH 7.5, 20 mg/mL) 
and incubated at 37ºC for 4 hours at 250 rpm.  The negative control used to blank the 
spectrophotometer was 1 mL of ECR solution with no strain supernatant.  Values were 
normalized to PAO1.  Rhamnolipid production was assayed using the orcinol method listed in 
Morici et al. (19).  All experiments were performed in triplicate (n=9). 
Macrophage Survival Assays 
 P. aeruginosa strains were incubated with ATCC J774a.1 or Raw 264.7 macrophages to 
assess macrophage survivability.  Macrophages were grown in Corning cellgro DMEM with L-
Glutamine, 4.5g/L Glucose, and 10% fetal bovine serum and 100 I.U./ml penicillin 100 µg/mL 
streptomycin.  Cells were maintained in a 37ºC incubator with 5% CO2 and humidity.  Cells were 
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counted and plated in 12-well plates at 1x10^6 cells per well in media without pen/strep.  
Overnight LB cultures of P. aeruginosa strains were diluted to 1% and allowed to grow for 2 
hours at 37ºC at 250 rpm.  Cultures were then centrifuged and washed with 1X PBS.  Strains 
were then aliquot to an OD600nm of 0.1 and incubated with macrophages up to 6 hours.   The 
inoculum of bacteria was also measured in CFU/mL.  Macrophages were collected at 2, 4, and 6 
hour time points and 1 mL of culture was mixed with 100 µL of 0.4% trypan blue to measure 
viability.  Experiments were performed in triplicate (n=9). 
Overexpression/complementation studies.  
 In order to overexpress algD54E, the coding sequence was amplified (Table 5.2) and 
cloned into the integrating vector pTJ1 for complementation or overexpression(20). 
Trimethoprim-resistant colonies were picked and patched on trimethoprim-irgasan media and 
0.1% arabinose PIA. The presence of the gene of interest was confirmed using primers 
pHERDSF and algRTJ1R. Cultures requiring induction used 0.1% arabinose and were grown for 
overnight in broth or on agar plates. 
β-galactosidase Assay  
 β-Galactosidase activity was determined by incubating cell extracts with o-nitrophenyl-β-
D-galactopyranoside (4 mg/ml) as described by Miller (20b).  Experiments were performed in 
triplicate (n=9). 
Statistical analyses.  
 Statistical analyses  (Student’s t-test) were performed using Microsoft Excel software 
(Microsoft, Redmond, WA).  
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RESULTS 
AlgZ interacts with AlgR and AlgR dimerizes 
  The response regulator AlgR has been thoroughly studied and also implicated to affect 
virulence in P. aeruginosa (4, 10).  While AlgR and its cognate sensor histidine kinase have been 
shown to be in an operon together, they have never been shown to actually interact (21).  It is 
important to demonstrate this interaction to complete a portion of P. aeruginosa knowledge.  
With TCSs the sensor will share a phosphate with the response regulator at specific amino acid 
residues, however they also have protein-protein interaction domains.  In the case of AlgZ and 
AlgR the C-terminus region of AlgZ is proposed to interact with AlgR.  By using a BACTH 
system, AlgZ and AlgR were shown to interact (Figure 5.1).  In this analysis, appropriate 
controls consist of empty vectors (T18 or T25), which produce pieces of adenylate cyclase, but 
do not interact.  The positive controls consisted of a leucine zipper (Zip) that is known to 
dimerize and allow adenylate cyclase to make cyclic AMP (cAMP).  Positive results consist of 
700 to 7000 miller units with a β-galactosidase assay and colorimetric indication by pH indicator 
phenol red on MacConkey agar or cleavage of X-gal on LB/IPTG/Xgal agar.   
  Since the AlgZ protein is incorporated into the inner membrane of the bacteria, the 
fusion was placed on the C-terminus, so that the adenylate cyclase portion on AlgR had greater 
potential to interact.  An empty vector and leucine zipper-containing vector were co-transformed 
with AlgZ carrying vector to test for any aberrant interactions.  While the full-length AlgZ and 
AlgR interaction did show positive results, some reporter activity was observed with our 
negative controls.  One possible explanation for these results is the fact that the structure of AlgZ 
has not been elucidated and this could lead to arbitrary interactions.  To combat this result, a 
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truncated form of AlgZ was cloned into the BACTH vector, which just included the C-terminus 
 
region (AlgZTrunc).  The truncated form of AlgZ did not interact with the leucine zipper, 
however the same reporter activity was observed with the truncated form of AlgZ and AlgR-T25.   
 Response regulators are commonly known to dimerize to activate their genetic targets.  
AlgR has been shown to activate the minor pilin operon and the posttranscriptional regulator 
Figure 5.1 AlgZ and AlgR interact.   
 
BACTH assay for AlgZ or truncated AlgZ interacting with AlgR using T18 or T25 
portions of adenylate cyclase. β-galactosidase assay, MacConkey agar supplemented 
with 1% maltose, and LB agar supplemented with IPTG/X-Gal were screened for 
interaction between AlgZ, AlgZ C-terminus, and AlgR. * signifies beta-galactosidase 
activity units between 700 – 7000, the significance threshold for the BACTH.  .  β-
galactosidase assay was repeated in triplicate (n=9). 
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rsmA with two binding sites (8, 11).  This consistent motif led us to also analyze the ability for 
 
AlgR to dimerize using the BACTH system.  The same controls were repeated in this experiment 
except with AlgR.   No activity with the empty vectors or the leucine zipper was reported with 
AlgR (Figure 5.2).  However, when both vectors containing AlgR were transformed, around 
4000 units of β-galactosidase activity was observed as well as increased colorimetric reporter.  
Figure 5.2 AlgR dimerizes.   
 
BACTH assay for AlgR-AlgR interaction using T18 or T25 portions of adenylate 
cyclase. β-galactosidase assay, MacConkey agar supplemented with 1% maltose, and 
LB agar supplemented with IPTG/X-Gal were screened for interaction between AlgR 
and AlgR (T18-AlgR, AlgR-T25). * signifies beta-galactosidase activity units between 
700 – 7000, the significance threshold for the BACTH.  β-galactosidase assay was 
repeated in triplicate (n=9). 
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Confirming the interactions of AlgZ with AlgR and AlgR dimerizing demonstrates the AlgZ/R 
TCS truly interacts.   
AlgZ levels are increased in pilW strain 
 When studying the effects of a pilY1 mutation, Luo et al. showed that the increase in 
minor pilin expression was due to AlgR and not the known regulator of algZ, Vfr (14).  
However, this group never investigated the effects on algZ expression; considering if AlgR needs 
to be phosphorylated to activate the minor pilin operon then there might be an increase in algZ to 
cause more phosphorylation.  Williams identified that not only was there increased algZ 
expression in a pilW strain but that this was dependent on AlgR (30).  Since Williams only 
investigated these effects with lacZ reporter fusions, algZ levels were examined with qPCR and 
western blot (Figure 5.3a).  Williams reported expression of algZ was maximal at 6 hours with 
an algZ-lacZ transcriptional fusion (30).   An algZ strain was used as a negative control in our 
experiment. The pilW mutant had a 8-fold increase in algZ expression compared to the PAO1 
wildtype strain.  Interestingly, the phospho-deficient AlgR pilW strain showed algZ expression 
levels less than PAO1.  These results further asserted that there was a phosphorylated AlgR 
dependent phenomenon causing the increase in algZ expression.  
 AlgZ levels between PAO1 and pilW were studied using a HA-epitope tagged algZ allele 
(Figure 5.3b).  These strains were also grown in LB and collected after 6 hours to mimic the 
qPCR experiments.  Western blot analysis also showed a significant increase in AlgZ levels in 
the pilW background.  The lower levels of AlgZ protein versus algZ transcript might be due to 
posttranscriptional regulation or the fact that cell lysates were assayed instead of membrane 
fractions also.   
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Figure 5.3 AlgZ levels are increased in a pilW mutant.   
 
A) qPCR analysis of algZ expression.  pilW has a significant increase  while the phospho-
deficient pilW was less than wildtype.  Values were normalized to housekeeper genes (uvrD 
and mreB) and compared to PAO1. *** signifies p < 0.01.  Experiments performed in 
triplicate (n=12).   B) Western blot analysis of AlgZ in PAO1HA and pilWHA from 6 hour 
cultures using anti-HA monoclonal antibodies.  PAO1* is lacking the HA epitope.  RpoA 
was used as a loading control. 
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Figure 5.4 AlgR levels are increased in a pilW mutant.   
 
A) qPCR analysis of algR expression.  pilW has a significant increase while the 
phospho-deficient pilW was less than wildtype.  Experiments were performed in 
triplicate at least three times. Values were normalized to housekeeper genes (uvrD and 
mreB) and compared to PAO1. *** signifies p < 0.01.  Experiments performed in 
triplicate (n=12).  B) Western blot analysis of AlgR in PAO1, algR, pilW,pilW vfr, and 
pilW algRD54A from 6 hour cultures using anti-AlgR serum.  RpoA was used as a 
loading control. 
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AlgR levels are increased in pilW strain 
 Since the AlgZ/R TCS is genetically organized in an operon, algR expression and protein 
levels were investigated.  Depending on which regulators are active, algR can be expressed as a 
message with algZ or the extracellular sigma factor AlgU can activate expression of algR with a 
promoter in the algZ coding region (14, 22).  Williams studied the effects of the AlgU dependent 
promoter in pilW and showed no increase in algR expression compared to PAO1.  The AlgZ 
levels were increased in the pilW strain as well as Williams confirming the Luo et al. data that 
minor pilin expression also significantly increased, which is an effect of phosphorylated AlgR.  
To see if algR mRNA was increased, algR expression was also investigated via qPCR (Figure 
5.4a).  This time the algR mutant was the negative control and the algZ mutant showed no 
difference in expression compared to PAO1.  The pilW strain showed an increase in expression 
levels similar to the algZ expression (Figure 5.3a).  Just like algZ expression, the phospho-
deficient AlgR pilW strain showed wildtype levels.  This datum showed more evidence of algZ/R 
co-transcription due to phosphorylated AlgR, but were AlgR protein levels also decreased?  
Western blot analysis showed significant increases in pilW and in the pilW vfr in AlgR levels 
(Figure 5.4b).  Luo et al. reported that while significant, the pilX vfr mutant still had increased 
levels of minor pilin expression compared to wildtype (14).  Williams also reported this same 
result with a pilW vfr mutant and transcriptional fusion analysis.  However, the phospho-
deficient AlgR pilW strain showed little AlgR protein present, further arguing the importance of 
phosphorylated AlgR on activating the expression of the algZ/R operon.   
pilW has decreased AlgR-regulated virulence factor production 
 AlgR has been show to regulate multiple virulence factors including pyoverdine, 
rhamnolipids, and TFP in a phosphorylation dependent manner (8, 9).  Since the pilW strain 
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showed increases in the AlgZ/R TCS, then were the same increases in virulence targets of AlgR 
present in this background?  Pyocyanin is known to be regulated by AlgR in a phosphorylation 
independent manner (9).  Little et al. showed that in a phospho-deficient AlgR strain, pyocyanin 
production was increased while in the phosphomimetic strain, pyocyanin levels were much lower 
than wildtype (9).  Pyocyanin production was assessed in minor pilin mutants (pilY1 and pilW) as 
well as strains lacking the ability to phosphorylate AlgR in a pilW (algR, algRD54A, 
Figure 5.5 Virulence factor production is decreased in pilW.   
 
A) Pyocyanin assay from overnight LB cultures.  Circles underneath the strain represent color 
taken from image of culture tube.  B) Rhamnolipid assay from overnight LB cultures.  C) 
Elastase assay using Elastin-Congo Red (ECR), and values were normalized to PAO1.  
Overnight LB cultures were pelleted and 100 µL of supernatant was incubated with ECR for 
four hours.   * represents p < 0.05 *** represents p < 0.01.  All experiments were repeated in 
triplicate (n=9). 
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algZH175E) (Figure 5.5a).  A lasR rhlR strain was used for a negative control as these regulators 
are known to contribute to pyocyanin production (23).  Bohn et al. and Siryaporn et al. have both 
characterized the effects of pilY1 mutations and how they mimic lasR mutations. Both minor 
pilin mutants showed decreases in pyocyanin production compared to wildtype (24, 25).  
However, loss of the algR allele in the pilW mutant or inability for this mutant to phosphorylate 
AlgR showed significant increases in pyocyanin levels.  Next, rhamnolipid production was 
assayed in pilW and pilW algRD54A (Figure 5.5b).  A similar pattern of decrease in pilW and 
increase in the phospho-deficient strain was observed.  The literature in this case is conflicting.  
Morici et al. states that AlgR represses the Rhl quorum sensing (QS) system and rhlA expression 
where an algR mutant has increased rhamnolipid production, while Okkotsu et al. demonstrate 
the opposite and AlgR actually activates rhlA.  Both also show AlgR binding upstream.  The 
results in Figure 5.5b were performed in a broth instead of collected from a biofilm on a plate 
and may explain the lack in distinct significance.  Also, the western blot analysis from Figure 
5.4b shows more AlgR present in pilW and less in pilW algRD54A, which supports the argument          
from Morici et al. that AlgR would be repressing rhamnolipid production.  Lastly, the quorum 
sensing target, elastase, was quantified.  Due to the effects of decreases in QS targets because of 
increased AlgR, an elastase assay was used to study the effects pilW had on elastase activity 
(Figure 5.5c).  Since elastase is a direct target of the Las and Rhl QSs, the lasR rhlR mutant again 
was used as a negative control.  Again, the same pattern of decrease in pilW and increase in pilW 
algRD54A was observed.  Further arguing the work of Morici et al. that increased AlgR levels 
are repressing the QS response.  These data also argue that minor pilin mutants can affect the QS 
response via AlgR’s ability to influence the Rhl quorum system.   
Increased macrophage survivability in pilW strain 
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 To find out if the decreases in virulence factors had any effect on virulence in the pilW 
mutant, macrophage survival was assayed (Figure 5.6).  Strains were incubated up to 6 hours 
with either J774a.1 (Figure 5.6a) or Raw 264.7 cells (Figure 5.6b).  PBS inoculated wells were 
used as a negative control in both experiments.  Both cell lines had increased survivability with 
Figure 5.6 Macrophages have increased survivability with pilW.   
 
A) J774a.1 and B) Raw 264.7 macrophages were incubated with PAO1, pilW, and pilW 
algRD54A for viability with 0.4% Trypan blue stain at 2, 4, and 6 hours.  * represents p < 
0.05 and *** represents p < 0.01.  All experiments were performed in triplicate (n=9).   
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the pilW strain.  There was also no significant difference between PAO1 and the pilW algRD54A 
strains.  Siryaporn et al. demonstrated that both pilY1 and pilW mutants were attenuated in killing 
the amoeba Dictyostelium discoideum (25).  These results were more visible in the incubation 
with the Raw 264.7 macrophages.  The major difference between J774a.1 and Raw 264.7 cells is 
the production of interleukin-1β (IL-1β) by J774a.1.  This overproduction of IL-1β with the pilW 
strain may be causing the lesser significance as compared to the Raw 264.7 cells.  However, due 
to overall decreased virulence products produced in the pilW mutant, the pilW mutant is 
attenuated when incubated with macrophages.  But when AlgR is unable to be phosphorylated in 
the pilW background, virulence factor production is equal to wildtype if not increased and this 
effect leads to macrophage death.   
Overexpression of phosphomimetic AlgR mimics pilW strain 
 The pilW strain not only has increased levels of AlgR but that these are increased levels 
of phosphorylated AlgR due to increases in AlgZ also.  The pilW strain also had decreased 
virulence factors and was attenuated with two lines of macrophages.  To further drive home the 
fact that this is due to increased levels of phosphorylated AlgR, an inducible phosphomimetic 
AlgR (pAlgRD54E) was constructed and put it in a strain that could not phosphorylate AlgR 
(algZH175E).  The pAlgRD54E construct was induced in all scenarios with 0.1% arabinose.  
This strain was first analyzed with the algZ-lacZ transcriptional fusion to confirm the increased 
algZ expression in the pilW was phosphorylated AlgR dependent (Figure 5.7a).  Upon induction, 
the expression of algZ increased by ~100 fold.  The algZH175E strain cannot phosphorylate 
AlgR due to the mutated histidine.   Due to the increase of algZ expression, pyocyanin was 
quantified in uninduced and induced strains (Figure 5.7b).  PAO1 was also incubated with 0.1% 
arabinose to show no effects of the added compound.  algR and algZH175E strains were also 
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Figure 5.7 Overexpression of phosphomimetic AlgR mimics pilW mutant and shows 
decreased virulence.   
 
A) β-galactosidase assay of algZ expression of uninduced and induced AlgRD54E in 
algZH175E strain that cannot phosphorylate AlgR.  B) Pyocyanin assay of uninduced and 
induced AlgRD54E.  PAO1† represents wildtype with 0.1% arabinose.  C) Macrophage 
survivability assay with J774a.1.  PBS† represents macrophages inoculated with PBS and 
0.1% arabinose.  All experiments were performed in triplicate (n=9).  * represents p < 0.05 
and *** represents p < 0.01. 
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used as controls in the comparison to the algZH175E pAlgRD54E strain.  The induced 
algZH175E pAlgRD54E strain had levels of pyocyanin similar to the lasR rhlR strain.  Lastly, 
this strain was assayed for macrophage survivability to see if increased levels of AlgRD54E had 
a decrease in virulence like pilW (Figure 5.7c).  An algRD54A strain was also assayed to show a 
similarity with the phospho-deficient strain algZH175E when pAlgRD54E was not induced.  The 
induced pAlgRD54E strain had significantly increased levels of macrophage survivability.  At 
the 6-hour time point, around 50% of macrophages survived which again mimics the lasR rhlR 
mutant strain (data not shown).  The overexpression of the phosphomimetic AlgR construct 
further suggests that the same activation of algZR expression and decrease in virulence occurs in 
the pilW mutant due to the increase in phosphorylated AlgR via autoregulation.   
 
DISCUSSION 
 The response regulator AlgR is used by P. aeruginosa to control the expression of 
multiple virulence factors and aid in establishing an infection and persisting in a compromised 
host a (8-10, 26).  While genetically arranged in an operon with algZ, no evidence to this date 
has demonstrated that AlgZ is the sensor histidine kinase to AlgR except for bioinformatic 
prediction.  We demonstrated using a BACTH system that AlgZ and AlgR do in fact interact.   
While more information can be determined from studying the 3D structure with X-ray 
crystallography of AlgZ and AlgR, overall this interaction proves a wide-held belief with this 
TCS in P. aeruginosa.  AlgR has also been proposed to have DNA binding sites that require two 
AlgRs (8, 11).  In activating these AlgR targets, AlgR would dimerize and bind the DNA 
consensus sequence.  By using the BACTH system we demonstrated that AlgR is capable of 
interacting with itself.  This datum affirms that like other response regulators, AlgR can, at least, 
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dimerize (27).  In the case with AlgZ and AlgR, a phosphotransfer assay would be more 
pertinent to show that actual exchange between these members of this TCS.  However, AlgR has 
the ability to autophosphorylate and could prove to be difficult to visualize unless studied in a 
time dependent manner(8, 13).   
 Confirming the interaction with AlgZ and AlgR is important for understanding the 
increase in algZR expression in a pilW mutant.  Williams demonstrated that not only did a pilW 
mutant have increased minor pilin expression confirming the Luo et al. work, but there was also 
increased algZ expression.  Autoregulation is common amongst TCSs that are arranged in an 
operon (6, 23).  We confirmed that there was increased algZR message and also increased levels 
of AlgR protein in pilW.  When AlgR was mutated to a phospho-deficient algRD54A these levels 
dropped.  Lastly, because AlgR regulates the expression of the minor pilin operon in a 
phosphorylation dependent manner and by overexpressing the AlgR phosphomimetic, 
pAlgRD54E, showed the same increase in algZ expression; we theorize that the pilW mutant has 
no way of turning off the algZR autoregulation mechanism.  Marko et al. demonstrated using the 
BACTH system that four minor pilin proteins, PilVWXY1, form a complex in the 
innermembrane/periplasmic space and interact with AlgZ(28).  This interaction would be a 
mechanism for AlgZ to “turn off” the phosphorylation of AlgR and decrease expression of minor 
pilins.  However, when one of these prominent minor pilins is missing, the off-switch is 
nonfunctional and the AlgZ/R autoregulation mechanism (Figure 5.8) increases algZ expression 
and minor pilin expression.  This mechanism would also  explain the effects on the Rhl quorum 
sensing system virulence factors all being decreased.  Since the pilW strain is also producing 
more AlgR and Morici et al. showed that increased levels of AlgR repress this QS mechanism, 
naturally pyocyanin, rhamnolipid, and elastase production would also decrease (19).   
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 Many groups have shown that pilY1 mutations or pilW mutations lead to attenuation with 
amoebae and C. elegans (25, 28).  in vivo studies and global knowledge experiments, like 
transcriptomics or proteomics, would allow for better understanding and the coordination 
between the AlgZ/R TCS, TFP,  and the Rhl QS network in P. aeruginosa virulence.  To this 
point, we showed that a pilW mutant and a strain overexpressing phosphomimetic AlgR were 
attenuated with macrophages.  These results lead the TFP of P. aeruginosa to be targeted as an 
Achilles’s heel to compromise the bacterium’s virulence capabilities.  Since the TFP are crucial 
for twitching motility and attaching to surfaces; by targeting this apparatus, a pilicide would not 
only render the bacterium unable to attach and twitch, but also decrease the production of 
virulence factors.  This effect in concert with an additional antimicrobial could allow for 
clearance of an infection, preventing the development of septicemia in acute infections or 
Figure 5.8 Model of pilW mutation and the effects on algZR expression. 
 
We show with this work herein that minor pillin mutants, in this case pilW, that the AlgZ/R 
TCS is no longer regulated in P. aeruginosa.  algZ/R expression increases greatly, therefore 
increasing minor pilin expression.  The effects of this increase also influence other 
phosphorylated AlgR dependent targets besides TFP and decreases virulence when incubated 
with J774a.1 macrophages. 
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persister cells in chronic infections.   
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CHAPTER 6 
 
CONCLUSIONS 
 
 
 P. aeruginosa is a versatile opportunistic pathogen capable of infecting any tissue in the 
human body (Winstanley et al. 2016; Moradali et al. 2017).  P. aeruginosa has always posed the 
most threat to immunocompromised individuals with HIV, type II diabetes, or cystic fibrosis 
(Bahemia et al. 2015; Winstanley et al. 2016; Stefani et al. 2017).  P. aeruginosa is the leading 
cause of morbidity and mortality in people with cystic fibrosis (Salunkhe et al. 2005).  However, 
over time P. aeruginosa infections are becoming more difficult to treat as the bacteria become 
more resistant to antibiotics, specifically carbapenem-resistant strains (Woodworth et al. 2018).  
New tactics for treating P. aeruginosa acute and chronic infections are necessary for increasing 
the quality of life for people susceptible to this pathogen.   
 Because P. aeruginosa has become resistant to multiple antibiotics and adapts to newly 
developed antibiotics, researchers have started looking for alternative means to clear bacterial 
infections.  In the case with uropathogenic E. coli (UPEC) the Hultgren lab has investigated 
crippling the pathogen by targeting the Fim pathway (Chorell et al. 2012).  This group has 
generated a compound called a pilicide that outcompetes the affinity for UPEC to bind host and 
instead inactivates the attachment mechanism clearing the pathogen from the bladder (Chorell et 
al. 2012; Greene et al. 2014).  Similar work is occurring with P. aeruginosa.  Multiple groups are 
investigating virulence targets of P. aeruginosa like: inhibiting the quorum sensing system, 
disrupting biofilms, and interfering with two component systems and adhesins (Fothergill et al. 
2014).  Antivirulence studies require understanding of genetic regulation and regulation of 
virulence factors in order to compromise the infectious pathogen.  This work investigates the 
multifactorial components of virulence factor regulation in both acute and chronic infections of 
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P. aeruginosa.  The regulation of the post-transcriptional regulator, rsmA, by two known 
regulators of virulence AlgU and AlgR, the RsmA regulon of virulence targets in the mucoid 
background, and the role of minor pilins of the type IV pili in regulating the algZ/R two-
component system.   
 RsmA has mainly been studied in nonmucoid strains of P. aeruginosa like PAO1 and 
PAK (Burrowes et al. 2006; Brencic and Lory 2009).  RsmA is studied in this background 
because RsmA has always been assumed to regulate virulence factors associated with 
establishing infections and repressing virulence factors known to be expressed in a chronic 
infection (Lapouge, Schubert, et al. 2007; Valentini et al. 2018).  With a P. aeruginosa infection 
in the cystic fibrosis lung, the bacteria face osmotic stress from reactive oxygen and nitrogen 
species (ROS and RNS) from the host immune system (Palmer et al. 2015).  This immune cell 
assault causes the release of the extracytoplasmic sigma factor, AlgU, which then activates the 
expression of its regulon(Schnider-Keel et al. 2001).  The most well known AlgU directed target 
is the alginate operon that produces a copious amount of exopolysaccharide (Hershberger et al. 
1995).  The alginate biofilm can protect P. aeruginosa from ROS and RNS, phagocytosis, and 
antibiotics (Firoved et al. 2002).  The overproduction of alginate allows for P. aeruginosa to 
persist in the cystic fibrosis lung and develop into a chronic infection.  The most common 
phenotype isolated from cystic fibrosis chronic infections are alginate overproducers of P. 
aeruginosa (Boucher et al. 2000; Winstanley et al. 2016).   
 Interestingly we identified a predicted AlgU consensus sequence upstream of the 
previously identified RpoD promoter for rsmA (Stacey and Pritchett 2016).  This work went 
against the paradigm that RsmA only had a role in regulating acute virulence factors and RsmA 
activity was repressed by the small RNA antagonists RsmY and RsmZ in later phases of growth 
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(Brencic and Lory 2009).  We showed that there was more RsmA present in a mucoid mutant of 
PAO1, mucA22 and the mucoid cystic fibrosis isolate, 2192.  The increase in RsmA was a result 
of AlgU activity in these mucoid strains.  AlgU’s role was confirmed via site directed mutation 
of the -35 consensus sequence and deletion of the algU allele.  While there was no direct 
interaction demonstrated between AlgU and this promoter, an electromobility shift assay to show 
protein-DNA interaction or interferometry between AlgU and RpoS to identify which sigma 
factor has a greater affinity of the distal rsmA promoter.  However, this discovery proved that 
RsmA has a role in mucoid strains and still contributes to virulence factor regulation in chronic 
infection strains.   
 In mucoid strains, AlgU is known to work in concert with the response regulator AlgR.  
Together they are known as the alginate regulators and contribute to expression of the algD 
operon that produces alginate (Salunkhe et al. 2005).  Our next study investigated if this co-
regulation occurred on the distal rsmA promoter.  Bioinformatics showed two possible AlgR 
binding sites upstream of the AlgU binding sites.  An algR mutant mucA22 showed decreases in 
RsmA levels and increases in RsmA targets hcnA and tssA1.  AlgR was shown to directly bind 
this distal rsmA promoter and both AlgR binding sites were required, a common feature of AlgR 
(Morici et al. 2007; Okkotsu et al. 2013).  AlgR also binds the rsmA promoter independent of 
phosphorylation, further arguing this is a mucoid strain phenomenon.  To reiterate not only is 
there more RsmA in mucoid strains but the increase is due to the alginate regulators, AlgU and 
AlgR.  These works demonstrated a new dimension to RsmA in P. aeruginosa virulence 
regulation and had importance in relation to pathogenesis in cystic fibrosis where the alginate 
regulators give way to chronic infections.   
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 The RsmA regulon has been studied in PAO1 and PAK by using global transcriptome 
experiments (Burrowes et al. 2006; Brencic and Lory 2009).  These strains are nonmucoid and 
are used as acute infection model strains.  These studies found that RsmA positively influences 
motility genes for flagellum synthesis and type IV pili, alginate and biofilm production, and the 
type III secretion system (Burrowes et al. 2006; Brencic and Lory 2009).  These virulence factors 
are used by P. aeruginosa for establishing an infection and creating a niche inside the host.  
RsmA was also found to repress the type VI secretion system, a multidrug efflux pump system, 
and genes involved in iron regulation(Burrowes et al. 2006; Brencic and Lory 2009).   These 
virulence factors are commonly found expressed in chronic infecting strains of P. aeruginosa, 
where the bacteria have to dominate other pathogens and acquire the valuable nutrient iron.  It is 
easy to see why RsmA would be associated with initiating a P. aeruginosa infection and be 
repressed in the chronic infection phase of growth.   
 However, due to the fact that RsmA is in abundance in mucoid strains, the RsmA regulon 
is more complex than believed.  Our proteomic approach of studying the RsmA regulon was 
more indicative of whether or not translation had occurred versus the transcriptome approach.  
The transcriptome approach will give better results to repressed targets, which will show 
increases in fold change, while targets positively influenced by RsmA are potentially indirect.  In 
our iTRAQ study, we identified similar targets that were repressed by RsmA like hcp1.  
However, some of our targets also differed in previously reported results.  AlgD , the protein 
regulated by AlgU and AlgR which generates alginate, was increased in the mucA22 rsmA strain 
while the rsmA mutant was reported to show a -3 fold change compared to wildtype (Burrowes et 
al. 2006).  Lastly, our study identified previously unknown targets.   We were able to confirm a 
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direct interaction with the P. aeruginosa small protease, PasP.  We can now argue that not only 
 
is RsmA important in the P. aeruginosa chronic infection, but it regulates multiple virulence 
factors not previously known (Figure 6.1).  This work has opened a door for further 
 
 
Figure 6.1 Schematic of RsmA production in nonmucoid (PAO1) and mucoid 
(mucA22) strains of Pseudomonas aeruginosa.  In mucoid strains, the alginate 
regulators, AlgU and AlgR, activate the distal promoter of rsmA, which causes 
an increase in RsmA levels in this background.  In the mucoid background, 
there is a previously unidentified target, the P. aeruginosa small protease, pasP.   
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understanding of the RsmA regulon and its role in infecting the cystic fibrosis lung, which has 
potential to lead to antivirulence drug targets. 
 Like CsrA in E. coli, RsmA has potential to positively interact with some of the products 
that were repressed in the mucA22 rsmA strain (Wei et al. 2001).  Using m-fold predictive 
software, alignments of known targets and these RsmA “positive targets” could show the 
possibility of the AGGA stem-loop motif.  These positive targets that present the RsmA binding 
motif would then be tested with purified RsmA.  P. aeruginosa RsmA has never been shown to 
interact with other proteins too, unlike CsrA in Campylobacter jejuni and Bacillus subtillis 
(Mukherjee et al. 2011; Dugar et al. 2016).  The interaction between CsrA and mRNA positively 
influences motility, which RsmA is known to contribute to also.  To identify possible protein-
protein interactions of RsmA a simple bait-prey experiment with the bacterial adenylate cyclase 
two-hybrid system could be performed.  The most important experiment to be performed to 
understand RsmA in mucoid strains is in vivo experiments.  Because RsmA influencing virulence 
factor regulation in mucoid strains is still relatively new, the mucA22 rsmA strain should be 
screened in a higher organism than C. elegans or macrophages.  If the mucA22 rsmA strain were 
attenuated in a respiratory infection in a mouse, rat, or cystic fibrosis mouse, then an 
antimicrobial compound targeting RsmA would be of the utmost importance in clearing P. 
aeruginosa infections.   
 Another important vulnerability in P. aeruginosa is the type IV pili.  Pili are commonly 
used for attachment, motility, mechanosensory mechanisms(Giltner et al. 2010; Luo et al. 2015).   
More recently they have been used as antivirulence targets (Greene et al. 2014; Novotny et al. 
2017).  This work examines the effects of P. aeruginosa with deficient type IV pili. If a single 
minor pilin protein is missing, the whole type IV pili is malformed and twitching and sensing are 
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no longer efficient (Giltner et al. 2010).  It has also been reported that if one of the four 
important minor pilins, PilVWXY1, are missing, then this complex cannot interact with AlgZ 
(Marko et al. 2017).  In a pilW mutant we showed increase AlgZ/R levels, and decreased 
virulence factor production. More work is still required to show a direct interaction of AlgR with 
the algZ promoter region and confirm the autoregulation effect.  But there is major potential for a 
pilicide compound to disrupt the of the type IV pili and send the AlgZ/R system into overdrive, 
decrease virulence, and limit the ability for P. aeruginosa to establish an infection (Figure 6.2).   
 AlgR has been studied ad nauseam but there are still global experiments yet to be 
performed.  While CHIP-SEQ has been performed with AlgR to identify targets as well as 
microarrays, no one has elucidated the difference between the AlgR regulon dependent and 
independent of phosphorylation(Lizewski et al. 2004; Kong et al. 2015).  Many researchers have 
used phosphodeficient and phosphomimetic forms of AlgR, AlgRD54A or N and AlgRD54E, 
however, we know these strains present phenotypically correct, but western blot analysis shows 
lower levels of AlgR present (data not shown).  Using iTRAQ with a pilW mutant strain, which 
 
Figure 6.2 The role of the response regulator, AlgR, in colonizing and establishing an 
infection in Pseudomonas aeruginosa.  Phosphorylated AlgR is extremely important in 
virulence factor production.   By deleting the minor pilin protein, PilW, this process is 
interrupted due to the lack of surface sensing capabilities in the type IV pili. 
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we have shown has more AlgZ/R, would be a better strain to identify AlgR targets dependent of 
phosphorylation.  Understanding the phospho-dependent targets of AlgR could lead to more 
virulence targets to combine with a minor pilin target and generate a multivalent vaccine.  
Therefore never allowing the P. aeruginosa strain to initiate an infection in the human host.   
 Overall, this work was to investigate virulence regulation in P. aeruginosa by a variety of 
factors.  Genetic regulation is multifactorial in terms of sigma factors, response regulators, post-
transcriptional regulation, and external sensing systems.  By understanding regulation of 
virulence factors in P. aeruginosa are regulated and visualizing these complex networks, 
researchers can provide the individuals susceptible to this opportunistic pathogen a little more 
hope with advanced treatments and preventative measures and less morbidity and mortality. 
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